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ABSTRACT	  
	   Here	  we	   describe	   the	   characterization	   of	   a	   novel	   Foxg1-­‐GOF	  model	  we	   created	   to	  
dissect	   the	   role	   of	   Foxg1	   in	   postmitotic	   neuronal	   differentiation	   and	   reconstruct	  
pathogenetic	  mechanisms	  which	  underlie	  the	  FOXG1	  duplication-­‐linked	  West	  syndrome.	  This	  
is	   a	   devastating	   neurological	   disorder,	   triggered	   by	   a	   complex	   variety	   of	   pathogenic	  
conditions.	   It	   is	   characterized	   by	   infantile	   spasms,	   abnormal	   EEG	  with	   hypsarrhytmia	   and	  
seizures	   and	   dramatic	   cognitive	   impairment.	   For	   it	   only	   symptomatic	   treatments	   are	  
presently	  available.	  
	   As	  expected,	   these	  Foxg1-­‐GOF	  mice	   showed	   increased	  neuronal	  activity	   in	  baseline	  
conditions	  and	  were	  more	  prone	  to	  limbic	  motor	  seizures	  upon	  kainic	  acid	  administration.	  
	   A	   preliminary	   developmental	   profiling	   of	   their	   cerebral	   cortex	   unveiled	   four	  major	  
histogenetic	  anomalies,	  likely	  contributing	  to	  their	  hyperexcitability.	  These	  anomalies	  were:	  
(1)	  an	  altered	  neocortical	   laminar	  blueprint	  with	   impaired	   layer	  VI/layer	  V	  segregation	  and	  
defective	  activation	  of	  layer	  IV-­‐II	  programs;	  (2)	  a	  substantial	  reduction	  of	  PV+	  interneurons;	  
(3)	  a	  patterned,	  area-­‐	  and	  lamina-­‐specific	  astrocyte	  deprivation;	  (4)	  a	  defective	  expression	  of	  
the	  Gabra1	  receptor	  subunit.	  Similar	  phenomena	  might	  concur	  to	  neurological	  anomalies	  of	  
West	  syndrome	  patients	  harboring	  FOXG1	  duplications.	  
	   A	  parallel	  in	  vitro	  study,	  run	  on	  dissociated	  cortico-­‐cerebral	  cultures,	  revealed	  that	  a	  
substantial	   Foxg1	   upregulation	   occurred	   upon	   delivery	   of	   depolarizing	   stimuli.	   Neuronal,	  
activity-­‐linked	   Foxg1	   elevation	   required	   the	   presence	   of	   astrocytes.	   Activity-­‐linked	   Foxg1	  
fluctuations	  were	   inter-­‐twinned	  with	   immediate-­‐early	  genes	  fluctuations	  and	  depended	  on	  
them,	   according	   to	   distinct,	   neuron-­‐	   and	   astrocyte-­‐specific	   patterns.	   In	   West	   syndrome	  
patients	  with	   augmented	   FOXG1	   dosage,	   a	   FOXG1-­‐mRNA	   increase	   evoked	   by	   depolarizing	  
stimuli	  might	  ignite	  a	  vicious	  circle,	  exacerbating	  neuronal	  hyperactivity	  and	  contributing	  to	  








1.	  INTRODUCTION	  .	   .	   .	   .	   .	   .	   .	   .	   .	   1	  	  
1.1	  Neocortex	  development.	  .	   .	   .	   .	   .	   .	   .	   .	   1	  
1.2	  Origin	  of	  glutamatergic	  and	  gabaergic	  neurons.	  .	   .	   .	   .	   .	   6	  	  
1.3	  Astrogenesis.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   11	  	  
1.4	  Astrocyte	  modulation	  of	  neuronal	  excitability.	   .	   .	   .	   .	   .	   15	  	  
Astrocyte	  buffering	  of	  extracellular	  K+.	   .	   .	   .	   .	   .	   16	  
Glutamate	  uptake.	   .	   .	   .	   .	   .	   .	   .	   .	   16	  	  
Glutamate	  release.	   .	   .	   .	   .	   .	   .	   .	   .	   17	  
Release	  of	  metabolic	  intermediates.	  .	   .	   .	   .	   .	   .	   17	  
1.5	  Foxg1	  gene,	  structure	  and	  function.	   .	   .	   .	   .	   .	   .	   18	  	  
1.6	  Foxg1	  in	  the	  telencephalic	  patterning.	   .	   .	   .	   .	   .	   .	   19	  
Rostro-­‐caudal	  specification.	   .	   .	   .	   .	   .	   .	   .	   20	  
Dorso-­‐ventral	  specification.	   .	   .	   .	   .	   .	   .	   .	   21	  	  
1.7	  Foxg1	  in	  cortical	  arealization.	   .	   .	   .	   .	   .	   .	   .	   23	  	  
1.8	  Foxg1	  in	  cortical	  precursors	  kinetics.	   .	   .	   .	   .	   .	   .	   24	  	  
1.9	  Foxg1	  in	  the	  migration	  of	  pyramidal	  neurons.	   .	   .	   .	   .	   .	   26	  	  
1.10	  Foxg1	  and	  neuronal	  differentiation.	   .	   .	   .	   .	   .	   .	   28	  	  
1.11	  Foxg1	  in	  astrogenesis	  control	  .	   .	   .	   .	   .	   .	   .	   .	   30	  
1.12	  West	  Syndrome	  (WS).	   .	   .	   .	   .	   .	   .	   .	   .	   30	  	  
Epidemiology.	  .	   .	   .	   .	   .	   .	   .	   .	   .	   31	  
Clinical	  manifestation.	   .	   .	   .	   .	   .	   .	   .	   31	  
Etiology.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   32	  
1.13	  Relationship	  between	  WS	  and	  FOXG1.	  .	   .	   .	   .	   .	   .	   33	  	  
2	  AIM	  OF	  THE	  WORK.	   .	   .	   .	   .	   .	   .	   .	   .	   35	  	  
3	  MATERIAL	  AND	  METHODS.	   .	   .	   .	   .	   .	   .	   .	   36	  	  
3.1	  Mouse	  handling.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   36	  	  
	   iii	  
3.2	  Validation	  of	  Foxg1-­‐GOF	  transgenic	  line	  "E"	  in	  vitro.	   .	   .	   .	   .	   36	  	  
3.3	  Primary,	  neuronal,	  astroglial	  and	  mixed	  cultures.	   .	   .	   .	   .	   37	  	  
	  3.3.1	  Cortico-­‐cerebral	  neuronal	  and	  mixed	  cultures.	   .	   .	   .	   .	   37	  	  
3.3.2	  Astroglial	  cultures.	   .	   .	   .	   .	   .	   .	   .	   .	   38	  	  
3.4	  Lentiviral	  production	  and	  titration.	   .	   .	   .	   .	   .	   .	   39	  
3.5	  Lentiviral	  plasmids	  constructions.	   .	   .	   .	   .	   .	   .	   39	  	  
3.6	  Quantitative	  RT-­‐PCR.	   .	   .	   .	   .	   .	   .	   .	   .	   42	  	  
3.7	  Immunofluorescence.	   .	   .	   .	   .	   .	   .	   .	   .	   45	  	  
3.8	  Images	  acquisitions.	   .	   .	   .	   .	   .	   .	   .	   .	   46	  	  
3.9	  EEG	  recordings.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   46	  	  
3.10	  Behavioral	  analysis,	  kainate-­‐evoked	  seizures.	   .	   .	   .	   .	   .	   47	  	  
3.11	  Statistical	  analysis.	   .	   .	   .	   .	   .	   .	   .	   .	   48	  	  
4	  RESULTS.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   .	   49	  	  
4.1	  Generation	  and	  preliminary	  characterization	  of	  Foxg1-­‐GOF	  mutant	  mice.	   .	   49	  	  
4.2	  Analysis	  of	  the	  Foxg1-­‐GOF	  transgene	  expression	  profile.	   .	   .	   .	   51	  	  
4.3	  Assaying	  neuronal	  excitability	  of	  Foxg1-­‐GOF	  mutants.	   .	   .	   .	   .	   59	  	  
4.4	  Putative	  mechanisms	  underlying	  neuronal	  hyperexcitability:	  abnormal	  neuronal	  
histogenesis	  and	  differentiation.	   .	   .	   .	   .	   .	   .	   .	   63	  	  
4.5	  Putative	  mechanisms	  underlying	  neuronal	  hyperexcitability:	  defective	  astrogenesis.	  68	  	  
4.6	  Putative	  mechanisms	  underlying	  neuronal	  hyperexcitability:	  activity-­‐linked	  Foxg1-­‐
modulation.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   .	   71	  	  
5	  DISCUSSION.	   .	   .	   .	   .	   .	   .	   .	   .	   .	   78	  	  
5.1	  A	  synopsis	  of	  major	  findings.	   .	   .	   .	   .	   .	   .	   .	   78	  	  
5.2	  Generation	  of	  Foxg1	  gain-­‐of-­‐function	  mouse	  models.	   .	   .	   .	   .	   79	  	  
5.3	  Hyperexcitability	  of	  Foxg1-­‐GOF	  mice.	   .	   .	   .	   .	   .	   .	   80	  	  
5.4	  Histogenetic	  disorders	  underlying	  Foxg1-­‐GOF	  mice	  hyperexcitability.	  .	   .	   81	  	  
5.5	  Activity-­‐dependent	  Foxg1	  regulation.	   .	   .	   .	   .	   .	   .	   83	  	  
6	  SUPPLEMENTARY	  MATERIAL.	   .	   .	   .	   .	   .	   .	   85	  	  
7	  ACKNOWLEDGEMENTS.	   .	   .	   .	   .	   .	   .	   .	   86	  	  
	   iv	  










1.1 Neocortex	  development	  
	  
The	  neocortex	  is	  a	  telencephalic	  structure	  unique	  to	  mammals.	  It	  is	  the	  largest	  region	  
of	   the	   cerebral	   cortex,	   positioned	   between	   two	   other	   regions,	   the	   archicortex	   (midline	  
cortex	   and	   hippocampus)	   and	   paleocortex	   (olfactory	   piriform	   cortex);	   the	   neocortex	   has	  
undergone	  the	  most	  considerable	  phylogenetic	  expansion	  and	  specialization	  (Doetsch	  et	  al.,	  
1999);(Krubitzer	   and	   Kaas,	   2005).	   It	   is	   also	   the	   most	   highly	   differentiated	   region	   of	   the	  
cerebral	   cortex,	   having	   a	   laminar	   patterning	   characterized	   by	   six	   layers	   in	   its	   radial	  
dimension	  (morphologically	  and	  connectionally	  distinct)	  while,	  in	  its	  tangential	  dimension,	  it	  
is	   subdivided	   in	   “areas“	   (i.e.	   functional	   subdivisions	   distinguished	   by	   differences	   in	  
cytoarchitecture,	  connections	  and	  gene	  pattern	  expression)	   (O’Leary	  and	  Nakagawa,	  2002;	  
O’Leary	  et	  al.,	  2007;	  Rash	  and	  Grove,	  2006;	  Sur	  and	  Rubenstein,	  2005).	  	  	  	  	  
The	   increase	   in	   the	   neocortical	   size	   and	   complexity	   is	   due	   to	   a	   rapid	   expanding	  
diversity	  of	  neuronal	  and	  glial	  subtypes	  (Edlund	  and	  Jessell,	  1999);(Ramon	  y	  Cajal,	  1995).	  	  
Initially,	   the	  neocortex	   is	  composed	  of	  a	   thin	  neuroepithelium	   lining	   the	  dorsal	  wall	  of	   the	  
lateral	  ventricles,	  called	  the	  ventricular	  zone	  (VZ).	  As	  neurogenesis	  proceeds,	  an	  additional	  
proliferative	  layer	  superficial	  to	  the	  VZ	  will	  form	  the	  subventricular	  zone	  (SVZ).	  
The	  first	  postmitotic	  neurons	  will	  accumulate	  on	  the	  top	  of	  the	  VZ,	  forming	  the	  preplate	  (PP)	  
that	   is	   positioned	   just	   beneath	   the	   pial	   surface.	   Subsequently	   generated	   neurons	   will	  
migrate	  along	  radial	  glia,	  aggregating	  within	  the	  PP,	  and	  forming	  the	  cortical	  plate	  (CP)	  which	  
will	  split	  the	  PP	  into	  a	  superficial	  marginal	  zone	  (MZ)	  and	  a	  deep	  subplate	  (SP).	  	  The	  CP	  will	  
develop	  between	  these	  two	  layers	  and	  will	  become	  the	  multilayered	  neocortex	  in	  an	  “inside-­‐
out	   fashion”,	  so	  that	  early-­‐born	  neurons	  populate	  deeper	  neocortical	   layers	   (layer	  VI,	   then	  
layer	  V),	  and	  late-­‐born	  neurons	  migrate	  past	  them	  to	  progressively	  populate	  more	  superficial	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In	   mice,	   this	   process	   starts	   at	   embryonic	   day	   9.5	   (E9.5)	   with	   the	   proliferation	   of	  
neuroepithelial	  cells	  that	  undergo	  symmetric	  cell	  divisions	  to	  expand	  the	  pool	  of	  multipotent	  
progenitors	   as	   well	   as	   a	   smaller	   percentage	   of	   asymmetric	   cell	   divisions	   to	   generate	   the	  
earliest	  born	  neurons.	  (Chenn	  and	  McConnell,	  1995;	  Götz	  and	  Huttner,	  2005;	  Smart,	  1973).	  
As	   the	   developing	   cortical	   epithelium	   thickens,	   neuroepithelial	   cells	   elongate	   and	  




that	  extends	  from	  the	  ventricular	  wall	  to	  the	  pial	  surface,	  having	  thus	  a	  crucial	  role	  in	  guiding	  
neurons	   to	   their	   final	   locations	   in	   the	   cortical	   plate,	   by	   serving	   as	   a	  migratory	   scaffolding	  
(Rakic,	   1972,	   2003).	   Moreover,	   radial	   glia	   function	   also	   as	   progenitors	   that	   make	   more	  
contributions	  to	  cortical	  neurogenesis	  by	  generating	  neurons	  directly	  in	  the	  VZ,	  or	  indirectly	  
through	   the	   production	   of	   proliferating	   intermediate	   progenitors	   (Anthony	   et	   al.,	   2004;	  
Malatesta	  et	  al.,	  2000;	  Miyata	  et	  al.,	  2004;	  Noctor	  et	  al.,	  2001).	  	  
Intermediate	   progenitors	   (also	   known	   as	   basal	   progenitors	   because	   they	   divide	  
without	   touching	   the	   apical	   surface)	   are	   the	   other	   major	   type	   of	   neuron-­‐producing	  
progenitor.	   They	   act	   primarily	   as	   transit-­‐amplifying	   cells,	   undergoing	   limited	   proliferative	  
divisions	  and	  more	  often	  dividing	  symmetrically	  to	  produce	  two	  neurons	  (Haubensak	  et	  al.,	  
2004;	   Kowalczyk	   et	   al.,	   2009;	  Noctor	   et	   al.,	   2004).	   They	   are	   located	   in	   the	   SVZ	   and	   in	   the	  
basal	  VZ	  early	  in	  neurogenesis	  before	  SVZ	  forms.	  The	  SVZ	  begins	  to	  form	  at	  E13.5	  in	  mice	  and	  
increases	   significantly	   during	   late	   corticogenesis	   (Smart,	   1982).	   The	   SVZ	   has	   further	  
expanded	   in	   primates	   giving	   rise	   to	   an	   inner	   and	   an	   outer	   SVZ,	   whose	   progenitors	   are	  
distinct.	  Inner	  SVZ	  progenitors	  resemble	  rodent	  SVZ	  intermediate	  progenitors,	  while	  primate	  
outer	   SVZ	   progenitors	   are	   more	   similar	   to	   radial	   glial	   cells,	   both	   in	   morphology	   and	  
molecular	   identity.	   Moreover,	   the	   radial	   glial-­‐like	   progenitors	   of	   the	   OSVZ	   are	   able	   to	  
undergo	   symmetric	   (self-­‐renewing),	   as	  well	   as	   asymmetric	   (neurogenic	   and	   self-­‐renewing)	  
divisions,	   thus	   generating	   progenitors	   that	   can	   further	   proliferate.	   This	   latter	   capacity	   of	  
OSVZ	  progenitors	  enhances	  neuronal	  output	  and	  represents	  an	  important	  evolutionary	  step	  
in	  the	  expansion	  of	  the	  neocortex	  (Fietz	  and	  Huttner,	  2011;	  Hansen	  et	  al.,	  2010;	  Smart	  et	  al.,	  
2002)(Fig.1.2).	  
Another	   class	   of	   progenitors	   are	   the	   short	   neural	   precursors.	   They	   appear	   to	   be	  
similar	   to	   intermediate	  progenitors,	   suggesting	   that	   they	  might	  be	   radial	  glia	   that	   is	   in	   the	  






	  	  Fig.1.2	  Comparison	  of	  germinal	  zones	  in	  rodent	  and	  primates	  embryonic	  neocortex	  during	  midneurogenesis	  	  	  	  
	  	  (mouse	  E13.5;	  Human	  8.5GW)	  
	  	  Adapted	  from	  (Tyler	  and	  Haydar,	  2010)	  
	  
	  
Given	   the	   heterogeneity	   of	   progenitor	   types	   and	   their	   different	   locations	   it	   is	   not	  
clear	  how	  the	  balance	  of	  extrinsic	  and	  intrinsic	  signals	  combines	  to	  determine	  neuronal	  fate.	  
The	  common	  view	  about	   layer-­‐specific	  production	   is	   that	  progenitor	   cells,	   after	   successive	  
rounds	  of	  asymmetric	  cell	  division,	  progressively	  restrict	  their	  competence	  producing	  at	  first	  
deep	   layer	   neurons	   (DL	   neurons)	   and	   then	   upper	   layer	   neurons	   (UL	   neurons)	   (Desai	   and	  
McConnell,	  2000;	  Frantz	  and	  McConnell,	  1996).	  	  
More	   recently,	   new	   studies	   have	   discovered	   UL	   fate-­‐committed	   early	   progenitors,	  
which	  raise	  an	  alternative	  view	  regarding	  the	   lineage	  relation	  between	  DL	  and	  UL	  neurons	  
(Franco	   et	   al.,	   2012)	   Besides,	   genetic	   studies	   have	   shown	   that	   a	   closed	   transcriptional	  
network	   is	   responsible	   to	   establish	   segregation	   among	   the	   principal	   layer	   subtypes	   of	   the	  
cerebral	   cortex.	   In	  particular,	   the	   cross-­‐repression	   among	   four	   transcription	   factors	   (TFs)	   -­‐	  
Fezf2,	   Ctip2,	   Satb2,	   and	   Tbr1-­‐	   is	   sufficient	   to	   establish	   the	   subcerebral,	   intracortical,	   and	  
cortico-­‐thalamic	   projection	   identities	  within	   the	   postmitotic	   neurons	   (Alcamo	   et	   al.,	   2008;	  




al.,	   2012).	   UL	   competence	   is	   tightly	   linked	   to	   DL	   neurogenesis	   and	   this	   sequence	   of	   layer	  














	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Fig.1.3	  Schematic	  model	  of	  identified	  genetic	  interactions	  between	  the	  layer-­‐subtype	  TFs.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Adapted	  from	  (Toma	  et	  al.,	  2014)	  
	  
	  
A	   continued	   repression	  of	  Tbr1,	   expressed	   in	   the	  majority	  of	   early-­‐born	  neurons	   including	  
preplate	   Cajal	   Retzius	   cells	   and	   subplate	   (SP)	   neurons	   (Hevner	   et	   al.,	   2001),	   favors	   the	  
acquisition	  of	  Fezf2	  DL	  neuron	  identity.	  Moreover,	  the	  subsequent	  transition	  from	  DL	  to	  UL	  
competence	  requires	   the	  repression	  of	  DL	  determinants	   to	   terminate	  DL	  competence.	  The	  
onset	   of	   UL	   competence	   is	   achieved	   thanks	   to	   negative	   feedback	   propagated	   from	  
postmitotic	  DL	  neurons	  (Toma	  et	  al.,	  2014).	  	  
Cortical	  neurogenesis	  is	  essentially	  completed	  during	  the	  embryonic	  period,	  followed	  








1.2	  Origin	  of	  glutamatergic	  and	  gabaergic	  neurons	  
	  
Two	  broad	  classes	  of	  neurons	  populate	   the	  neocortex:	   interneurons	  and	  projection	  
neurons.	  Projection	  neurons	  are	  excitatory	  glutamatergic	  neurons	  characterized	  by	  a	  typical	  
pyramidal	   morphology	   and	   extend	   their	   axons	   to	   distant	   intracortical,	   subcortical	   and	  
subcerebral	   targets	   in	   order	   to	   transmit	   information	   from	   the	   neocortex	   to	   other	   cortical	  
areas.	   By	   contrast,	   GABA	   (ϒ-­‐aminobutyric	   acid)-­‐containing	   interneurons	   are	   nonpyramidal	  
neurons,	  which	  connect	  locally	  within	  the	  neocortex	  and	  are	  largely	  inhibitory	  (Molyneaux	  et	  
al.,	   2007).	   During	   development,	   they	   are	   generated	   by	   different	   progenitor	   zones.	  
Interneurons	   are	   generated	   by	   progenitors	   in	   the	   ventral	   (subpallial)	   telencephalon	   and	  
migrate	   tangentially	   over	   long	   distances	   to	   reach	   their	   final	   position	  within	   the	   neocortex	  
(Wonders	  and	  Anderson,	  2006);	  projection	  neurons	  are	  generated	  from	  progenitors	  of	   the	  
neocortical	  germinal	  zone	  located	  in	  the	  dorsolateral	  (pallial)	  wall	  of	  the	  telencephalon	  and	  
migrate	  radially	  to	  their	  final	  neocortical	  position	  (Anderson	  et	  al.,	  2002;	  Gorski	  et	  al.,	  2002;	  
Leone	  et	  al.,	  2008;	  Molyneaux	  et	  al.,	  2007;	  Rakic,	  1972).	  
Upon	  induction	  by	  gradients	  of	  different	  signalling	  molecules	  such	  as	  sonic	  hedgehog	  
(Shh),	  fibroblast	  growth	  factor	  (Fgf)	  and	  bone	  morphogenetic	  proteins	  (BMP),	  the	  interplay	  
between	   different	   transcription	   factor	   genes	   will	   lead	   to	   the	   progressive	   specification	   of	  
projection	   neurons.	   These	   include	   LIM	   homeobox	   2	   (Lhx2),	   Foxg1,	   empty	   spiracles	  
homologue	  2	  (Emx2)	  and	  paired	  box	  6	  (Pax6).	  These	  TFs	  have	  crucial	  roles	  in	  in	  establish	  the	  
neocortical	   progenitor	   domain	   by	   repressing	   dorsal	  midline	   (Lhx2	   and	   Foxg1)	   and	   ventral	  
(Emx2	  and	  Pax6)	  fates.	  	  
Within	   the	  mature	   neocortex,	   there	   are	   distinct	   populations	   of	   projection	   neurons	  
located	  in	  different	  cortical	   layers	  and	  areas,	  with	  unique	  morphological	  features	  and	  gene	  
expression	  and	  ultimately	  serving	  different	  functions.	  Projection	  neurons	  can	  be	  divided	  into	  
three	   broad	   types	   according	   to	   whether	   they	   extend	   axons	   within	   a	   single	   cortical	  
hemisphere	   (associative	   projection	   neurons),	   across	   the	   midline	   to	   the	   contralateral	  
hemisphere	   (commissural	   projection	   neurons),	   or	   away	   from	   the	   cortex	   (corticofugal	  







	  Fig.1.4	  Projection	  neuron	  diversity	  in	  the	  cerebral	  cortex	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Modified	  from	  (Greig	  et	  al.,	  2013)	  	  
	  
Axons	   from	   commissural	   projection	   neurons	   cross	   the	  midline	   through	   the	   corpus	  
callosum	   (CC).	   These	   neurons	   are	   called	   callosal	   projection	   neurons	   (CPNs).	   Axons	   from	   a	  
smaller	   population	   of	   these	   neurons	   cross	   through	   the	   anterior	   commissure.	   CPNs	   reside	  
mainly	   in	   layer	   II/III,	   with	   fewer	   residing	   in	   layers	   V	   and	   VI,	   all	   of	   them	   enabling	   bilateral	  
integration	   of	   information	   by	   extending	   axons	   to	   mirror-­‐image	   locations	   in	   the	   same	  
functional	  area	  of	  the	  contralateral	  hemisphere.	  
Associative	  projection	  neurons	  are	  present	  in	  all	  cortical	  layers.	  They	  include:	  
• Short-­‐distance	   intrahemispheric	   projection	   neurons,	   which	   extend	   axons	   within	   a	  
single	  cortical	  column	  or	  to	  the	  nearby	  cortical	  columns.	  
• Long-­‐distance	   intrahemispheric	  projection	  neurons,	  which	  extend	  axons	  to	  adjacent	  
or	  distant	  cortical	  areas.	  	  
Corticofugal	  projection	  neurons	   include	  corticothalamic	  projection	  neurons	  (CThPN),	  which	  
reside	   in	   layer	  VI	   and	  extend	  axons	   to	   specific	   thalamic	  nuclei,	   and	   subcerebral	  projection	  
neurons	  (SCPN),	  which	  reside	  in	  layer	  V	  and	  extend	  axons	  to	  different	  primary	  targets	  in	  the	  
brainstem	  and	  spinal	  cord.	  	  
	  
As	   for	   interneurons,	   they	  account	   for	  about	  20%	  of	  all	   cortical	  neurons.	  They	  were	  
described	  firstly	  	  by	  Ramon	  y	  Cajal	  as	  ”cells	  with	  short	  axons”	  (locally	  projecting	  axon),	  aspiny	  
or	   sparsely	   spiny	   dendrites	   and	   with	   a	   cell	   soma	   smaller	   than	   most	   cortical	   pyramidal	  
neurons.	  They	  are	  across	  all	  cortical	  layers	  and	  establish	  unique	  connections	  with	  excitatory	  
and	   inhibitory	   cells	   in	   their	   vicinity.	   Some	   of	   them	   extend	   horizontal	   or	   vertical	   axon	  




Many	  efforts	  have	  been	  made	  to	  classify	  them	  and	  are	  still	  underway,	  but	  are	  complicated	  
because	  of	   their	   variability	   in	  morphology,	   connectivity,	  neurochemistry	  and	  expression	  of	  
ion/physiology	  channel	  (Markram	  et	  al.,	  2004).	  	  
	  
Cortical	   interneurons	  originate	  within	  different	  regions	  of	  the	  ventral	  telencephalon	  
over	  a	  period	  of	  time	  that	  spans	  from	  embryonic	  day	  E9.0	  until	  birth.	   In	  particular,	  most	   if	  
not	  all	  cortical	  interneurons	  arise	  from	  the	  ventral	  ganglionic	  eminences,	  namely,	  the	  medial	  
ganglionic	   eminence	   (MGE)	   and	   the	   caudal	   ganglionic	   eminence	   (CGE)	   (Ang	   et	   al.,	   2003;	  
Marín	   and	   Rubenstein,	   2003;	   Nery	   et	   al.,	   2002).	   These	   ganglionic	   eminences	   arise	   in	   a	  
discrete	   temporal	   order	   with	   the	   ’earlier-­‐generated	   ventral	   eminence’	   named	   MGE	  
appearing	  at	   the	   telencephalic-­‐diencephalic	   junction,	   followed	  by	  a	   ‘later	  appearing	  dorsal	  
eminence’,	   later	  named	   the	   lateral	   ganglionic	  eminence	   (LGE)	   (Smart,	  1976).	  The	  CGE	  was	  
proposed	  more	  recently	  as	  a	  discrete	  entity,	  being	  defined	  as	  the	  eminence	  that	  is	  posterior	  
to	  the	  fusion	  of	  the	  MGE	  and	  LGE	  (Anderson	  et	  al.,	  2001).	  Even	  in	  this	  case,	  regional	  identity	  
is	   regulated	  by	   a	   combination	  of	   TFs	  with	   overlapping	   expression	  patterns,	   some	  of	   them	  
showing	  cell	  fate	  restriction	  functions	  (Anderson	  et	  al.,	  1997;	  Flames	  and	  Marín,	  2005;	  Sussel	  
et	  al.,	  1999).	  From	  E9,	  Shh	  act	  on	  MGE	  cells	  inducing	  the	  expression	  of	  Nkx2.1	  and	  Lhx6	  TFs.	  
As	  for	  the	  CGE	  specification,	  TFs	  involved	  are	  CoupTF1/2,	  Gsh1/2	  (Sousa	  et	  al.,	  2009);(Lee	  et	  
al.,	   2010).	  Gsh1/2	   controls	   in	   turn	   the	  expression	  of	  Mash1,	  ASCL1,	  Dlx2	   required	   for	  CGE	  
patterning(Fig.1.5).	  	  
Fig.	   1.5	   Transcriptional	   facors	   involved	   in	  
pallial	  and	  subpallial	  patterning	  












GABAergic	   interneurons	   that	   populate	   the	   neocortex	   typically	   express	   distinct	  
neuropeptide	   that	   helps	   to	   define	   their	   multiple	   subclasses	   like	   somatostatin	   (SST),	  
neuropeptide-­‐Y	  (NPY),	  vasoactive	  intestinal	  peptide	  (VIP)	  and	  	  calcium-­‐binding	  proteins	  like	  
parvalbumin	   (PV),	   calretinin	   (CR)	   and	   calbindin	   (CB)(Cherubini	   and	   Conti,	   2001;	   DeFelipe,	  
1993;	  Gonchar	   et	   al.,	   2007;	   Houser	   et	   al.,	   1983;	   Kawaguchi	   and	   Kondo,	   2002;	   Krimer	   and	  
Goldman-­‐Rakic,	   2001).	   Thanks	   to	   several	   fate	   mapping	   experiments	   and	   transgenic	   mice	  
became	  available,	  it	  has	  been	  possible	  to	  establish	  a	  correlation	  between	  the	  place	  and	  time	  
of	  origin	  of	   interneuron	  precursors	  and	  determine	   their	  ultimate	   fate.	  Most	  MGE-­‐	  derived	  
interneurons	   contain	   either	   parvalbumin	   (PV)	   or	   somatostatin	   (SST).	   PV	   and	   SST	  
interneurons	   are	   the	   two	   most	   abundant	   classes	   of	   cortical	   interneurons	   with	   non-­‐
overlapping	  molecular	  identities	  (DeFelipe,	  1993,	  1997).	  GABAergic	  interneurons	  expressing	  
PV	  make	  up	  ~40%	  of	  all	  cortical	  interneurons	  of	  which	  basket	  and	  chandelier	  cells	  are	  typical	  
members.	   SST-­‐expressing	   interneurons,	  on	   the	  other	  hands,	   comprise	   ~30%	  of	   the	   cortical	  
inhibitory	  cells,	  distributed	  across	  deep	  cortical	  layers	  V-­‐VI	  and	  axons	  branching	  into	  layer	  I	  
where	  they	  exert	  	  inhibitory	  control	  over	  distal	  dendritic	  processes	  of	  pyramidal	  neurons.	  
The	  other	  major	  contributing	  region	  for	  the	  generation	  of	  cortical	  GABAergic	  interneurons	  is	  
the	  CGE.	  It	  is	  the	  source	  of	  VIP-­‐	  and	  Reelin-­‐expressing	  (SST-­‐negative)	  interneurons	  (Miyoshi	  
et	  al.,	  2007;	  Vucurovic	  et	  al.,	  2010)	   (Fig.1.6).	  Temporal	   fate	  mapping	  has	   shown	   that	  MGE	  
progenitors	   give	   rise	   to	   different	   cortical	   interneurons	   subtypes	   at	   discrete	   ages	   or	  
developmental	  times	  (Miyoshi	  et	  al.,	  2007).	  Furthermore,	  MGE-­‐derived	  cortical	  interneurons	  
show	   the	   same	   inside-­‐out	   pattern	   of	   generation	   that	   is	   observed	   for	   pyramidal	   cells	  
(Anderson	   et	   al.,	   2002;	   Cavanagh	   and	   Parnavelas,	   1989).	   Early	   born	   MGE-­‐derived	  
interneurons	   end	   up	   in	   deep	   layers,	   while	   late-­‐	   born	   IN	   occupy	   superficial	   layers	   of	   the	  








Fig.	  1.6	  Relative	  contribution	  of	  MGE	  and	  CGE	  to	  cortical	  interneuron	  subgroups	  	  
Adapted	  from	  (Wonders	  and	  Anderson,	  2006)	  
	  
CGE-­‐	   derived	   interneurons	   are	   late-­‐born	   cells	   with	   peak	   production	   around	   E16.5;	   they	  
migrate	  tangentially	  toward	  the	  pallium	  through	  the	  SVZ	  and	  MZ	  (Cavanagh	  and	  Parnavelas,	  
1989).	   They	   do	   not	   follow	   a	   temporal-­‐positioning	   code,	   but	   instead	   are	   distributed	  
homogeneously	  across	  superficial	  cortical	   layers	  (layer	  I-­‐III).	  An	  exception	  to	  this	  rule	  is	  the	  
outside-­‐in	  neurogenic	  gradient	  observed	  in	  CR-­‐positive	  interneurons	  (Lee	  et	  al.,	  2010)	  follow	  
different	  temporal	  rules	  than	  MGE-­‐derived	  internuerons	  (Miyoshi	  and	  Fishell,	  2011).	  	  
Interneurons	  then	  enter	  the	  cortex	  through	  two	  different	  migratory	  routes,	  both	  of	  
which	  avoid	  the	  cortical	  plate:	  a	  superficial	  path	  within	  the	  marginal	  zone	  (MZ);	  and	  a	  deep	  
route	   positioned	   at	   the	   subplate-­‐SVZ	   interface	   (Lavdas	   et	   al.,	   1999).	   After	   a	   period	   of	  
tangential	  migration,	   interneurons	  shift	  to	  a	  radial	  mode	  of	  migration	  when	  they	  enter	  the	  
cortical	   plate	   (Ang	   et	   al.,	   2003;	   Polleux	   et	   al.,	   2002).	   The	   timing	   of	   this	   shift	   seems	   to	   be	  
regulated	  by	  chemokines	  (Stumm	  et	  al.,	  2003;	  Tiveron	  et	  al.,	  2006).	  (Fig.1.7)	  
	  
Fig.	   1.7	   Migration	   pathways	   of	   cortical	   interneuron	   from	   the	  
ventral	  telencephalon	  








Cajal-­‐Retzius	  neurons,	  a	  third	  general	  category	  of	  cortical	  neurons,	  populate	  the	  MZ	  
(layer	   I)	   and	   express	   Reelin,	   a	   secreted	   protein	   required	   for	   a	   proper	   cortical	   layering	   by	  
influencing	  the	  radial	  migration	  and	  settling	  patterns	  of	  cortical	  neurons	  (Tissir	  and	  Goffinet,	  
2003).	  Cajal-­‐Retzius	  neurons	  are	  generated	  mainly	  within	  the	  cortical	  hem,	  subpallium	  and	  
septum	  (Bielle	  et	  al.,	  2005;	  Yoshida	  et	  al.,	  2006).	  






Astrocytes	   are	   specialized	   star-­‐shaped	   glial	   cells	   and	   the	   most	   numerous	   non-­‐
neuronal	   cells	   type	   in	   the	   central	   nervous	   system.	   These	   cells	   perform	   several	   essential	  
functions	   for	   normal	   neuronal	   activity,	   from	   structural	   support	   to	   maintenance	   of	   water	  
balance,	  ion	  distribution	  and	  neurotransmitter	  metabolism	  as	  well	  as	  blood	  flow	  (Sofroniew	  
and	  Vinters,	  2010).	  	  
Astrocytes	  are	  classically	  divided	  into	  three	  major	  types	  according	  to	  morphology	  and	  
spatial	  organization:	  radial	  astrocytes	  surrounding	  ventricles,	  protoplasmic	  astrocytes	  in	  grey	  
matter	  and	   fibrous	  astrocytes	   located	   in	  white	  matter	   (Privat,	  1995).	  Radial	   astrocytes	  are	  
perpendicularly	   oriented	   to	   the	   ventricular	   surface	   and	   have	   long	   and	   unbranched	  
processes;	   protoplasmic	   astrocytes	   have	   a	   bushy	  morphology	   with	  many	   highly	   branched	  
short	   processes,	   while	   fibrous	   astrocytes	   display	   a	   stellate	   shape	   with	   smooth	   and	   long	  
processes	  less	  branched.	  	  
Astrocytes	   are	   generated	   after	   neurons	   from	   the	   same	   pool	   of	   neural	   stem	   cells	  
(NSCs)	   located	   in	   the	   ventricular	   and	   subventricular	   zone	   in	   the	   gliogenic	   phase	   of	   late	  













Fig.	  1.8	  Timing	  of	  mice	  cortico-­‐cerebral	  histogenesis	  
	  
During	   development,	  when	   the	  morphology	   of	   NSCs	   changes,	   they	   start	   to	   display	  
extended	  radial	  processes	  to	  the	  pial	  surface	  from	  their	  somata	  and	  become	  known	  as	  radial	  
glial	   cells	   (RGCs).	   RGCs	  will	   generate	  more	  neurons,	   yet	   having	   the	   additional	   potential	   to	  
differentiate	   into	   astrocytes	   and	   oligodendrocytes.	   At	   late	   gestational	   and	   early	   postnatal	  
stages,	  most	  RGCs	  begin	  to	  detach	  from	  the	  apical	  side	  and	  migrate	  to	  the	  cortex	  where	  they	  
differentiate	  into	  astrocytes	  (Juliandi	  et	  al.,	  2010;	  Kriegstein	  and	  Alvarez-­‐Buylla,	  2009).	  	  
	  
The	   onset	   of	   astrogenesis	   is	   a	   crucial	   point	   in	   the	   developing	   brain.	   Neuron-­‐to-­‐
astrocyte	   switch	  must	   be	   tightly	   controlled	   and	   cooperation	   between	   environmental	   cues	  
and	   cell-­‐intrinsic	   program	   is	   necessary	   in	   order	   to	   get	   the	   correct	   timing,	   allowing	   the	  
generation	  of	  a	  sufficient	  amount	  of	  neurons	  to	  form	  all	  neuronal	  layers.	  	  
JAK/STAT	   is	   the	   key	   signaling	   pathway	   involved	   in	   the	   induction	   of	   astrocyte	  
specification.	  It	  is	  induced	  via	  cytokines	  such	  as	  ciliary	  neurotrophic	  factor	  (CNTF),	  leukaemia	  
inhibitory	   factor	   (LIF)	   and	   interleukin-­‐6	   (IL-­‐6)(Heinrich	   et	   al.,	   1998).	   These	   astrogenic	  
cytokines	  bind	   to	   their	  co-­‐receptor	  and	  trigger	   the	  heterodimerization	  of	   the	   Jak	   receptor.	  
Following	   receptor	   activation,	   phosphorylation	   and	   acetylation	   activate	   STAT3,	   which	  
dimerizes	  and	  translocate	  in	  the	  nucleus	  to	  activate	  transcription	  of	  key	  astrocyte	  genes	  like	  









Fig.	  1.9	  JAK/ST	  AT	  signalling	  pathways	  	  







During	   neurogenesis,	   pro-­‐neural	   factor	   like	   Neurogenin1	   (Ngn1),	   binds	   the	   p300/CBP,	   co-­‐
activator	   complex,	   preventing	   its	   interaction	   with	   STAT3	   (Sun	   et	   al.,	   2001);	   this	   prevents	  
STAT3-­‐dependent	   transcription	   and	   reduced	   acetylation	   at	   the	   binding	   sites	   on	   the	  
promoters	  of	   astrocytic	   genes.	   Even	   the	   loss	  of	  other	  bHLH	   transcription	   factors,	   essential	  
for	   neuronal	   differentiation,	   such	   Ngn2,	   NeuroD1	   and	  Mash1,	   has	   been	   demonstrated	   to	  
lead	  astrocyte	  differentiation	  	  induction	  (Nieto	  et	  al.,	  2001).	  	  
	  
Besides,	   JAK/STAT	   act	   synergistically	   with	   the	   Notch	   signalling	   to	   promote	  
astrogenesis.	  Notch	  signalling	  has	  an	  important	  role	  in	  the	  NSC	  fate	  during	  development;	  it	  
maintains	   neural	   stem	   cell	   (NSC)	   renewal	   by	   inhibition	   of	   their	   differentiation	   until	   the	  
correct	  differentiation	  cue	  is	  available.	  Thus,	  
Notch	   signalling	   can	   be	   considered	   a	  major	  
point	   of	   convergence	   between	   different	  
regulators	  of	  the	  neuron-­‐to	  astrocyte	  switch	  
(Fig.1.10).	  
Fig.	   1.10	   Roles	   of	   Notch	   signalling	   pathway	   in	  
differentiation	  process	  	  





Notch	  and	  JAK/STAT	  interaction	  is	  mainly	  established	  by	  STAT3.	  STAT3	  induces	  Notch	  
ligand	   Dll1,	   which	   in	   turn	   activates	   Notch	   signalling	   in	   adjacent	   cells.	   Notch	   appears	   to	  
promote	  the	  astrocytic	  phenotype	  through	  its	  downstream	  effectors,	  hairy	  enhancer	  of	  split	  
(Hes),	  Hes1	  and	  Hes5,	  which	  are	  known	  to	  promote	  astrocytic	  differentiation	  via	  suppressing	  
the	   function	   of	   proneural	   bHLHs	   (Kopan	   and	   Ilagan,	   2009).	   New	   born	   neurons	   stimulate	  
Notch	   signalling	   in	   NSCs	   by	   expressing	   Notch	   ligands	   such	   as	   Jagged	   1	   and	   Delta-­‐like	   1	  
(Namihira	   et	   al.,	   2009).	   This	   activation	   is	   necessary	   and	   sufficient	   to	   induce	   astrocyte	  
differentiation.	  Upon	  ligand	  binding,	  Notch	  is	  cleaved	  by	  the	  ϒ-­‐secretase	  complex,	  releasing	  
the	  notch	  intracellular	  domain	  (NICD).	  NICD	  translocates	  into	  the	  nucleus,	  where	  it	  regulates	  
transcription	  of	  Notch	  target	  genes	  via	  DNA	  binding	  proteins	  (Guruharsha	  et	  al.,	  2012).	  	  
In	  addition,	  calcium	  signalling	  stimulates	  astrogenesis	  as	  well.	  The	  cAMP-­‐dependent	  
pituitary	   adenylate	   cyclase-­‐activating	   polypeptide	   (PACAP)	   triggers	   intracellular	   cAMP	  
production	   and	   in	   turn,	   entry	   of	   calcium	   in	   NSCs.	   Calcium	   will	   activate	   the	   transcription	  
factor	  DREAM	  whose	  binding	  to	  responsive	  elements	  in	  the	  GFAP	  promoter	  will	  stimulate	  its	  
expression.	  Moreover,	   the	   PACAP/DREAM	   pathway	   can	   act	   in	   synergy	   with	   the	   JAK/STAT	  
pathway	  via	  the	  NF1A	  transcription	  factor,	  downstream	  factor	  of	  Notch.	  (Fig.1.11)	  	  	  
Fig.	   1.11	   PACAP/Dream	   and	   JAK/STAT	  
pathway	  interactions	  	  





Lastly,	  another	  pathway	  play	  a	  special	  role	   in	  astrogenesis,	   in	  particular	   is	  crucial	  to	  
prevent	   premature	   astrogenesis	   in	   vivo.	   It	   is	   the	   ErbB4-­‐NCoR	   signalling,	   activated	   by	  
neuregulins	   secreted	   by	   neurons	   (Fox	   and	   Kornblum,	   2005).	   ErbB4	   is	   a	   tyrosine	   kinase	  
receptor	  of	  the	  EGF	  receptor	  family,	  which	  forms	  a	  repressor	  complex	  together	  with	  NcoR.	  




together	   with	   NcoR	   into	   the	   nucleus	   to	   inactivate	   GFAP	   expression	   (Sardi	   et	   al.,	  
2006)(Fig.1.12).	  	  
	  Fig.	  1.12	  ErbB4-­‐NCoR	  signalling	  	  	  












1.4	  Astrocyte	  modulation	  of	  neuronal	  excitability	  
	  
For	   a	   long	   time	   glial	   cells	   and	   astrocytes	   in	   particular	   have	   been	   largely	   viewed	   as	  
simple	  gap	  fillers.	  More	  recently,	  the	  function	  of	  astrocytes	  has	  been	  reconsidered	  playing	  a	  
number	  of	  active	  roles	  in	  the	  brain.	  There	  is	  a	  body	  of	  evidence	  that	  glia	  actively	  signal	  with	  
neurons	  and	  influence	  synaptic	  development,	  neuronal	  excitability	  and	  plasticity	  through	  an	  
array	  of	  secreted	  and	  contact-­‐dependent	  signals.	   It	   is	  clear	  that	  a	  disruption	   in	  neuron-­‐glia	  
signalling	   contributes	   to	   the	   initiation	  and	  progression	  of	  many	  neurological	  disorders	  and	  
diseases,	  in	  particular	  epilepsy.	  Epilepsy	  is	  a	  condition	  of	  the	  brain	  characterized	  by	  periodic	  
manifestation	   of	   burst	   of	   electrical	   activity	   (seizures),	   in	   which	   unusual	   intense	   neuronal	  
firing	  occurs.	  Development	  of	  an	  epileptic	  seizure	  requires	  physiological	  changes	  that	  lead	  to	  




Considering	   all	   the	  many	   functions	   exerted	   by	   astrocytes,	   it	   is	   clear	   that	   each	   of	   them	   if	  
disrupted	  can	  affect	  neuronal	  excitability	  and	  thus	  play	  prominent	  roles	   in	  pathogenesis	  of	  
neurological	  disorders.	  	  	  
	  
Astrocyte	  buffering	  of	  extracellular	  K+	  
Neuronal	  excitability	  is	  tightly	  coupled	  to	  the	  extracellular	  space	  (ECS)	  volume	  and	  its	  
K+	   levels.	  Astrocytes	   regulate	  K+	   flow	  between	  neurons	  and	  the	  extracellular	  space.	  During	  
normal	  periods	  of	  activity,	  much	  of	  the	  potassium	  released	  into	  the	  ESC	  by	  spiking	  neurons	  is	  
taken	  up	  by	  astrocytes	  and	  neurons.	  	  Impaired	  astrocytic	  K+	  buffering	  results	  in	  a	  slower	  K+	  
clearance,	   which	   in	   turn	   lower	   seizure	   threshold	   and	   thereby	   contribute	   to	   seizure	  
generation.	  Astrocytes	  exhibits	  both	  passive	  and	  active	  mechanisms	  for	  limiting	  elevations	  in	  
extracellular	  K+.	  The	   inward	  rectifying	  K+	  channel,	  Kir4.1,	   is	  the	  main	  Kir	  channel	  subunit	   in	  
astrocytes	   and	   in	   charge	   for	   the	   spatial	   buffering	   of	   the	   K+	   (Kofuji	   and	   Newman,	   2004).	  
Genetic	   downregulation	   of	   Kir4.1,	   strongly	   impair	   the	   ability	   of	   astrocytes	   to	   remove	  
glutamate	  and	  K+	  from	  the	  ECS,	  both	  in	  cell	  culture	  (Kucheryavykh	  et	  al.,	  2007)	  and	  in	  vivo	  
(Djukic	  et	  al.,	  2007).	  Besides,	  from	  ultrastructural	  analyses	  in	  rat,	  it	  resulted	  there	  is	  a	  spatial	  
overlap	  of	  Kir4.1	  and	  the	  water	  channel	  aquaporin	  4	  (AQP4)	  in	  astroglial	  endfeet	  contacting	  
the	  capillaries	  (Higashi	  et	  al.,	  2001;	  Nielsen	  et	  al.,	  1997).	  The	  idea	  is	  they	  act	  in	  concert	  in	  the	  
clearance	   of	   the	   K+	   and	   water	   after	   neural	   activity:	   potassium	   uptake	   is	   accompanied	   by	  
water	   influx	   via	   AQP4	   into	   astrocytes,	   to	   dissipate	   osmotic	   imbalances	   due	   to	   K+	  
redistribution.	  More	  marked	  accumulations	  in	  extracellular	  K+	  trigger	  active	  uptake	  of	  K+,	  via	  
the	   activation	   of	   astrocyte	   Na+/K+	   ATPase	   (Walz	   and	   Hertz,	   1982)	   and	   the	   Na-­‐K-­‐Cl	   co-­‐
transporter	  NKCC1,	  at	   the	  cost	  of	   cell	   swelling	  due	   to	  a	   subsequent	  osmotic	  movement	  of	  
water	  (Kofuji	  and	  Newman,	  2004).	  	  
	  
Glutamate	  uptake	  	  
Glutamate	  uptake	  from	  the	  extracellular	  space	  helps	  to	  terminate	  the	  action	  of	  this	  
neurotransmitter	   at	   synapses.	   Uptake	   mechanisms	   are	   of	   particular	   importance	   as	   they	  




neighbouring	  synapses	  and	  the	  activation	  of	  perisynaptic/extrsynaptic	  glutamate	  receptors.	  
Glutamate	   uptake	   is	   mainly	   mediated	   by	   transporters	   localized	   at	   the	   astrocytes	  
membranes.	  Five	  glutamate	  transporters	  are	  present	  in	  the	  brain;	  GLAST	  and	  GLT-­‐1	  (human	  
forms:	  EAAT1	  and	  EAAT2,	  respectively)	  are	  glial-­‐specific	  transporters	  expressed	  in	  astrocytes,	  
largely	  responsible	  for	  glutamate	  clearance	  from	  the	  extracellular	  space	  (Lehre	  et	  al.,	  1995;	  
Rothstein	   et	   al.,	   1994).	   Several	   experiments	   in	   knockout	   mice	   suggest	   that	   impaired	  
glutamate	   uptake	   by	   astrocytes	   has	   the	   potential	   to	   contribute	   to	   the	   development	   of	  
seizures	  (Tanaka	  et	  al.,	  1997).	  	  
	  
Glutamate	  release	  
Glutamate	   released	   from	   neurons	   activates	   metabotropic	   glutamate	   receptors	  
(mGluRs),	   in	   particular	   mGluR3	   and	   mGluR5,	   predominant	   subtypes	   expressed	   in	  
neighbouring	  astrocytes.	  Activation	  of	  these	  receptors	  affects	  cAMP	  accumulation	  and	  leads	  
to	  increase	  in	  their	  cytosolic	  Ca2+	  (Araque	  et	  al.,	  1999).	   Increased	  intracellular	  Ca2+	   	   induces	  
astrocytes	  to	  release	  glutamate.	  Glutamate	  once	  released	  will	  modulate	  synaptic	  activity	  in	  
nearby	   neurons	   and	   thus	   increasing	   their	   excitability.	   Besides,	   as	   single	   astrocytes	   are	   in	  
close	   proximity	   to	   a	   large	   number	   of	   neurons	   they	   can	   promote	   synchrony	   of	   neuronal	  
action	  potential	  firing	  (Fellin	  and	  Carmignoto,	  2004;	  Parri	  et	  al.,	  2001).	  In	  addition,	  astrocyte	  
swelling	  induced	  by	  elevated	  extracellular	  K+	  or	  other	  factors	  can	  induce	  glutamate	  efflux	  via	  
volume	  sensitive	  anion	  channels	  (Kimelberg	  and	  Kettenmann,	  1990).	  	  Both	  alterations	  in	  this	  
glia-­‐derived	  excitatory	  pathway	  and	  impaired	  glutamate	  uptake	  might	  increase	  excitability	  of	  
the	   neuron-­‐astrocyte	   network,	   favour	   neuronal	   synchronization	   and	   ultimately	   predispose	  
neurons	  to	  seizure.	  
	  
Release	  of	  metabolic	  intermediates	  
	  
Glutamate	  released	  during	  neurotransmission	   is	  taken	  up	  primarily	  by	  neighbouring	  
astrocytes	   through	   excitatory	   amino	   acid	   transporters	   GLAST	   and	   GLT-­‐1.	   A	   fraction	   of	  
astrocyte	  glutamate	  is	  then	  converted	  to	  glutamine	  by	  glutamine	  synthetase.	  Glutamine	  is	  in	  




and	   then	   packaged	   into	   synaptic	   vesicles	   (Pow	   and	   Robinson,	   1994;	   Shigeri	   et	   al.,	   2004).	  
Several	   evidences	   support	   the	   idea	   that	   impaired	   glutamate	   to	   glutamine	   cycling	   can	  
contribute	   to	   neuronal	   hyperexcitability	   and	   lead	   to	   seizures.	   An	   example	   is	   a	  
downregulation	  of	  glutamine	  synthetase.	  This	  can	  results	   in	  the	  accumulation	  of	  glutamate	  
in	   astrocytes	   and	   thus	   its	   build-­‐up	   in	   the	   extracellular	   space	   (glutamate	   uptake	   into	  
astrocytes	  need	  a	  rapid	  metabolism	  of	  the	  intracellular	  glutamate)	  (Otis	  and	  Jahr,	  1998).	  	  
Moreover,	   its	   downregulation	   can	   partially	   deplete	   inhibitory	   synaptic	   terminals	   of	   GABA	  




1.5	  Foxg1	  gene,	  structure	  and	  function	  
	  
FoxG1	   (Forkhead	   box	   G1)	   is	   an	   evolutionary	   conserved	   transcription	   factor	   gene	  
belonging	  to	  the	  forkhead	  box	  family,	  named	  after	  the	  first	  member,	  forkhead,	  discovered	  in	  
Drosophila	   (123).	  Forkhead	  genes	  play	  central	   roles	   in	  patterning,	  morphogenesis,	  cell	   fate	  
determination	  and	  proliferation	   (122).	  Currently,	   they	  are	  divided	   into	  17	   subclasses	   (A	   to	  
Q),	  according	  to	  the	  amino	  acid	  sequence	  of	  their	  conserved	  forkhead	  domains	  (Kaestner	  et	  








The	  defining	   feature	  of	   FOX	  proteins	   is	   the	   forkhead	  box,	   a	   sequence	  of	   80	   to	  100	  
amino	   acids	   forming	   a	   motif	   that	   binds	   to	   DNA,	   highly	   conserved	   across	   all	   members.	   It	  
consists	   in	   three	   amino-­‐terminal	   alpha	   helices,	   three	   beta	   strands,	   and	   two	   loops.	   The	  
peculiar	  folding	  of	  the	  loops	  around	  the	  helices	  resembles	  butterfly	  wings	  and	  accounts	  for	  
the	  'winged	  helix'	  nickname.	  	  
Foxg1,	  play	  a	  central	  role	  in	  the	  developing	  telencephalon	  (Tao	  and	  Lai,	  1992).	  Being	  
one	  of	  the	  first	  TFs	  expressed	  in	  the	  developing	  rostral	  brain	  it	  is	  crucial	  for	  many	  aspects	  of	  
cerebral	   cortex	   development:	   from	   cerebral	   cortex	   morphogenesis,	   including	   early	  
distinction	   between	  pallial	   and	   subpallial	   fields,	   to	   dorsoventral	   patterning	   of	   the	   pallium,	  
regulation	   of	   the	   balance	   between	   neural	   progenitor	   proliferation	   and	   differentiation,	  
neocortical	  layering	  and	  tuning	  of	  astrogenesis	  rates.	  	  The	  body	  of	  functions	  exerted	  by	  this	  
TF	   suggest	   that	   a	   proper	   dosage	   allele	   of	   this	   gene	   is	   extremely	   crucial,	   even	   subtle	  




1.6	  Foxg1	  in	  the	  telencephalic	  patterning	  	  
	  
The	   telencephalon	   arises	   from	   the	   most	   rostral	   region	   of	   the	   neural	   tube.	   The	  
patterning	  of	   the	   telencephalon	   is	   regulated	  by	  distinct	  mechanisms	  operating	   in	  different	  
parts	  of	   this	   structure	   in	  a	  concerted	  action.	  Regional	   specification,	  growth,	  differentiation	  
and	  subdivisions	  of	  the	  telencephalon	  occurs	  through	  the	  action	  of	  morphogens.	  These	  are	  
signalling	  molecules	  secreted	  from	  a	  localized	  area	  that	  direct	  tissue	  patterning	  by	  forming	  a	  
concentration	   gradient	   thus	   producing	   concentration-­‐dependent	   responses.	   Thus,	   by	  
specifying	   the	   overall	   R-­‐C	   and	  D-­‐V	   coordinates,	   pools	   of	   progenitors	   cells	   can	   be	   given	   an	  








Starting	   from	   E7,	   the	   early	   rostro-­‐caudal	   patterning	   of	   the	   anterior	   and	   posterior	  
neural	  tissues	  is	  mediated	  from	  signals	  coming	  from	  the	  primitive	  node	  or	  organizer	  and	  the	  
anterior	  visceral	  endoderm	  (AVE),	   required	  for	  neural	   induction	  and	  maintenance	  (Thomas	  
and	  Beddington,	  1996)	  (Fig.1.14a).	  The	  AVE,	  an	  extra-­‐embryonic	  tissue	  underlying	  the	  neural	  
plate,	   secretes	   molecules	   like	   cerberus	   and	   dickkopf.	   These	   two	   protein	   antagonize	   the	  
effects	   of	   posteriorizing	   molecules	   expressed	   by	   the	   neural	   plate,	   including	   Wnt	   and	  
fibroblast	   growth	   factor	   (Fgfs)	   family	  members	   as	  well	   as	   retinoic	   acid	   (RA)	   (Altmann	   and	  
Brivanlou,	  2001;	  Sasai	  and	  De	  Robertis,	  1997)(Fig.1.14b).	  	  	  
	  







	  	  Fig.	  1.14	  Tissue	  and	  signals	  involved	  in	  anterior	  necural	  character	  specification	  
	  	  a)	  Anterior	  visceral	  endoderm	  (AVE),	  located	  beneath	  the	  future	  neural	  plate	  
	  	  b)	  Progressive	  specification	  of	  the	  telencephalon	  
	  	  Modified	  from	  (Rallu	  et	  al.,	  2002)	  
	  
After	  the	  anterior	  neural	  induction	  a	  secondary	  organizer,	  the	  Anterior	  Neural	  Ridge	  
(ANR),	  promotes	   telencephalic	  development	   triggering	  Foxg1	  expression	  via	  Fgf8	  secretion	  




prevents	   the	   expression	   of	   the	   telencephalic	   markers	   Foxg1	   and	   Emx1	   (Shimamura	   and	  
Rubenstein,	   1997).	   Besides,	   also	   Hedgehog	   signalling	   contributes	   in	   Foxg1	   induction	   as	  
demonstrated	  that	  its	  block	  before	  telencephalon	  specification	  strongly	  impairs	  initial	  levels	  
of	  Foxg1	  expression	  (Danesin	  et	  al.,	  2009).	  The	  concomitant	  activation	  of	  Foxg1	  expression	  
by	   Fgf8	   from	   the	   ANR	   and	   Shh	   provided	   by	   the	   prechordal	   plate,	   allow	   a	   graded	   Foxg1	  
expression:	  high	  ventral/anterior	  to	  low	  dorsal/posterior.	  	  
	  
	  
Dorso-­‐ventral	  specification	  	  
	  
The	   initial	   subdivision	   defining	   dorsal	   and	   ventral	   telencephalon	   is	   due	   to	   the	  
dorsalizing	  effects	  of	  Gli3	  (a	  zinc-­‐finger	  transcription	  factor)	  expression	  and	  the	  ventralizing	  
influence	   of	   Shh	   expression.	   Gli3	   knockouts	   reveals	   a	   disrupted	   dorsal	   telencephalon	  
development	   (choroid	   plexus,	   cortical	   hem	   and	   hippocampus	   fail	   to	   form	   and	   neocortex	  
development	  is	  progressively	  compromised)	  (Grove	  et	  al.,	  1998;	  Kuschel	  et	  al.,	  2003;	  Theil	  et	  
al.,	   1999).	   As	   for	   Sonic	   hedgehog	   protein	   (Shh),	   it	   is	   expressed	   in	   the	   ventral	   midline	  
throughout	   the	   development	   and	   counteracts	   the	   dorsalizing	   effect	   of	   Gli3.	   Shh-­‐/-­‐	   mouse	  
embryos	  display	  a	  telencephalon	  reduced	  in	  size	  and	  ventral	  cell	  type	  are	  lost	  (Ohkubo	  et	  al.,	  
2002).	   In	  double	  mutants	  mice	   that	   lack	  both	  Shh	   and	  Gli3,	  however,	  ventral	  patterning	   is	  
largely	   rescued	   suggesting	   a	   role	   for	   Shh	   in	   promoting	   ventral	   identity	   by	   preventing	  
dorsalizaton	  of	   the	   telencephalon	   rather	   than	  a	  direct	  promotion	  of	   the	  ventral	   character.	  
Moreover,	  it	  means	  that	  other	  genes	  acting	  independently	  or	  downstream	  of	  Shh	  function	  to	  
generate	   ventral	   cell	   types	   (Rallu	   et	   al.,	   2002).	   This	   ventralizing	   signal	   is	  mediated	   by	   the	  
cooperation	  of	  Foxg1	  and	  Fgfs.	  	  In	  Foxg1	  -­‐/-­‐	  mice,	  the	  formation	  of	  the	  subpallium	  is	  strongly	  
impaired	   (Xuan	   et	   al.,	   1995)	   and	   ventral	   cells	   are	   not	   rescued	   by	   removal	   of	   Gli3.	  
Telencephalon	   is	   completely	   lost	   in	   Foxg1/Gli3	   double	   mutant,	   suggesting	   that	   Gli3	   and	  
Foxg1	  are	  essential	  for	  generate	  and	  maintain	  respectively	  dorsal	  and	  ventral	  subdivisions	  of	  
the	  telencephalon	  (Hanashima	  et	  al.,	  2007).	  Fgf	  signalling	  is	  essential	  too	  for	  the	  generation	  
of	  the	  ventral	  cell	  types	  (Gutin	  et	  al.,	  2006).	  It	  acts	  in	  a	  dose-­‐dependent	  manner:	  moderate	  




telencephalon	   specification	   upon	   deletion	   of	   multiple	   Fgf	   receptors	   (Fgfr1,Fgfr2	   and	  
Fgfr3)(Paek	  et	  al.,	  2009).	  Foxg1	  is	  required	  for	  Fgf8	  expression	  from	  the	  ANR	  (Martynoga	  et	  
al.,	   2005)	   and	   conversely,	   Foxg1	   expression	   is	   itself	   regulated	   by	   FGF	   signalling	   forming	   a	  
positive	  feedback	  loop	  (Shimamura	  and	  Rubenstein,	  1997;	  Storm	  et	  al.,	  2006).	  	  Besides,	  to	  its	  
key	   role	   in	   determining	   ventral	   character	   in	   the	   telencephalon,	   Foxg1	   is	   also	   required	   to	  
restrict	  dorsal	  fates	  limiting	  expression	  of	  Wnt	  ligands.	  Foxg1	  binds	  to	  Wnt8b	  promoter	  and	  
represses	   its	   transcriptional	   activity,	   preventing	   thus	   expansion	   of	   the	   Wnt-­‐secreted	  
population	   (Danesin	   et	   al.,	   2009).	   Therefore,	   Foxg1	   act	   as	   an	   integrator	   of	   a	   complex	  
network	   of	   interactions	   between	   several	   signalling	   pathways:	   promotes	   ventral	   identity	  
downstream	   of	   Shh	   and	   concomitantly	   controls	   the	   extension	   of	   dorsal	   territory	   through	  







Fig.	  1.15	  Foxg1,	  integrator	  between	  several	  signalling	  pathways	  	  
Modified	  from	  (Danesin	  and	  Houart,	  2012)	  
	  
As	  a	  results	  of	  R-­‐C	  and	  D-­‐V	  patterning	  events,	  the	  telencephalon	  will	  be	  subdivided	  in	  
pallial	   and	   subpallial	   territories,	   characterized	  by	   the	  expression	  of	   specific	   set	  of	   TFs.	   The	  
subpallium	   will	   give	   rise	   to	   the	   medial	   ganglionic	   eminence	   (MGE)	   and	   to	   the	   lateral	  
ganglionic	   eminence	   (LGE)	   expressing	   respectively	   the	   TFs	  Nkx2.1	   and	  Gsh2;	   while	   in	   the	  







1.7	  Foxg1	  in	  cortical	  arealization	  
	  
The	   interplay	   between	   intrinsic	   and	   extrinsic	   factors	   in	   the	   telencephalic	   field	   will	  
further	   subdivide	   the	   cerebral	   cortex	   in	   distinct	   anatomical	   and	   functional	   areas.	   This	  
process	   is	   the	  cortical	  arealization.	  Area	  patterning	   is	  a	  critical	  development	  event,	  even	  a	  
small	  change	  during	  its	  steps	  may	  lead	  to	  severe	  defect	  in	  brain	  functioning.	  
In	  the	  mouse,	  cortical	  arealization	  starts	  at	  early	  stages	  (E9.5)	  with	  different	  secreted	  
ligands	   released	   from	   structures	   lying	   at	   the	  borders	   of	   the	   cortical	   field.	   Such	  molecules,	  
diffusing	   through	   the	   cortical	   field,	   will	   regulate	   the	   expression	   of	   cortical	   transcription	  
factor	  genes	   in	  a	  dose-­‐dependent	  manner	  accounting	   in	  this	  way	  for	   further	  generation	  of	  
concentration	  gradients	  of	  this	   latter.	  Transcription	  factors	  gradients	  will	   finally	  encode	  for	  
positional	   values	   specifying	   area	   identity.	   Subsequently,	   from	   E13.5	   onward,	   cortical	  
arealization	  will	  be	  refined	  based	  on	  information	  transported	  by	  thalamocortical	  axons	  (TCA)	  
relaying	  sensory	  information	  from	  the	  principal	  sensory	  nuclei	  of	  dorsal	  thalamus.	  
Patterning	  centres	  most	  directly	  implicated	  in	  the	  cortical	  arealization	  are:	  
1) rostrally,	  the	  commissural	  plate	  (CoP)	  secreting	  Fgfs	  (Fgf3,8,17,and	  18)	  
2) dorsocaudally,	   the	   cortical	   hem	   secreting	   bone	   morphogenetic	   proteins	  
(Bmp2,4,5,6,7)	  and	  Wnt	  (Wnt2b,	  3a,	  5a,	  tb,	  8b)	  
3) lateroventrally,	   the	   cortical	   antihem	   secreting	   epidermal	   growth	   factor	   family	  
members	  (Tgfα,	  Nrg1	  and	  Nrg3),	  Fgf7,	  as	  well	  as	  the	  Wnt	  signaling	  inhibitor	  Sfrp2	  (Fig.1.16)	  
	  
Fig.	   1.16	   Patterning	   centers	   and	   their	   secreted	  
ligands	  implicated	  in	  the	  cortical	  arealization	  	  








Several	   transcription	   factor	   genes	   involved	   in	   specification	   of	   cortical	   areas	   are	  
expressed	   by	   neural	   progenitors	   of	   the	   developing	   neocortex.	   They	   include	   Lhx2,	   Foxg1,	  
Pax6,	   Emx2,	   Coup-­‐tf1	   and	   Sp8.	   Graded	   expression	   of	   these	   TFs	   will	   impart	   positional	  
identities	  to	  cortical	  progenitors	  which	  is	  imparted	  to	  their	  neuronal	  progeny	  that	  form	  the	  
cortical	  plate.	  	  	  
Foxg1	   is	   expressed	   in	   progenitors	   along	   a	   caudo/mediallow	   to	   rostro/lateral	   high	  
gradient.	   As	   previously	   described,	   Foxg1	   is	   necessary	   to	   establish	   ventral	   identity	   of	   the	  
telencephalon.	  Early	  expression	  of	  Foxg1	   is	   triggered	  by	  Fgf8	   (Shimamura	  and	  Rubenstein,	  
1997)	  and	  Fgf8	   is,	   in	   turn,	  down	  regulated	   in	  Foxg1-­‐/-­‐	   (Martynoga	  et	  al.,	  2005).	  Besides,	   in	  
Foxg1-­‐/-­‐	  cortical	  field	  is	  abnormally	  specified	  as	  a	  hippocampal	  anlage	  (Muzio	  and	  Mallamaci,	  




1.8	  Foxg1	  in	  cortical	  precursors	  kinetics	  
	  
During	   corticogenesis,	   neural	   precursors	   will	   give	   rise	   to	   all	   cells	   populating	   the	  
cortex.	  In	  order	  to	  assure	  a	  correct	  final	  output	  of	  neurons	  and	  glial	  cells	  at	  the	  end	  of	  the	  
embryonic	   life,	   the	   balance	   between	   proliferation	   and	   differentiation	   must	   be	   tightly	  
regulated.	  Control	  of	   the	  cell	  cycle	  progression	   is	  a	  major	  key	  point	   in	  this	  balance.	  During	  
the	  neurogenesis,	   there	   is	  a	  progressive	   lengthening	  of	   the	  cell	   cycle	  duration	   that	   can	  be	  
largely	   attributed	   to	   a	   lengthening	   of	   the	   G1	   phase.	   Besides,	   lengthening	   of	   the	   cycle	   is	  
accompanied	  by	  an	  increase	  in	  the	  fraction	  of	  cells	  exiting	  from	  cell	  cycle	  (Q)	  (Takahashi	  et	  
al.,	  1995).	  The	  increase	  in	  Q	  is	  due	  to	  a	  switch	  from	  proliferative	  to	  differentiative	  divisions.	  
As	   the	  G1	   phase	   length	   increase,	   cell	   division	   switch	   from	   a	   symmetrical	   self-­‐renewing	   to	  
asymmetrical	   neurogenic	   differentiating	   pattern	   and,	   lastly	   to	   an	   asymmetrical	  
differentiative	   one	   (Calegari	   and	   Huttner,	   2003;	   Götz	   and	   Huttner,	   2005).	   Therefore,	   the	  
transition	  through	  the	  G1	  to	  S	  phase	  is	  particularly	  crucial	  for	  proliferative	  or	  differentiative	  




complex	   inhibitors	  of	   the	  Kip/Cip	   family	   (p21Cip1,	  p27Kip1,	  p57Kip2)	   and	   Ink4	   (p16Ink4,	  p15Ink4,	  
p19Ink4	   p18Ink4).	   P21Cip1	   knockout	   lead	   to	   exhaustion	   of	   proliferative	   pools	   in	   embryonic	  
cortical	  progenitor	  in	  vitro	  culture	  (Kippin	  et	  al.,	  2005)(Fig.1.17).	  	  
	  
Fig.	  1.17	  Structure	  and	  regulation	  of	  the	  cell	  cycle	  	  
Cyclin-­‐CDK	   (cyclin-­‐dependent	   kinase)	   complexes	   and	   their	  
inhibitors	  (Ink4	  family	  and	  Kip/Cip	  family)	  control	  the	  transition	  
from	  a	  phase	  of	  the	  cell	  cycle	  to	  the	  next.	  	  	  




Besides,	   evidences	   point	   to	   the	   G1	   mode	   of	   division	   relationship	   as	   an	   essential	  
control	  mechanism	  of	  corticogenesis.	  Cyclin	  D1	  and	  cyclin	  E1	  overexpression	  experiments	  by	  
in	  utero	  electroporation	   in	  mouse	  embryo	  demonstrated	  there	   is	  a	  causative	   link	  between	  
G1	  phase	  and	   the	  mode	  of	  division.	   	   In	   these	  experiments,	  G1	  phase	   reduction	  promoted	  
apical	  progenitors	  self-­‐renewal	  followed	  by	  an	  increased	  transition	  to	  the	  basal	  progenitors	  
compartment	  and,	  subsequently	  an	  expansion	  of	  the	  basal	  progenitors	  compartment	  at	  the	  
expense	   of	   neurogenesis.	   Moreover,	   there	   is	   an	   impact	   also	   on	   laminar	   fate	   and	  
cytoarchitecture	  (Pilaz	  et	  al.,	  2009).	  	  
Foxg1	   contributes	   to	   the	   development	   of	   the	   telencephalon	   by	   maintaining	  
telencephalic	   progenitor	   status	   and	   ensuring	   that	   these	   progenitors	  maintain	   appropriate	  
cell	  cycle	  kinetics,	  particularly	  in	  the	  rostral	  telencephalon.	  Foxg1	   is	  highly	  expressed	  in	  the	  
proliferating	   cells	   of	   the	   neuroepithelium	   during	   the	   necortical	   development	   and	   its	  
expression	  decline	  as	  the	  cells	  become	  postmitotic.	  In	  Foxg1-­‐/-­‐	  mice	  the	  size	  of	  the	  cerebral	  
hemispheres	  are	  reduced;	  ventral	  telencephalic	  development	  is	  more	  severely	  affected	  than	  
the	   dorsal	   one.	   Telencephalic	   neuroepithelial	   cells	   are	   specified	   but	   their	   proliferation	   is	  




progenitor	  population),	  cell	  cycle	  lengthening	  and	  reduction	  in	  apoptosis.	  (Hanashima	  et	  al.,	  
2002;	  Martynoga	  et	  al.,	  2005;	  Xuan	  et	  al.,	  1995).	  	  
Foxg1	   proliferative	   effects	   depend	   on	   its	   ability	   to	   inhibit	   the	   FoxO-­‐Smad	  
transcriptional	   complex	   and,	   therefore,	   to	   block	   p21Cip1	   induction	   by	   TGF-­‐beta	   signals	   in	  
neuroepithelial	   cells.	   Smad	  proteins,	  activated	  by	  TGF-­‐beta	   signaling,	   form	  a	  complex	  with	  
FoxO	  proteins	   to	   turn	   on	   p21Cip1	   gene.	   This	   latter,	  mediates	   cell	   cycle	   arrest	   at	  G1	   phase.	  
Dysregulation	   of	   p21	   has	   the	   potential	   to	   induce	   cell	   cycle	   exit	   and	   thus	   influence	   the	  
proliferative	   fate	   choices	   of	   progenitor	   cell	   population.	   An	   example	   are	   experiments	  with	  
Foxg1+/-­‐	  heterozygous	  mice	  where	   it	  has	  been	  shown	  that	  Foxg1	  reduces	  the	   intermediate	  
progenitor	   cell	   population	   increasing	   p21	   expression.	   (Siegenthaler	   et	   al.,	   2008).	   In	  
accordance	  with	   this	   role	   in	   progenitors	   proliferation,	   Foxg1	  mutant	   display	   a	   remarkable	  
reduction	  of	  the	  telencephalic	  vesicles	  due	  to	  a	  compromised	  growth	  of	  the	  telencephalon.	  
Besides,	   Foxg1	   act	  with	   Polycomb	   factor	   Bmi-­‐1,	   repressor	   of	   the	   cell	   cycle	   inhibitors	   p16,	  
p19,	  and	  p21.	  Bmi-­‐1	  overexpression	   rapidly	  upregulates	  Foxg1	   that	   is	   in	   turn	  necessary	   to	  
mediate	   promotion	   of	   neural	   progenitor	   cells	   (NPCs)	   self-­‐renewal	   (Fasano	   et	   al.,	   2009).	  	  
Furthermore,	   Foxg1	   overexpression	   experiments	   in	   neural	   stem	   cells	   (NSCs)	   lead	   to	   an	  
expansion	   of	   this	   compartment,	   possibly	   by	   increasing	   NSCs	   self-­‐renewal,	   promotion	   of	  
progenitor	   survival	   and	   delayed	   neurogenesis.	  Moreover,	  Foxg1	   overexpression	   under	   the	  
control	  of	  the	  neuronal	   lineage-­‐specific	  promoter	  Tubulin	  alpha1	  (ptα1)	  neural	  progenitors	  
are	  forced	  to	  keep	  proliferating,	  thus	  impairing	  neuron	  maturation.	  (Brancaccio	  et	  al.,	  2010).	  	  
	  
	  
1.9	  Foxg1	  in	  the	  migration	  of	  pyramidal	  neurons	  
	  
Pyramidal	   neurons	   are	   born	   within	   the	   proliferative	   layers	   of	   the	   cerebral	   cortex	  
(Götz	   and	   Huttner,	   2005).	   The	   appropriate	   laminar	   position	   will	   be	   achieved	   not	   only	  
through	   vertical	  migration	   along	   radial	   glial	   fibers	   but,	   like	   interneurons,	   they	   tangentially	  
disperse	   during	   their	   integration	   in	   the	   cortex	   (O’Rourke	   et	   al.,	   1992).	   During	   this	   phase,	  




“multipolar”	  morphology,	  detach	  from	  the	  radial	  glia	  scaffold	  and	  initiate	  axonal	  outgrowth	  
(Barnes	   et	   al.,	   2007)	   prior	   entering	   the	   cortical	   plate	   (Noctor	   et	   al.,	   2004;	   Tabata	   and	  
Nakajima,	   2003).	   As	   pyramidal	   neurons	   transit	   through	   these	   migratory	   phases	   Foxg1	   is	  
expressed	  in	  a	  dynamic	  manner.	  This	  dynamic	  expression	  is	  critical;	  it	  regulates	  the	  assembly	  
and	   integration	   of	   pyramidal	   neuron	   precursors	   into	   the	   cortical	   network	   (Miyoshi	   and	  
Fishell,	   2012).	   In	   a	   first	   phase	   Foxg1	   expression	   is	   transiently	   downregulated	   in	   nascent	  
pyramidal	   neuron	   precursors.	   Downregulation	   occurs	   precisely	   at	   the	   beginning	   of	   the	  
multipolar	  cell	  phase,	  coincident	  with	  the	  starting	  point	  of	  NeuroD1	  expression;	   it	   is	  called	  
“early	   phase”.	   Foxg1	   downregulation	   is	   necessary	   to	   initiate	   Unc5d	   expression,	   which	   is	  
critical	   for	   the	   rapid	   transition	   to	   the	   “late”	   multipolar	   phase.	   Failure	   in	   Foxg1	  
downregulation	  at	  the	  beginning	  of	  the	  multipolar	  phase	  transiently	  stalls	  pyramidal	  neuron	  
precursors	  within	   the	   lower	   intermediate	   zone	   delaying	   their	   entry	   into	   the	   cortical	   plate	  
resulting	  in	  a	  switch	  in	  their	  laminar	  identity.	  Subsequently,	  Foxg1	  upregulation	  is	  specifically	  
required	   for	   cells	   to	   transit	   out	   of	   the	   multipolar	   state	   and	   enter	   into	   the	   cortical	   plate.	  
Failure	   in	   Foxg1	   upregulation	   results	   in	   a	   regression	   to	   the	   early	  multipolar	   phase	   by	   re-­‐
expressing	  genes	  associated	  with	  this	  phase	  (Neurod1	  and	  Uncd5)	  and	  in	  a	  permanently	  loss	  
of	  pyramidal	  neuron	  precursors	  to	  enter	  into	  the	  cortical	  plate.	  Thus,	  timing	  and	  duration	  of	  
the	  multipolar	   phase	   during	   tangential	   neuronal	  migration	   is	   precisely	   regulated	  by	  Foxg1	  
activity	  and	  is	  therefore	  crucial	  to	  the	  assembly	  of	  the	  laminar	  organization	  suggesting	  once	  













Fig.	  1.18	  Dynamic	  Foxg1	  expression	  
in	  pyramidal	  neurons	  
a)	   Dynamic	   Foxg1	   expression	  
through	   the	   multipolar	   phase	   of	  
pyramidal	  neurons	  
b)	   Scheme	   summarizing	  Foxg1	   roles	  
in	  pyramidal	  neuron	  development.	  











1.10	  Foxg1	  and	  neuronal	  differentiation	  
	  
During	   early	   phases	   of	   cortical	   development,	   Foxg1	   is	   essential	   for	   the	   correct	  
neurogenesis	  of	  the	  telencephalic	  progenitor	  cells.	  However,	  the	  protein	  is	  still	  expressed	  in	  
post-­‐natal	   tissues,	   suggesting	   that	   its	   function	   could	   be	   essential	   also	   in	   post-­‐mitotic	  
neurons.	   In	   fact,	   several	   evidences	   are	   starting	   to	   cast	   light	   on	   its	   function	   in	   neuronal	  
differentiation.	  
In	   particular,	   Foxg1	   has	   a	   role	   in	   the	   timing	   of	   layer	   neurogenesis.	   It	   confers	   the	  
sequence	   of	   deep	   layer	   (DL)	   and	   upper	   layer	   (UL)	   competence	   through	   Tbr1	   repression	  
(Toma	   et	   al.,	   2014).	   Foxg1	   is	   a	   nuclear-­‐cytosolic	   transcription	   factor	   and	   its	   intracellular	  
localization	  is	  controlled	  post	  translationally	  (Regad	  et	  al.,	  2007).	  Specifically,	  it	  is	  alternated	  
between	   the	   nucleus	   and	   the	   cytoplasm:	   in	   areas	   of	   active	   neurogenesis	   Foxg1	   is	  




differentiation	   areas.	   In	   the	   nucleus,	   Foxg1	   act	   as	   a	   transcriptional	   repressor;	   targets	  
examples	  include	  FGFs,	  Shh	  and	  cell-­‐cycle	  inhibitors	  such	  as	  p21Cip1	  (Seoane	  et	  al.,	  2004).	  In	  
the	   cytoplasm,	   Foxg1	   inhibit	   TGF-­‐β	   signalling	   by	   binding	   to	   Smad	   and	   FoxO	   transcription	  
factor	  (Dou	  et	  al.,	  1999;	  Seoane	  et	  al.,	  2004).	  
Recent	  studies,	  started	  to	  provide	  insights	  on	  Foxg1	  subcellular	  localization	  (Pancrazi	  
et	  al.,	  2015).	  It	  has	  been	  shown	  that	  a	  fraction	  of	  Foxg1,	  having	  a	  unique	  domain	  responsible	  
for	   its	   targeting,	   localizes	   in	   the	   mitochondria.	   Mitochondria	   have	   a	   role	   in	   controlling	  
fundamental	   processes	   in	   neurodevelopment	   and	   neuroplasticity,	   including	   the	  
differentiation	   of	   neurons,	   the	   growth	   of	   axons	   and	   dendrites,	   and	   finally	   formation	   and	  
reorganization	  of	  synapse	  	  (Gioran	  et	  al.,	  2014;	  Mattson	  et	  al.,	  2008).	  Foxg1	  may	  represent	  
thus	   a	   key	   link	   between	   mitochondrial	   function	   and	   neuronal	   differentiation.	   Full-­‐length	  
Foxg1	  forms	  (both	  mitochondrial	  and	  cytosolic)	  promotes	  mitochondrial	  fission	  and	  cellular	  
proliferation,	   whereas	  mt-­‐Foxg1	   form	   (proteolized	   form,	   exclusively	  mitochondrial)	   favors	  
mitochondrial	  fusion	  and	  an	  early	  phase	  of	  neuronal	  differentiation.	  	  
Besides,	   Foxg1	   overexpressed	   under	   the	   control	   of	   the	   neuronal	   lineage-­‐specific	  
Tubulin	   alpha	   1	   promoter	   (pTα1),	   it	   force	   to	   keep	   proliferating	   neural	   progenitors	   (NP).	  
However,	   if	   the	   transgene	   is	   shut	  down,	  NPs	  exit	   cell	   cycle	   and	   the	   result	   is	   a	   remarkable	  
increase	   of	   the	   neuronal	   output.	   Furthermore,	   these	   neurons	   show	   a	   prominent	   neurite	  
overgrowth	  (Brancaccio	  et	  al.,	  2010).	  
Moreover,	  in	  experiments	  done	  using	  three-­‐dimensional	  neural	  cultures	  derived	  from	  
induced	  pluripotent	   stem	  cells	   (iPSCs)	  of	   individuals	  with	  severe	   idiopatic	  ASD,	   it	  has	  been	  
found	  that	  Foxg1	  overexpression	  is	  correlated	  with	  an	  increase	  in	  proliferation	  and	  number	  
of	   GABA	   precursors	   cells	   (Mariani	   et	   al.,	   2015).	   In	   addition	   to	   the	   GABAergic	   neuron	  










1.11	  Foxg1	  in	  astrogenesis	  control	  
	  
Recent	  studies	  revealed	  the	  implication	  of	  Foxg1	  in	  the	  astrogenesis.	  In	  particular,	  in	  
vitro	  studies	  made	  by	  Brancaccio	  et	  al.	  (2010),	  demonstrated	  that	  overexpression	  of	  Foxg1	  in	  
neural	   stem	   cells	   (NSCs)	   enlarge	   this	   compartment	   and	   halved	   their	   astroglial	   output	  
possibly	   because	   of	   impaired	   commitment	   of	   these	   cells	   to	   glial	   fates	   and	   defective	  
progression	  of	  early	  glia	  committed	  progenitors.	  Until	  now,	  in	  vertebrates	  no	  one	  reported	  
anti-­‐gliogenic	   activity	   of	   Foxg1,	   however	   this	   activity	   is	   not	   phylogenetically	   novel.	   Two	  
Drosophila	   Foxg1	   orthologs,	   Sloppy	   paired-­‐1	   and	   -­‐2	   (Slp1	   and	   Slp2),	   have	   been	   shown	   to	  
promote	  neurogenesis	  at	  the	  expenses	  of	  gliogenesis	  (Bhat	  et	  al.,	  2000)	  and	  Foxg1	  rescues	  
the	  Slp1&2	  null	  phenotype	  (Mondal	  et	  al.,	  2007).	  An	  explanation	  to	  the	  behaviour	  of	  Foxg1-­‐
GOF	  NSCs	   could	   rely	   on	   the	   unbalanced	   expression	   of	   Hes1,	   a	   key	   promoter	   of	   NSC	   self-­‐
renewal	  (Ohtsuka	  et	  al.,	  2001)	  and	  key	  gliogenesis	  promoters	  such	  Coup-­‐tf1,	  Nf1a	  and	  Olig2	  




1.12	  West	  Syndrome	  (WS)	  
	  
West	   syndrome	   is	   a	   severe	   epilepsy	   syndrome	   composed	   of	   the	   triad	   of	   infantile	  
spasms,	   an	   interictal	   electroencephalogram	   (EEG)	   pattern	   termed	   hypsarrhythmia,	   and	  
mental	  retardation.	  However	  the	  diagnosis	  can	  be	  made	  even	  if	  one	  of	  the	  three	  elements	  is	  
missing	  (according	  to	  the	  international	  classification)	  (Taghdiri	  and	  Nemati,	  2014).	  	  
The	   syndrome's	   namesake,	   Dr	   W.	   J.	   West,	   gave	   the	   first	   detailed	   description	   of	  
infantile	  spasms,	  which	  occurred	  in	  his	  own	  child,	  in	  the	  1840s.	  
West	   syndrome	   is	   an	   age-­‐dependent	   expression	   of	   a	   damaged	   brain,	   and	   most	  
patients	  with	  infantile	  spasms	  have	  some	  degree	  of	  developmental	  delay.	  The	  term	  infantile	  






Infantile	  spasm	  constitutes	  2%	  of	  childhood	  epilepsies	  but	  25%	  of	  epilepsy	  with	  onset	  
in	  the	  first	  year	  of	  life.	  The	  rate	  of	  infantile	  spasm	  is	  estimated	  to	  be	  2.5-­‐6.0	  cases	  per	  10,000	  
live	  births	   (Hrachovy	  and	  Frost,	  1989).	  Males	  are	  affected	  by	   infantile	   spasm	  slightly	  more	  
often	   than	   females.	   Ninety	   percent	   of	   infantile	   spasms	   begin	   in	   infants	   younger	   than	   12	  
months.	  Peak	  onset	  is	  at	  age	  4-­‐6	  months	  (Zupanc,	  2003).	  	  
	  
Clinical	  manifestation	  
Spasms	  begin	  with	  a	  sudden,	  rapid,	  tonic	  contraction	  of	  trunk	  and	  limb	  musculature	  
that	  gradually	  relaxes	  over	  0.5-­‐2	  seconds.	  Contractions	  can	  last	  5-­‐10	  seconds.	  The	  intensity	  
of	   spasms	   may	   vary	   from	   a	   subtle	   head	   nodding	   to	   a	   powerful	   contraction	   of	   the	   body.	  
Infantile	   spasms	  usually	  occur	   in	  clusters,	  often	  several	  dozen,	   separated	  by	  5-­‐30	  seconds.	  
Spasms	   frequently	   occur	   just	   before	   sleep	   or	   upon	   awakening.	   Spasms	   can	   be	   flexor,	  
extensor,	  or	  a	  mixture	  of	  flexion	  and	  extension	  that	  is	  the	  most	  common	  type.	  	  In	  70-­‐95%	  of	  
patients,	   the	   onset	   of	   spasms	   is	   accompanied	   by	   an	   arrest	   or	   regression	   of	   psychomotor	  
development.	  	  
Moreover,	  patients	  may	  exhibit	  from	  moderate	  to	  severe	  growth	  delay,	  but	  this	  is	  a	  
nonspecific	   finding	   as	   it	   could	   reflect	   the	   underlying	   brain	   injury.	   Besides,	   patients	   with	  
infantile	  spasms	  demonstrates	  abnormalities	  in	  mental	  status	  function,	  specifically	  delays	  in	  
developmental	  signs	  consistent	  with	  developmental	  delay	  or	  regression.	  EEG	  abnormalities	  
consist	   in	  a	  pattern	  called	  ‘hypsarrhythmia’:	  high	  amplitude	  and	  irregular	  waves	  and	  spikes	  
in	  a	  background	  of	  chaotic	  and	  disorganized	  activity.	  Basically,	  brain	  electrical	  activity	  is	  very	  
chaotic	  and	  disorganized	  with	  no	  recognizable	  pattern,	  whereas	  a	  normal	  EEG	  shows	  clear	  
separation	   between	   each	   signal	   and	   visible	   pattern.	   The	   ‘chaotic’	   pattern	   becomes	   more	  
organized	  with	  time	  and	  in	  most	  cases	  of	  infantile	  spasms,	  hypsarrhythmia	  either	  disappears	  
or	   improves	   during	   a	   cluster	   of	   spasms	   and/or	   REM	   sleep.	   Hypsarrhythmia	   rarely	   persists	  






	  	  	  	  	  	  Fig.	  1.19	  EEG	  recordings	  in	  a	  West	  syndrome	  patient	  	  
	  	  	  	  	  	  Modified	  from	  (Bertossi	  et	  al.,	  2014)	  
	  
Etiology	  
Infantile	   spasms	   are	   believed	   to	   reflect	   abnormal	   interactions	   between	   the	   cortex	  
and	  brainstem	  structures.	  Focal	  lesions	  early	  in	  life	  may	  secondarily	  affect	  other	  sites	  in	  the	  
brain,	  and	  hypsarrhythmia	  may	  represent	  this	  abnormal	  activity	  arising	  from	  multiple	  brain	  
sites.	   The	   frequent	  onset	  of	   infantile	   spasms	   in	   infancy	   suggests	   that	   an	   immature	   central	  
nervous	  system	  (CNS)	  may	  be	  important	  in	  the	  syndrome’s	  pathogenesis.	  
Infantile	   spasms	   can	   be	   classified	   according	   to	   their	   suspected	   etiology	   as	  
symptomatic,	  cryptogenic,	  or	   idiopathic.	  Patients	  are	  diagnosed	  with	  symptomatic	   infantile	  
spasms	   if	   an	   identifiable	   factor	   is	   responsible	   for	   the	   syndrome	   (ILAE	   Task	   Force,	   1989).	  
Virtually	   any	   disorder	   that	   can	   produce	   brain	   damage	   can	   be	   associated	   with	   infantile	  
spasms.	  If	  there	  is	  no	  cause	  identified	  but	  a	  cause	  is	  suspected	  and	  the	  epilepsy	  is	  presumed	  
to	  be	  symptomatic,	  the	  infantile	  spasm	  is	  cryptogenic	  (Matsumoto	  et	  al.,	  1981;	  Vigevano	  et	  
al.,	   1993).	   Patients	   may	   be	   considered	   to	   have	   idiopathic	   infantile	   spasms	   if	   there	   is	   a	  
possible	  hereditary	  predisposition,	  such	  a	  family	  history	  of	  epilepsy	  (ILAE	  Task	  Force,	  1992).	  	  
Two	   specific	   genetic	   defects	   have	   a	   phenotypic	   presentation	   similar	   to	   that	   of	   the	   early	  
onset	  of	  infantile	  spasms.	  The	  first	  is	  an	  abnormality	  in	  the	  short	  arm	  of	  chromosome	  X.	  The	  
gene	   ARX	   is	   associated	   with	   a	   wide	   variety	   of	   structural	   abnormalities	   and	   early	   onset	  




The	   second	   abnormality	   is	   in	   the	   cyclin-­‐dependent	   kinase-­‐like	   protein	   5	   (CDKL5)	   and	   has	  




1.13	  Relationship	  between	  WS	  and	  FOXG1	  
	  
Duplications	   of	   chromosome	   14q12	   harbouring	   FOXG1	   locus	   have	   been	   recently	  
reported	   in	   patients	   with	   infantile	   spasm	   and	   developmental	   delay	   of	   variable	   severity	  
(Brunetti-­‐Pierri	  et	  al.,	  2011;	  Pontrelli	  et	  al.,	  2014;	  Yeung	  et	  al.,	  2009).	  Size	  of	  the	  duplication	  
may	  differ,	   from	  88	  Kb	   to	  84	  Mb.	   To	  date,	   15	  patients	  with	  14dup.	   including	  FOXG1	   have	  
been	  reported	  and	  nine	  of	  them	  presented	  epilepsy	  with	  a	  mean	  age	  at	  onset	  4.9	  months.	  
Therefore,	   a	   new	   theory	   is	   emerging	   regarding	   the	   potential	   role	   of	  FOXG1	   duplication	   in	  
determining	  infantile	  spasm,	  developmental	  delay	  and	  severe	  epilepsy	  because	  of	  increased	  
gene	  dosage.	  The	  contribution	  of	  FOXG1	  in	  the	  phenotype	  of	  reported	  patients	  is	  related	  to	  
its	  key	  function	  in	  brain	  development.	  	  	  
However,	   there	   are	   some	   reports	   of	   individuals	   with	   14q12	   duplication,	   including	  
FOXG1,	  with	  normal	  phenotype,	   intellect	  and	  no	  epilepsy	   (Amor	  et	  al.,	  2012;	  Shaikh	  et	  al.,	  
2009).	  The	  explanation	  to	  these	  phenotypic	  variabilities	  could	  be	  an	  incomplete	  penetrance	  
of	  FOXG1	  duplication,	  the	  variable	  involvement	  of	  its	  regulatory	  elements	  other	  genes	  in	  the	  
duplicated	   regions	   and	   genetic	  mosaicism	   (Brunetti-­‐Pierri	   et	   al.,	   2011;	   Falace	   et	   al.,	   2013;	  
Tohyama	  et	  al.,	  2011).	  	  
Remarkably,	   Foxg1	   overexpression	   in	   neuronal	   cultures	   increase	   neuronal	   output	  
while	  reducing	  the	  astroglial	  one	  and	  besides	  it	  promotes	  neurite	  growth	  (Brancaccio	  et	  al.,	  
2010).	   Neurite	   outgrowth	   (including	   axons	   and	   dendrites)	   may	   determine	   the	  
hyperexcitability	  of	  the	  cortex	  because	  of	  the	  enlarged	  afferent	  basin	  of	  neurons.	  Besides,	  if	  
the	   ratio	   astrocytes/neurons	   is	   lowered,	   astrocytes	   function	   in	   neurotransmitter	   and	  




neuronal	  excitability.	  All	   these	  phenomena	  may	  contribute	  to	  abnormal	  electrical	  activities	  

























2. AIM	  OF	  THE	  WORK	  
	  
	   Aim	   of	   this	   study	   was	   to	   model	   etiopathogenetic	   mechanisms	   linking	   FOXG1	  
duplication	   to	   neurodevelopmental	   and	  neurological	   disorders	   peculiar	   to	   human	  patients	  
affected	  by	  the	  FOXG1-­‐duplication-­‐associated	  variant	  of	  the	  West	  syndrome.	  	  
	   Such	   modeling	   was	   performed	   in	   mutant	   Foxg1-­‐GOF	   mouse	   models	   as	   well	   in	  



























3.	  MATERIAL	  AND	  METHODS	  
	  
3.1 	  Mouse	  handling	  
Transgenic	  founders	  of	  Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐	  line	  E	  and	  Foxg1+/+;Tg:Tre-­‐Foxg1-­‐
IRES-­‐Egfp+/-­‐	  line	  D	  	  were	  generated	  at	  the	  Core	  Facility	  for	  Conditional	  Mutagenesis	  of	  the	  San	  
Raffaele	  Scientific	  Institute,	  Milan,	  Italy.	  The	  "Tre-­‐Foxg1-­‐IRES-­‐Egfp"	  transgene	  was	  delivered	  
to	   CBA1xC57Bl6	   zygotes	   by	   subzonal	   injection	   of	   the	   lentiviral	   vector	   LV_TREt-­‐Foxg1-­‐IRES-­‐
EGFP	   (Fig.	   1A)	   (Brancaccio	   et	   al.,	   2010).	   Injected	   embryos	   were	   implanted	   in	   CD1	   foster	  
mothers.	   Three,	   PCR-­‐positive,	  male	   founders	  were	   selected,	   in	   the	   Laboratory	   of	   Cerebral	  
Cortex	  Development,	  at	  SISSA,	  Trieste,	  Italy.	  These	  mice	  and	  their	  transgenic	  progenies	  were	  
repeteadly	  backcrossed	  against	  a	  CD1	  outbred	  background	   (>15	  generations),	   so	  obtaining	  
three	  single-­‐transgene	  insertion,	  CD1-­‐congenic	  subfounders,	  "C",	  "D"	  and	  "E".	  
	   Foxg1tTA/+	  founders	  (Hanashima	  et	  al.,	  2002)	  were	  kindly	  provided	  by	  Dr.	  Ugo	  Borello,	  
at	  Inserm	  U846,	  Stem	  Cell	  and	  Brain	  Research	  Institute,	  Bron,	  France	  
	   Wild	   type	   mice	   (strains	   CD1	   purchased	   from	   Harlan-­‐Italy)	   used	   in	   this	   study	   were	  
maintained	  at	  the	  SISSA	  mouse	  facility.	  	  
	   Animals	   handling	   and	   subsequent	   procedures	   were	   in	   accordance	   with	   European	  
laws	   [European	   Communities	   Council	   Directive	   of	   November	   24,	   1986	   (86/609/EEC)]	   and	  
with	  National	  Institutes	  of	  Health	  guidelines.	  	  
	   Embryos	  were	  staged	  by	  timed	  breeding	  and	  vaginal	  plug	  inspection.	  	  	  	  
	  
	  
3.2	  Validation	  of	  Foxg1-­‐GOF	  transgenic	  line	  "E"	  in	  vitro	  
	  
Cortico-­‐cerebral	   precursors	   were	   harvested	   from	   E12.5	   Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐mice,	  
acutely	   infected	  by	  LV_Pgk1p-­‐rtTAM2	  at	  m.o.i	  =	  8	  and	  cultured	  as	  floating	  neurospheres	  in	  
pro-­‐proliferative	   medium	   [1:1	   DMEM-­‐F12,	   1X	   Glutamax	   (Gibco),	   1X	   N2	   supplement	  
(Invitrogen),	   1mg/ml	   BSA,	   0.6%	   w/v	   glucose,	   2μg/ml	   heparin	   (Stemcell	   technologies),	  




fungizone	  (Gibco)]	  	  ,	  under	  2µg/ml	  doxycyclin,	  for	  4	  days.	  EGFP	  expression	  was	  firstly	  evaluated	  
by	  fluorescence	  microscope	  at	  DIV	  4.	   	  Subsequently,	  part	  of	  the	  culture	  was	  transferred	  to	  
polylysinated	   coverslips	   and	   kept	   under	   pro-­‐differentiative	   medium	   [1:1	   DMEM-­‐F12,	   1X	  
Glutamax,	  1X	  N2	  supplement,	  1X	  B27	  supplement,	  6	  mg/ml	  glucose,	  1mg/ml	  BSA,	  2.0	  µg/ml	  
heparin,	  5%	  heat	  inactivated	  FBS],	  supplemented	  with	  2µg/ml	  doxycyclin,	  when	  required,	  for	  	  5	  




3.3	  Primary,	  neuronal,	  astroglial	  and	  mixed	  cultures	  	  
	  
3.3.1	  Cortico-­‐cerebral	  neuronal	  and	  mixed	  cultures	  
	  
Cortical	   tissue	   from	   E16.5	  mice	  was	   chopped	   to	   small	   pieces	   for	   5	  minutes,	   in	   the	  
smallest	  volume	  of	   ice-­‐cold	  1X	  PBS-­‐0,6%	  glucose-­‐0,1%	  DNaseI.	  The	  minced	  tissue	  was	  then	  
resuspended	   and	   digested	   in	   0.25mg/ml	   trypsin-­‐	   4mg/ml	   DNAseI	   for	   5	   minutes	   at	   37°C.	  
Digestion	   was	   stopped	   by	   adding	   ≥1.5	   volumes	   of	   DMEM/F12/10%FBS.	   Cortices	   were	  
spinned	  down	  and	  transferred	  to	  differentiative	  medium.	  The	  suspension	  was	  pipetted	  5-­‐8	  
times	   with	   a	   P1000	   gilson	   pipette	   and	   undissociated	   tissue	   was	   left	   to	   sediment	   for	   1-­‐2	  
minutes.	   The	   supernatant	   was	   harvested	   and	   the	   living	   cells	   counted.	   1x10^6	   cells	   were	  
plated	   on	   poly-­‐L-­‐Lysine	   coated	   12	   multiwell	   plates,	   in	   600	   μl	   of	   culturing	   medium:	  
Neurobasal-­‐A,	   1X	   Glutamax	   (Gibco),	   1X	   B27	   supplement	   (Invitrogen),	   L-­‐glutamate	   25µM,	  
25μM	  β-­‐Mercaptoethanol,	  2%	  FBS,	  10	  µM	  Cytosine	  β-­‐D-­‐arabinofuranoside	  “AraC”	   (Sigma),	  
1X	   Pen/Strept	   (Gibco),	   10	   pg/ml	   fungizone	   (Gibco)].	  Medium	  was	   half-­‐replaced	  with	   fresh	  
one	  every	  3.5	  days.	  	  	  
The	  same	  protocol	  was	  followed	  for	  mixed	  cultures,	  except	  for	  the	  addition	  of	  AraC	  
which	  was	  omitted.	  
When	  required,	  neuronal	  and	  mixed	  cultures	  were	  infected	  with	  dominant	  negative	  




doxycycline	  (Clontech)	  was	  added	  at	  DIV	  5	  except	  for	  the	  infection	  with	  LV_dn	  CREB	  and	  its	  
relative	  control	  where	  doxycycline	  has	  been	  lowered	  to	  0.062	  µg/ml.	  	  
As	   for	   Foxg1-­‐gain	   of	   function	   neuronal	   cultures,	   primary	   cortical	   precursors	   were	  
harvested	   from	  E14.5	  mice.	   The	   same	  neuronal	   culture	  procedure	   as	  previously	  described	  
was	   followed.	   	   Infection	   has	   been	   made	   at	   E15.5	   with	   LV_pTα1-­‐rtTA2S-­‐M2	   and	   LV_Tre-­‐
Foxg1-­‐EGFP	  or	  LV_Tre-­‐EGFP.	  Each	  LV	  was	  used	  at	  m.o.i	  =	  8.	  
	  
	  
3.3.2	  Astroglial	  cultures	  
	  
On	  day	  0,	  neural	  precursors	  were	  isolated	  from	  E12.5	  embryonic	  cortices	  and	  plated	  
onto	  uncoated	  24	  multiwell	  (BD	  Falcon)	  after	  gentle	  mechanical	  dissociation	  to	  single	  cells.	  
3x105	  cortical	  precursors	  were	  plated	  for	  each	  well	   in	  300μl	  of	  serum	  free	  pro-­‐proliferative	  
medium	  [1:1	  DMEM-­‐F12,	  1X	  Glutamax	  (Gibco),	  1X	  N2	  supplement	  (Invitrogen),	  1mg/ml	  BSA,	  
0.6%	   w/v	   glucose,	   2μg/ml	   heparin	   (Stemcell	   technologies),	   20ng/ml	   bFGF	   (Invitrogen),	  
20ng/ml	  EGF	  (Invitrogen),	  1X	  Pen/Strept	  (Gibco),	  10pg/ml	  fungizone	  (Gibco)]	  and	  cultured	  as	  
floating	  neuropspheres.	  On	  day	  in	  vitro	  2	  (DIV2),	  if	  necessary	  neurospheres	  were	  harvested	  
by	   centrifugation	   (300g	   for	   3'	   at	   RT)	   and	   dissociated	   by	   trypsin	   1X	   (Sigma)	   at	   RT	   for	   2’.	  
Trypsin	   was	   neutralized	   by	   adding	   1	   volume	   of	   DMEM/F12	  medium	   containing	   Soy	   bean	  
Trypsin	   Inhibitor140	  μg/ml	  and	  DNAseI	  10	  μg/ml.	  Afterwards,	   the	  cells	  were	  centrifugated	  
(200g	  for	  7'	  at	  RT)	  resuspended	  and	  ri-­‐plated	  at	  3x105	  in	  pro-­‐proliferative	  medium	  as	  on	  day	  
0.	  On	  day	  in	  vitro	  4	  (DIV4),	  the	  neurospheres	  were	  dissociated	  as	  previously	  described	  and	  
resuspended	  in	  a	  differentiative	  –	  medium	  [1:1	  DMEM,	  Glutamax	  (Gibco)	  ,	  10%	  FBS]	  at	  3x105	  
on	  200	  µg/ml	  poly-­‐L-­‐lysine-­‐coated	  12	  multiwells.	  Medium	  was	  half-­‐replaced	  with	  fresh	  one	  
every	  3.5	  days.	  	  	  
When	   required,	   astroglial	   cultures	   were	   infected	   at	   day	   0	   with	   LV_dn	   as	   shown	   in	  
figure	  R13.	  Each	  LV	  was	  used	  at	  m.o.i=8.	  2	  µg/ml	  of	  doxycycline	  (Clontech)	  was	  added	  at	  DIV	  
9	  except	   for	   the	   infection	  with	   LV_dn	  CREB	  and	   its	   relative	   control	  where	  doxycycline	  has	  





	  3.4	  Lentiviral	  production	  and	  titration	  
	  
Third	   generation	   self-­‐inactivating	   (SIN)	   lentiviral	   vectors	   were	   produced	   as	   previously	  
described	  (Follenzi	  and	  Naldini,	  2002)	  with	  some	  modifications.	  Briefly,	  293T	  cells	  were	  co-­‐
transfected	   by	   LipoD	   (SignaGen)	  with	   the	   transfer	   vector	   plasmid	   together	  with	   the	   three	  
auxiliary	   plasmids	   (pMD2	   VSV.G,	   pMDLg/pRRE,	   pRSV-­‐REV).	   The	   conditioned	   medium	   was	  
collected	  after	  24	  and	  48	  hrs,	  filtered	  and	  ultracentrifugated	  at	  50000	  RCF	  on	  a	  fixed	  angle	  
rotor	  (JA	  25.50	  Beckmann	  Coulter)	  for	  150	  min	  at	  4°C.	  Viral	  pellets	  were	  resuspended	  in	  PBS	  
without	  BSA	  (Gibco).	  
Lentiviral	  vectors	  were	  generally	  titrated	  by	  Real	  Time	  quantitative	  PCR	  after	  infection	  of	  
HEK293T	   cells,	   as	   previously	   reported	   (Sastry	   et	   al.,	   2002).	   One	   end	   point	   fluorescence	   –
titrated	  LV	  was	   included	   in	  eeach	  PCR	  titration	  session	  and	  PCR-­‐titers	  were	  converted	   into	  
fluorescence	  equivalent	  titers	  throught	  the	  study.	  	  
	  
	  
	  3.5	  Lentiviral	  plasmids	  constructions	  
	  
Basic	   DNA	   manipulations	   (extraction,	   purification,	   ligation)	   as	   well	   as	   bacterial	  
cultures	   and	   transformation,	  media	   and	  buffer	   preparations	  were	  performed	   according	   to	  
standard	   methods.	   Restriction	   enzymes	   were	   obtained	   from	   Promega	   and	   New	   England	  
Biolabs;	  DNA	   fragments	  were	  purified	   from	  agarose	  gel	  by	   the	  QIAquick	  Gel	  Extraction	  Kit	  
(QIAGEN).	  Plasmids	  were	  grown	  in	  E.Coli,	  Xl1-­‐blue	  or	  ElectroMAXTM	  Stbl4TM	  Competent	  Cells	  
(Invitrogen).	  
Lentiviral	  vectors	  employed	  in	  this	  study	  include:	  




-­‐LV_TREt-­‐IRES2-­‐EGFP	   derived	   from	   LV_TREt-­‐luc-­‐IRES2-­‐EGFP	   (Brancaccio	   et	   al.,	   2010),	   via	  
deletion	  of	  the	  luc	  cassette	  
-­‐LV_pTα1-­‐rtTA2S-­‐M2	  (Brancaccio	  et	  al.,	  2010)	  
-­‐LV_Tre-­‐Foxg1-­‐EGFP	  (Brancaccio	  et	  al.,	  2010)	  
-­‐LV_Tre-­‐EGFP	  (Brancaccio	  et	  al.,	  2010)	  
Dominant	   negative	   (DN)	   constructs	  were	   builded	   from	   LV_TREt-­‐IRES2-­‐EGFP	   (Brancaccio	   et	  
al.,	  2010)	  by	  replacing	  the	  EGFP	  cassette	  with	  the	  DN	  coding	  sequence	  (cds).	  
	  
	  
DN	  [ref]	   DN	  cds	  
Fos-­‐DN	  
(A-­‐Fos,	  JBC272(30):	  18586–18594	  	  































(A-­‐CebpA, JBC	  274:211-­‐217	  











	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Nfkb-­‐DN	  
(mmu-­‐IKBaM,	  	  Mol	  Cell	  Biol	  16(7):3554–3559	  
Schwarz	  et	  al.,	  1996	  &	  Science	  
































(A-­‐Creb,	  Mol	  Cell	  Biol	  18(2):967-­‐977	  












	  3.6	  Quantitative	  RT-­‐PCR	  
	  	  
	  	   In	   each	   experimental	   session,	   1x106	   cells	   were	   processed	   for	   RNA	   extraction	   by	  
Trizol®	   Reagent	   (AmbionTM)	   according	   to	   manufacturer’s	   instructions.	   RNA	   preparations	  
were	   treated	   by	   TURBOTMDNase	   (2U/µl)(AmbionTM)	   1	   hour	   at	   37°C.	   At	   least	   0.750	   µg	   of	  
genomic	   DNA-­‐free	   total	   RNA	   from	   each	   sample	   was	   retro-­‐transcribed	   by	   SuperScriptIIITM	  	  
(Invitrogen)	  in	  the	  presence	  of	  random	  hexamers,	  according	  to	  manufacturer’s	  instructions.	  
1/100	   of	   the	   resulting	   cDNA	   was	   used	   as	   substrate	   of	   any	   qPCR	   reaction.	   Limited	   to	  
intronless	   amplicons,	   negative	   controls	   PCRs	   were	   run	   on	   RT(-­‐)	   RNA	   preparations.	   PCR	  
reactions	  were	  performed	  by	  the	  SsoAdvanced	  STBR	  Green	  Supermix	   TM	  platform	  (Biorad),	  
according	   to	  manufacturer’s	   instructions.	   Per	   each	   transcript	   under	   examination	   and	  each	  
sample,	  cDNA	  was	  PCR-­‐analyzed	   in	   technical	   triplicate	  and	  result	  averaged.	  Averages	  were	  
further	   normalized	   against	   Gapdh.	   Experiments	   were	   performed	   in	   at	   least	   biological	  







Oligos	  were	  as	  follows:	  
mFoxg1cds/F 5’ CGA CCC TGC CCT GTG AGT CTT TAA G 3’ 
mFoxg1cds/R 5’ GGG TTG GAA GAA GAC CCC TGA TTT TGA TG 3’ 
mGapdh5/F 5’ ATC TTC TTG TGC AGT GCC AGC CTC GTC 3’ 
mGapdh5/R 5’ GAA CAT GTA GAC CAT GTA GTT GAG GTC AAT GAA GG 3’ 
mmuGluA1/F 5' TCC ATG TGA TCG AAA TGA AGC ATG ATG GAA TCC 3' 
 
mmuGluA1/R 5' CGA TGT AGG TTC TAT TCT GGA CGC TTG AGT TG 3' 
 
mmuGluN1/F 5' CGA GGA TAC CAG ATG TCC ACC AGA CTA AAG A 3' 
 
mmuGluN1/R 5' CTT GAC AGG GTC ACC ATT GAC TGT GAA CT 3' 
 
mmuGluD1/F 5' AAG GAC TGA CTC TCA AAG TGG TGA CTG TCT T 3' 
 
mmuGluD1/R 5' CCT TAG CCA GTG CAT CCA GCA CAT CTA TG 3' 
 
 
mmuGabra1/F 5' AAA CCA GTA TGA CCT TCT TGG ACA AAC AGT TGA C 
3' 
 
mmuGabra1/R 5' GTG GAA GTG AGT CGT CAT AAC CAC ATA TTC TC 3' 
 
mmuvGluT1/F 5' CAT GGA GTT CCG GCA GGA GGA GTT TCG 3' 
 
mmuvGluT1/R 5' CGT CGG CAC TCA GCT CCA GTG TCT C 3'   
 
mmuvGluT2/F 5' TTT TGC TGG AAA ATC CCT CGG ACA GAT CTA CA 3' 
 






mFos/F1N 5' CTG ACA GAT ACA CTC CAA GCG GAG ACA G 3' 
 
mFos/R1N 5' ACA TCT CCT CTG GGA AGC CAA GGT CAT C 3' 
 
mEgr1/F1 5' AAC CCT ATG AGC ACC TGA CCA CAG AGT C 3' 
 
mEgr1/R1 5' CGT TTG GCT GGG ATA ACT CGT CTC CAC 3' 
 
mEgr2/F1 5' AGG CCC CTT TGA CCA GAT GAA CGG AGT 3' 
 
mEgr2/R1 5' GTT TCT AGG TGC AGA GAT GGG AGC GAA G 3' 
 
 
Protocol	  was	  as	  follows:	  
• Incubate	  at	  98°C	  for	  00:04:00	  
• Incubate	  at	  98°C	  for	  00:00:10	  
• Incubate	  at	  Ta°C	  for	  00:00:15	  
• Incubate	  at	  72°C	  for	  00:00:20	  
• Incubate	  at	  78°C	  for	  00:00:03+	  plate	  read	  
• Incubate	  at	  80°C	  for	  00:00:03+	  plate	  read	  
• Incubate	  at	  82°C	  for	  00:00:03+	  plate	  read	  
• Go	  to	  line	  2	  for	  39	  more	  times	  




Ta	   	  
60	   GluA1,GluN1,	  GluD1,	  Gabra1,	  vGluT1,	  vGluT2	  
62	   Foxg1cds	  




70	   Gapdh5	  
	  
	  
	  	  3.7	  Immunofluorescence	  
	  
For	  immunocytofluorescence	  cells	  were	  fixed	  directly	  on	  poly-­‐L-­‐lysine	  coated	  1	  cm	  Ø	  
glass	   coverslips	   in	   24	  multiwell	   plates	  with	   4%	   paraformaldehyde	   (PFA)	   for	   20	  min	   at	   RT.	  
Subsequently	  cells	  were	  washed	  3	  times	  in	  1X	  PBS.	  	  
As	  for	  immunofluorescence	  on	  brain	  sections,	  slices	  were	  allowed	  to	  dry	  at	  least	  one	  
hour	  at	  RT,	  they	  were	  post-­‐fixed	  5	  minutes	  in	  4%	  paraformaldehyde	  at	  RT,	  followed	  by	  three	  
washes	  in	  1X	  PBS.	  In	  all	  cases,	  samples	  were	  subsequently	  treated	  with	  blocking	  mix	  (1X	  PBS;	  
10%	  FBS;	  1mg/ml	  BSA;	  0.1%	  Triton	  X100)	  for	  at	  least	  1	  hour	  at	  RT.	  After	  that,	  incubation	  with	  
primary	  antibody	  was	  performed	   in	  blocking	  mix,	  overnight	  at	  4°C.	  The	  day	  after,	   samples	  
were	  washed	  in	  “1X	  PBS-­‐0.1%	  Triton	  X-­‐100”	  3	  times	  for	  5	  minutes	  and	  then	  incubated	  with	  a	  
secondary	  antibody	  in	  blocking	  mix,	  for	  2	  hours	  at	  RT.	  Samples	  were	  finally	  washed	  in	  1X	  PBS	  
for	   5	   minutes,	   3	   times	   and	   subsequently	   counterstained	   with	   DAPI	   (4’,	   6’-­‐diamidino-­‐2-­‐
phenylindole)	  and	  mounted	  in	  Vectashield	  Mounting	  Medium	  (Vector).	  In	  case	  of	  immunos	  
with	   anti-­‐Cux1,	   rabbit	   polyclonal	   (Santa	   Cruz,	   1:20)	   antigen	   retrieval	   was	   performed	   by	  
baking	  samples	  in	  500	  ml	  of	  10	  mM	  citrate	  buffer	  (pH	  6.0),	  at	  700	  W	  for	  5	  min.	  	  
The	   following	   primary	   antibodies	   were	   used:	   anti-­‐GFP,	   chicken	   polyclonal	   (Abcam	  
ab13970,	  1:400);	  anti-­‐Foxg1,	  rabbit	  polyclonal	  (gift	  from	  G.Corte,	  1;200);	  anti-­‐Tubβ3,	  mouse	  
monoclonal,	  (clone	  Tuj1,	  Covance	  MMS-­‐435P,	  1:1000);	  anti-­‐NeuN,	  mouse	  monoclonal	  (clone	  
A60,	   Millipore	   MAB	   377,	   1:80);	   anti-­‐GFAP,	   rabbit	   polyclonal	   (DAKO	   Z0334,	   1:500);	   anti-­‐
S100β,	   rabbit	   polyclonal	   (DAKO	   Z0311,	   1:300);	   anti-­‐Foxp2,	   rabbit	   polyclonal	   (Abcam,	  
ab16046	   1:800);	   anti-­‐Ctip2,	   rat	   monoclonal	   (Abcam	   ab18465,	   1:200);	   anti-­‐PV,	   mouse	  
monoclonal	   (Swant	  235,	  1:5000);	  anti-­‐SST,	   rat	  monoclonal	   (Millipore	  MAB	  354,	  1:50);	  anti-­‐
CR,	  rabbit	  polyclonal	  (Swant	  7697,	  1:1000).	  






	  	  3.8	  Images	  acquisitions	  
	  
Immunoprofiled	  cultured	  cells	  and	  brain	  sections	  were	  photographed	  on	  a	  Nikon	  TI-­‐E	  
microscope,	  equipped	  with	  20X	  or	  40X	  objectives	  and	  a	  Hamamatsu	  C4742-­‐95	  camera.	  
For	  figure	  R4	  brain	  sections	  were	  photographed	  on	  a	  Nikon	  TI-­‐E	  confocal	  microscope	  
equipped	  with	  20	  or	  40X	  objectives.	  Samples	  were	  collected	  as	  6µm	  Z-­‐stacks	  of	  1024*1024	  
pixel	  images.	  
For	   figure	   R7	   brain	   section	   has	   been	   photographed	   on	   Leica	   confocal	   microscope	  
equipped	  with	  40X	  objectives.	  Samples	  were	  collected	  as	  6µm	  Z-­‐stacks	  of	  1024*1024	  pixel	  
images.	  
All	  images	  were	  processed	  using	  Adobe	  9.0.2	  Photoshop	  2	  CS2	  software	  and	  ImageJ.	  	  
	  
	  
3.9	  	  EEG	  recordings	  
	  
EEG	   recordings	   were	   performed	   by	   Dr.	   Manuela	   Allegra	   in	   the	   laboratory	   of	   Dr.	  
Matteo	  Caleo	  at	  the	  CNR	  Neuroscience	  Institute	  in	  Pisa.	  	  
Briefly,	  electrical	  activity	  of	  P41	  Foxg1-­‐GOF	  and	  WT	  controls	   (n=4,4)	  was	  monitored	  	  
within	  the	  hippocampus.	  	  A	  bipolar	  electrode	  with	  its	  500	  placed	  µm-­‐spaced	  pins	  ending	  in	  
CA1	  and	  DG/hilus	   regions	  was	  used.	   It	  was	   secured	   to	   the	   skull	   and	  electrical	   activity	  was	  
monitored	  for	  three	  days,	  two	  hours	  per	  day.	  The	  temporal	  distribution	  of	  spikes,	  i.e	  voltage	  
fluctuations	  with	  amplitude	  exceeding	  4	  standard	  deviations	  (SD)	  was	  analyzed.	  Spikes	  were	  
categorised	  as	  "isolated"	  and	  "clustered",	  if	  alone	  or	  groupable	  in	  sets	  of	  at	  least	  two	  ones,	  
spaced	   less	   than	   0,5	   sec,	   respectively.	   Spike	   clusters	   were	   further	   distinguished	   into	  






3.10	  	  Behavioral	  analysis,	  kainate-­‐evoked	  seizures	  	  
	  
Behavioral	   analysis	   was	   performed	   in	   collaboration	   with	   Prof.	   Yuri	   Bozzi	   and	   Dr.	  
Giovanni	   Provenzano,	   at	   Centre	   for	   Integrative	   Biology	   (CIBIO),	   in	   Trent,	   and	   SISSA,	   in	  
Trieste.	  	  
Each	   mouse,	   at	   the	   P35/40	   stage,	   was	   weighted	   and	   kainic	   acid	   (SIGMA)	   was	  
administered	  20mg/kg	  by	  intraperitoneal	  injection.	  	  Subsequently	  mice	  were	  observed	  for	  2	  
hours	  and	  a	  score,	  based	  on	  the	  Racine’s	  stages,	  was	  given	  every	  ten	  minutes.	  
	  
Racine’s	  stages:	  
Stage	  0:	  normal	  activity	  	  
Stage	  1:	  immobility	  
Stage	  2:	  forelimb	  and/or	  tail	  extension,	  rigid	  posture,	  “hunchback	  position”	  
Stage	  3:	  repetitive	  movements,	  head	  bobbing	  
Stage	  4:	  rearing	  and	  falling	  with	  forelimb	  clonus	  and	  “praying	  posture”	  (limbic	  motor	  seizure,	  
LMS)	  
Stage	  5:	  continuous	  rearing	  and	  falling	  
Stage	  6:	  severe	  tonic-­‐clonic	  seizures	  (TCS)	  
Stage	  7:	  death	  
	  
At	  the	  end	  of	  the	  behavioral	  observation	  mice	  were	  sacrificed,	  brains	  were	  dissected	  
and	  included	  into	  Killik	  (Bio-­‐Optica)	  and	  further	  analyzed	  by	  in	  situ	  hybridization	  performed	  
by	  Dr.	  Giovanni	  Provenzano.	  	  	  	  	  	  
	  
	  





Generally,	   when	   not	   otherwise	   stated,	   experiments	   were	   performed	   at	   least	   in	  
biological	  triplicate.	  Results	  were	  averaged	  and	  their	  statistical	  significance	  was	  evaluated	  by	  























4.1	  Generation	  and	  preliminary	  characterization	  of	  Foxg1-­‐GOF	  mutant	  mice	  
	   To	  model	  etiopathogenetic	  mechanisms	   linking	  exaggerated	  FOXG1	  allele	  dosage	  to	  
pronounced	  neuronal	   hyperexcitability	   peculiar	   to	  West	   syndrome	  patients,	  we	   generated	  
mice	  gain	  of	  function	  for	  Foxg1,	  by	  lentiviral	  TetOFF	  transgenesis.	  
	   The	   "Tre-­‐Foxg1-­‐IRES-­‐Egfp"	   transgene	   was	   delivered	   to	   CBA1xC57Bl6	   zygotes	   by	  
subzonal	   injection	  of	  the	   lentiviral	  vector	  LV_TREt-­‐Foxg1-­‐IRES-­‐EGFP	  (Fig.	  1A)	   (Brancaccio	  et	  
al.,	   2010).	   Injected	   embryos	   were	   implanted	   in	   CD1	   foster	   mothers.	   Three,	   PCR-­‐positive,	  
male	   founders	  were	   selected.	   These	  mice	   and	   their	   transgenic	   progenies	  were	   repeteadly	  
backcrossed	  against	  a	  CD1	  outbred	  background	  (>15	  generations),	  so	  obtaining	  three	  single-­‐
transgene	  insertion,	  CD1-­‐congenic	  subfounders,	  "C",	  "D"	  and	  "E".	  
	   To	   preliminarly	   assess	   transgene	   functionality,	   we	   dissected	   out	   cortico-­‐cerebral	  
precursors	  from	  E12.5	  Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐	  embryos,	  acutely	  infected	  them	  by	  
LV_Pgk1p-­‐rtTAM2	   (driving	   constitutive	   expression	   of	   a	   doxycycline-­‐activatable	   rtTAM2	  
transactivator)	   and	   cultured	   them	   as	   floating	   neurospheres	   in	   pro-­‐proliferative	   medium,	  
under	  2µg/ml	  doxycyclin.	  4	  days	   later,	  we	   inspected	   them	  for	  EGFP	   fluorescence	   (Fig.	  1B).	  
The	  transgene	  was	  silent	  in	  the	  "C"	  line.	  A	  signal	  was	  only	  detectable	  in	  case	  of	  D	  (weaker)	  
and	   E	   (stronger)	   lines.	   To	   get	   preliminary	   hints	   about	   the	   articulation	   of	   the	   transgene	  
expression	  domain,	  we	  dissociated	  DIV4,	   LV_Pgk1p-­‐rtTAM2-­‐infected,	  Foxg1+/+;Tg:Tre-­‐Foxg1-­‐
IRES-­‐Egfp+/-­‐	  neurospheres	  to	  single	  cells	  and	  transferred	  them	  onto	  polylysinated	  coverslips,	  
under	   a	   prodifferentiative,	   doxycycline-­‐containing	   medium.	   5	   days	   later,	   we	  
coimmunoprofiled	   the	   resulting	   cultures	   for	  EGFP	  and	  Tubβ3	   immunoreactivity.	  We	   found	  












Figure	   R1.	  Generation	   and	   preliminary	   characterization	   of	   the	  Foxg1-­‐GOF	   transgenic	   line	   "E"	   (A)	  
Schematics	  of	   the	   two	  Foxg1	   locus	  alleles	  and	   the	  Tre-­‐Foxg1-­‐IRES-­‐Egfp	   transgene	  employed	   in	   this	  
study.	   (B)	   EGFP	   fluorescence	   profiling	   of	   Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐	   cortico-­‐cerebral	  
precursors	   dissected	   out	   at	   E12.5,	   acutely	   infected	   by	   LV_Pgk1p-­‐rtTAM2	   and	   cultured	   as	   floating	  
neurospheres	   in	   pro-­‐proliferative	   medium,	   under	   2µg/ml	   doxycyclin,	   for	   4	   days.	   (C)	   EGFP/Tubβ3	  
immunoprofiling	   of	   precursors	   referred	   to	   in	   (B),	   further	   transferred	   at	   DIV4	   to	   polylysinated	  
coverslips	   and	   kept	   under	   pro-­‐differentiative	   medium	   5	   more	   days.	   (D)	   Foxg1-­‐mRNA	   levels	   in	  
neocortex	  of	  Foxg1-­‐GOF,	  Foxg1-­‐LOF	  and	  wild	   type	   (WT),	  Foxg1(tTA-­‐or-­‐+)/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp±/-­‐	  P0	  
mice,	   as	   measured	   by	   qRTPCR.	   Data	   double	   normalized	   against	   Gapdh-­‐mRNA	   and	   WT	   controls.	  
Statistical	   significance	   (p)	   evaluated	   by	   t-­‐test	   (one-­‐tailed,	   unpaired).	   n	   is	   the	   number	   of	   biological	  
replicates.	  
	  
To	   confirm	   transgene	   functionality	   in	   vivo,	   we	   crossed	   Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐
Egfp+/-­‐	   founders	  to	  Foxg1tTA/+	  mutants,	  expressing	  the	  tTA	  TetOFF	  transactivator	  within	  the	  
Foxg1	   expression	   domain	   (Hanashima	   et	   al.,	   2002)	   and	   kept	   pregnant	   female	   under	  
doxycycline-­‐free	   diet.	   We	   harvested	   neocortices	   from	   P0	   progenies	   originating	   from	   this	  
crossing,	  genotyped	  them	  by	  PCR	  and	  evaluated	  their	  cumulative	  Foxg1-­‐mRNA	  content.	  This	  
was	   done	   by	   quantifying	   an	   amplicon	   within	   the	   3'-­‐most	   Foxg1-­‐cds,	   shared	   by	   all	   Foxg1	  
alleles	   employed	   in	   this	   study.	   As	   expected,	   this	   content	   was	   very	   similar	   in	   wild	   type	  
(Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐),	  congenic	  "wild	  type"	  (Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐
),	   and	  Foxg1-­‐LOF	   (Foxg1tTa/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐)	  mice.	  Moreover,	   it	  was	   upregulated	  
by	   2.08±0.18	   in	   Foxg1-­‐GOF	   (Foxg1tTa/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐)	   pups,	   compared	   to	   wild	  
type	  pups	  (p<0.002	  and	  n=3,3),	  so	  corroborating	  previous	  in	  vitro	  results.	  (Fig.	  1D).	  
	  
	  
4.2	  Analysis	  of	  the	  Foxg1-­‐GOF	  transgene	  expression	  profile	  
	   We	  took	  advantage	  of	  EGFP	  immunoreactivity	  of	  cells	  expressing	  Tg:Tre-­‐Foxg1-­‐IRES-­‐
Egfp	   to	   reconstruct	   the	   transgene	   expression	   profile	   and	   compare	   its	   spatio-­‐temporal	  









Figure	   R2	   EGFP	   expression	   profile	   in	   Foxg1-­‐GOF,	   Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐	  mutants,	   at	  
different	  embryonic	  and	  postnatal	  stages:	  mid-­‐coronal	  telencephalic	  sections.	  E14.5	  (A),	  E16.5	  (B),	  
P0	  (C),	  P7	  (D),	  P15	  (E),	  and	  P35	  (F)	  samples.	  Foxg1-­‐promoter-­‐driven	  EGFP	  is	  revealed	  in	  green,	  total	  
Foxg1	  in	  red.	  Scale	  bars:	  500µm.	  
	  
	  
We	  found	  that	  at	  E14.5,	  a	  weak	  transgene	  expression	  was	  only	  detectable	  within	  the	  
neocortical	   field.	   (Fig.	   R2A).	   A	   similar	   tangential	   restriction	   was	   found	   at	   E16.5,	   when	   -­‐	  
although	   much	   stronger	   -­‐	   the	   transgene	   was	   active	   within	   neocortex	   but	   not	   in	  
hippocampus,	  paleocortex	  and	  basal	  ganglia	  (Fig.	  R2B).	  This	  pattern	  remained	  substantially	  
immutated	  at	   later	  developmental	  ages.	  Transgene	  expression	   level	  reached	   its	  peak	  at	  P7	  
and	  started	  to	  decline	  around	  P15.	  By	  P35	  no	  EGFP	  could	  be	  detected	  anymore	  (Fig.	  R2C-­‐F).	  
	  
	   Specifically	   within	   neocortex,	   transgene	   products	   showed	   a	   higly	   dynamic	   radial	  
distribution.	   At	   E14.5,	   a	   faint	   signal	  was	   only	   detectable	  within	   a	   few	   cells	   located	   in	   the	  
uppermost	   cortical	   plate	   (Fig.	   R3A,	   arrowheads).	   At	   E16.5	   a	   large	   fraction	   of	   presumptive	  
pyramidal	   neurons	   populating	   the	   cortical	   plate	   was	   strongly	   immunoreactive	   for	   EGFP,	  
which	   also	   stained	   large	   bundles	   of	   cortico-­‐fugal	   fibers	   running	   within	   the	   subplate	   and	  
below	  it	  (Fig.	  R3B).	  A	  similar	  radial	  pattern	  was	  retained	  at	  P0	  and	  P7,	  when	  -­‐	  however	  -­‐	  the	  
cortical	   plate	   signal	   was	   mainly	   limited	   to	   deeper	   layers	   and	   the	   EGFP-­‐positive	   fibers	  
clustered	   just	   above	   subventricular	   zone	   and	   ependyma	   (Fig.	   R3C,D).	   [At	   the	   same	   ages,	  
these	  bundles	  could	  be	  easily	  recognized	  while	  crossing	  the	  striatal	  field	  (Fig.	  R3F,	  arrows)].	  
Neocortical	  transgene	  activity	  declined	  substantially	  at	  P15,	  when	  a	  few	  EGFP+	  cells	  could	  be	  
only	  detected	  within	  presumptive	   layer	  VI.	  Remarkably,	  at	  no	  developmental	  age	  analyzed	  
any	  transgene	  activity	  could	  be	  detectable	  within	  periventricular	  proliferative	  layers,	  where	  












	   	  
Figure	   R3	   EGFP	   expression	   profile	   in	   Foxg1-­‐GOF,	   Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐	  mutants,	   at	  
different	   embryonic	   and	   postnatal	   stages:	   high	   power	   fields.	   (A-­‐E)	   E14.5,	   E16.5,	   P0,	   P7	   and	   P15	  
neocortical	   sectors,	   and	   (F)	   P0	   striatum.	   	   Arrowheads	   in	   (A)	   point	   to	   early	   EGFP	   expression	   in	  
superficial	   cortical	   plate.	   Arrows	   in	   (C,D,F)	   point	   to	   presumptive	   cortico-­‐fugal	   fibers	   within	   white	  
matter	   (C,D)	   and	   striatum	   (F).	   Stars	   in	   (A,B,C)	   label	   periventricular	   precursors	   weakly	   expressing	  
Foxg1.	  Abbreviations:	  mz,	  marginal	  zone;	  cp,	  cortical	  plate;	  sp,	  subplate;	  svz,	  subventricular	  zone;	  vz,	  
ventricular	   zone;	   i,ii-­‐iv,v,vi	   refers	   to	   cortical	   layers;	   wm,	   white	   matter;	   svz/e,	   subventricular	  
zone/ependyma;	  str,striatum.	  Scale	  bars:	  100µm.	  	  
Next,	  we	  addressed	  the	  histological	  identity	  of	  neural	  cells	  expressing	  the	  transgene.	  
We	   confirmed	   our	   previous	   suspicion	   that	   a	   large	   fraction	   of	   them	   were	   postmitotic	  
neurons,	  by	  extensively	  colocalizing	  EGFP	  with	  established	  pan-­‐neuronal	  markers,	  Tubβ3	  and	  
NeuN,	  at	  E16.5	  through	  P7.	  Based	  on	  obvious	  morphological	  criteria	  (a	  thin	  apical	  dendrite	  
emerging	   from	   a	   radially	   oriented	   soma,	   see	   Fig.	   R4A,B),	   these	   cells	   turned	   out	   to	   be	  





Figure	   R4	   Colocalization	   of	   Foxg1-­‐promoter-­‐driven	   EGFP	   with	   pan-­‐neuronal	   markers.	   (A,B)	  
EGFP/Tubβ3	   immunoprofiling	   of	   E16.5	   and	   P0	   neocortices.	   (Aa’)	   and	   (Bb’)	   are	   confocal	  
magnifications	   of	   boxed	   regions	   in	   (A)	   and	   (B),	   respectively.	   Arrows	   in	   (a')	   and	   (b')	   point	   to	  
EGFP/Tubβ3	   colocalization	   in	   presumptive	   apical	   dendrites	   of	   pyramidal	   neurons.	   (C)	   EGFP/NeuN	  
immunoprofiling	  of	  P7	  neocortex.	  	  (Cc’)	  is	  a	  confocal	  magnification	  of	  the	  boxed	  region	  in	  (C).	  
	  
Comparison	  of	  their	  radial	  distribution	  at	  P7	  with	  DAPI+	  nuclear	  packaging	  profile	  and	  
radial	  activation	  pattern	  of	   three	  established	   layer-­‐specific	  markers,	  FoxP2	   (layer	  VI),	  Ctip2	  
(layer	  V)	  and	  Cux1	  (layers	  IV-­‐II),	  suggested	  a	  presumptive	  layer	  VI/V	  identity	  (Fig.	  R5A-­‐C).	  	  
	  
	  
Figure	   R5	  Neocortical	   laminar	   distribution	   of	   cells	   expressing	   Foxg1-­‐promoter-­‐driven	   EGFP.	  Here	  




the	  P7	  neocortex.	  Abbreviations:	   i,ii-­‐iv,v,vi	  refers	  to	  cortical	   layers;	  wm/e,	  white	  matter/ependyma.	  
Scale	  bars:	  100µm.	  
	  
To	   corroborate	  glutamatergic	   identity	   of	   these	   cells,	  we	   coimmunoprofiled	   P7	   and	  
P15	   brains	   for	   EGFP	   and	   three	   calcium-­‐binding	   proteins	   brightly	   labelling	   the	   majority	   of	  
gabaergic	   interneurons	  at	   these	  developmental	  ages,	  parvalbumin	  (PV),	  somatostatin	   (SST)	  
and	  calretinin	  (CR).	  As	  expected,	  no	  colocalization	  could	  be	  detected	  at	  all	  (Fig.	  R6A-­‐F).	  	  
Finally,	   we	   wondered	   if	   transgene-­‐expressing	   cells	   might	   include	   non-­‐neuronal	  
elements,	   such	   as	   astrocytes.	   To	   address	   this	   issue,	   we	   co-­‐immunoprofiled	   transgenic	   P7	  
brains	  for	  EGFP	  and	  the	  mature	  astrocyte	  marker	  S100β.	  No	  colocalization	  was	  detected	  at	  
























Figure	   R6	   Coimmunoprofiling	   of	   Foxg1-­‐GOF	   brains	   for	   Foxg1-­‐promoter-­‐driven	   EGFP	   and	   inter-­‐
neuronal	   markers.	   Distribution	   of	   EGFP	   and	   Parvalbumin	   (PV)	   in	   P15	   neocortex	   (A,B),	   EGFP	   and	  
Somatostatin	   (SST)	   in	   P7	   neocortex	   (C,D),	   and	   EGFP	   and	   Calretinin	   (CR)	   in	   P7	   neocortex	   (E)	   and	  
paleocortex	  (F).	  Solid	  arrowheads	  point	  to	  EGFP+	  cells,	  empty	  arrowheads	  to	  PV+,	  SST+	  and	  CR+	  cells.	  
Scale	  bars:	  100µm.	  
	  
	  
Figure	   R7	   Coimmunoprofiling	   of	   Foxg1-­‐GOF	   brains	   for	   Foxg1-­‐promoter-­‐driven	   EGFP	   and	   the	  
astrocyte	  marker	  S100β.	  (a’)	  is	  a	  confocal	  magnification	  of	  the	  boxed	  region	  (a).	  
	  
	  
4.3	  Assaying	  neuronal	  excitability	  of	  Foxg1-­‐GOF	  mutants	  
	   As	  mentioned	  above,	  Foxg1-­‐GOF	  mutants	  were	  generated	  as	  a	  model	  for	  dissecting	  
neurodevelopmental	   and	   neurophysiological	   abnormalities	   of	   human	   patients	   affected	   by	  
FOXG1-­‐duplication-­‐linked	   West	   syndrome.	   To	   preliminarly	   assess	   the	   suitability	   of	   these	  
mutants	  for	  such	  purpose,	  these	  animals	  were	  subject	  of	  two	  dedicated	  sets	  of	  experiments.	  
	   First,	  electrical	  activity	  of	  their	  brains	  was	  profiled	  by	  electroencephalography	  (EEG)	  
in	   basal	   awake	   conditions.	   Electrical	   activity	  was	  monitored	  within	   the	   hippocampus.	   This	  
structure	  was	  selected,	  as	   receiving	  and	   integrating	  afferences	  coming	   from	  all	   the	  cortex,	  
via	  the	  entorhino-­‐hippocampal	  bundle,	  and	  so	  acting	  as	  a	  comfortable	  proxy	  of	  entire	  brain	  
electrical	  activity.	  A	  bipolar	  electrode	  was	  placed	   into	   the	  hippocampus	  of	  P41	  Foxg1-­‐GOF	  
mutants	  (Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐)	  and	  wild	  type	  controls	  (Foxg1+/+;Tg:Tre-­‐Foxg1-­‐
IRES-­‐Egfp-­‐/-­‐),	  with	  its	  two	  500µm-­‐spaced	  pins	  ending	  in	  CA1	  and	  DG/hilus	  regions	  (Fig.	  R8A).	  




per	  day.	  The	  EEG	  was	  inspected,	  paying	  special	  attention	  to	  temporal	  distribution	  of	  spikes,	  
i.e.	   voltage	   fluctuations	  with	   amplitude	  exceeding	  4	   standard	  deviations	   (SD).	   Spikes	  were	  
categorised	  as	  "isolated"	  and	  "clustered",	  if	  alone	  or	  groupable	  in	  sets	  of	  at	  least	  two	  ones,	  
spaced	   less	   than	   0,5	   sec,	   respectively.	   Spike	   clusters	   were	   further	   distinguished	   into	  
interictal,	  if	  lasting	  <4sec,	  and	  ictal,	  i.e.	  lasting	  ≥4sec	  (Fig.	  R8B).	  Interestingly,	  both	  total	  spike	  
frequency	   and	   interictal	   cluster	   frequency	   were	   increased	   by	   about	   50%	   in	   Foxg1-­‐GOF	  
mutants	   as	   compared	   to	   controls	   (with	   n=4,4,	   and	   p<0.01).	   Isolated	   spike	   frequency	   was	  
unaffected.	   Ictal	   cluster	   frequency	   was	   increased	   >3	   times,	   however	   this	   did	   not	   result	  
statistically	   significant	   (Fig.	  R8C).	  Altogether,	   these	  data	  point	   to	  a	  appreciable	   increase	  of	  
neuronal	  activity	  occurting	  in	  FOXG1-­‐GOF	  mutants	  compared	  to	  controls.	  
	  
Figure	   R8	   EEG	   recordings	   of	   P35	   Foxg1-­‐GOF	   (Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐)	   and	   WT	  
(Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐)	  mice.	   (A)	   Schematics	   of	   bipolar	   electrodes	   placement	   into	   the	  
hippocampal	  field.	  (B)	  Classification	  of	  isolated	  spikes,	  interictal	  spike	  clusters	  and	  ictal	  spike	  clusters	  
(or	   seizures).	   (C)	  Graphical	   summary	   of	   control-­‐normalized,	   (1)	   total	   spike	   frequency,	   (2)	   isolated	  
spike	  frequency,	  (3)	  interictal	  spike	  cluster	  frequency	  and	  (4)	  ictal	  spike	  cluster	  frequency,	  in	  Foxg1-­‐






	   Encouraged	  by	  these	  results,	  to	  confirm	  the	  suitability	  of	  FOXG1-­‐GOF	  mutants	  for	  our	  
purposes,	  we	  challenged	  them	  (as	  well	  as	  FOXG1-­‐LOF	  and	  control	  mice)	  with	  an	  established	  
proconvulsant	   agent	   promoting	   glutamatergic	   transmission,	   kainic	   acid	   (KA).	   We	  
administered	   P35	   animals	   with	   20	   mg	   of	   KA	   per	   kg	   of	   body	   weight,	   by	   intraperitoneal	  
injection,	  and	  monitored	  their	  behaviour	  over	  the	  following	  two	  hours,	  paying	  attention	  to	  
specific	  signs	  of	  altered	  brain	  activity	  (e.g.,	  immobility,	  rigid	  posture,	  head	  bobbing,	  forelimb	  
clonus	  with	  rearing	  and	  falling,	  etc).	  Every	  10	  min,	  a	  score	  was	  given,	  according	  to	  Racine's	  
staging	  criteria	  (Fig.	  R9A).	  
	   The	  majority	  of	  animals	  did	  not	  go	  beyond	  Racine	  stage	  (RS)	  3,	  repetitive	  movements	  
&	  head	  bobbing	  (5/14,	  12/17	  and	  7/9,	  in	  case	  of	  GOF,	  WT	  and	  LOF,	  respectively),	  a	  subset	  of	  
them	   reached	   RS4,	   limbic	   motor	   seizure	   (4/14,	   4/17	   and	   2/9,	   as	   for	   GOF,	   WT	   and	   LOF,	  
respectively).	  Only	  a	   few	  got	  up	   to	  RS5,	  continuous	   rearing	  and	   falling,	   and	  beyond	   (5/14,	  
1/17	  and	  0/9	   in	  case	  of	  GOF,	  WT	  and	  LOF,	  respectively)	   (p<0.073,	  χ-­‐square	  test;	  Fig.	  R9B).	  
Longitudinal	  analysis	  of	  data	  showed	  that,	   for	  each	  group,	  RS	   increased	  progressively	   from	  
the	  onset	  of	  the	  experiment	  to	  about	  1	  hour	  later,	  then	  smothly	  declining.	  The	  RS(t)	  curve	  of	  
the	  GOF	  group	  was	  on	  average	  1.3	  units	  above	  WT	  controls	  (this	  average	  gap	  resulted	  to	  be	  
only	  0.3	  between	  LOF	  and	  WT	  animals).	  In	  particular,	  the	  distance	  between	  the	  GOF	  and	  the	  
WT	   curves	   peaked	   at	   90	   and	   100	   min,	   reaching	   1.7	   and	   1.9,	   respectively,	   with	   p<0.01	  
(ANOVA)	  in	  both	  cases	  (Fig.	  R9C).	  Altogether,	  these	  data	  point	  to	  an	  remarkable	  increase	  of	  
neuronal	  excitability,	  occurring	  in	  GOF	  models	  compared	  to	  control,	  and	  rule	  out	  that	  such	  
effect	  may	  stem	  from	  dominant	  negative	  effects. 	  
	   Upon	  completion	  of	  Racine	   tests,	  mice	  were	  sacrificed	  and	  their	  brains	  snap-­‐frozen	  
for	  subsequent	  analysis.	  Brains	  from	  animals	  which	  reached	  different	  Racine's	  stages,	  from	  
different	   groups,	  were	   processed.	   They	  were	   sliced	   and	  profiled	   by	   not-­‐radioactive	   in	   situ	  
hybridization,	   for	   expression	   of	   the	   ieg-­‐gene	   c-­‐fos.	  Within	   GOF	   brains,	   c-­‐fos	   was	   strongly	  
activated	   throughout	   the	   hippocampus,	   including	   the	   dentate	   gyrus	   (DG),	   as	   well	   as	   in	  
scattered	  neocortical	  cells.	  In	  case	  of	  WT	  brains,	  a	  cFos	  signal	  was	  present	  in	  Cornu	  Ammonis	  
fields	  1-­‐3	  (CA1)	  and,	  to	  a	  lesser	  extent,	  in	  the	  DG.	  Finally,	  cFos	  activation	  in	  LOF	  brains	  was	  
very	   weak,	   or	   not	   detectable	   at	   all	   (Fig.	   R9D).	   This	   scenario	   is	   nicely	   consistent	   with	  
behaviourial	  data	  reported	  above	  and	  strenghtens	  the	  hypothesis	  that	  a	  specific	  increase	  of	  





Figure	  R9	  Behavioral	  analysis	   in	  Foxg1-­‐GOF,	  Foxg1-­‐LOF	  and	  WT,	  Foxg1(tTA-­‐or-­‐+)/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐
Egfp±/-­‐	   	  mice	  at	  P35-­‐40.	  (A)	  Temporal	  Racine	  profiling	  of	  Foxg1-­‐GOF,	  Foxg1-­‐LOF	  and	  WT	  mice,	  upon	  




Foxg1+/+;Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐	   and	   Foxg1+/+;Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐,	   among	   which	   no	   statistically	  
significant	  differences	  were	  previously	  found.	  (B)	  Cumulative/non-­‐parametric	  (χ-­‐square	  test)	  and	  (C)	  
timed/parametric	   (ANOVA)	   evaluation	   of	   the	   resulting	   Racine	   profiling	   (D)	   Acute	   c-­‐fos	   in	   situ	  
hybridization	   of	   KA-­‐treated	  mice,	   upon	   completion	   of	   Racine	   profiling,	   mid-­‐frontal	   brain	   sections.	  
Abbreviations:	  RS,	  Racine	  stage,	  maximal	  animal-­‐specific	  value;	  ctx,	  cortex;	  DG,	  dentate	  gyrus;	  CA1-­‐3,	  
Cornu	  Ammonis	  1-­‐3	  fields.	  
	  
4.4	   Putative	   mechanisms	   underlying	   neuronal	   hyperexcitability:	   abnormal	  
neuronal	  histogenesis	  and	  differentiation	  
	   To	   cast	   light	   on	   possible	   histogenetic	   abnormalities	   triggered	   by	   Foxg1	  
overexpression,	  we	  scored	  P0	  and	  P7,	  GOF	  and	  WT	  neocortices	  for	  their	  neuronal	  packaging	  
profile,	  as	  evaluated	  by	  DAPI	  staining,	  and	  the	  expression	  profiles	  of	  FoxP2,	  Ctip2	  and	  Cux1,	  
layer	   VI,	   V	   and	   II-­‐IV	   markers,	   respectively.	   At	   P0	   (Fig.	   R10A),	   FoxP2	   was	   slightly	   down-­‐
regulated,	   and	   Ctip2,	  which	   is	   normally	   confined	   to	   the	   intermediate	   third	   of	   the	   cortical	  
plate	   (corresponding	   to	   presumptive	   V	   layer)	   spread	   into	   the	   deeper	   third	   of	   it	  
(corresponding	  to	  putative	  VI	  layer).	  Cux1,	  normally	  labelling	  the	  superficial	  third	  of	  cortical	  
plate	  (with	  layer	  IV-­‐II	  identity)	  was	  dramatically	  downregulated	  and	  hardly	  detectable.	  At	  P7	  
(Fig.	   R10B),	   FoxP2+	   cells,	   which	  were	   closely	   packaged	   in	   VI	   layer	   of	  WT	   neocortex,	   were	  
more	  loosely	  distributed	  through	  layer	  VI,	  V	  and	  -­‐	  to	  some	  extent	  -­‐	  IV	  of	  the	  GOF	  neocortex.	  
Conversely,	  Ctip2+	  cells,	  normally	  limited	  to	  layer	  V,	  partially	  spread	  into	  layer	  VI	  of	  mutant	  
neocortex	  (Fig.	  R10B,	  arrows).	  Finally,	  the	  Cux1+	  layer	  IV-­‐II	  was	  halved	  in	  its	  radial	  extension.	  
All	   that	   points	   to	   a	   defective	   segregation	   of	   layer	   V	   and	   layer	   VI	   neurons	   as	  well	   as	   to	   a	  





Figure	  R10	  Comparison	  of	  neocortical	  lamination	  in	  Foxg1-­‐GOF	  mutants	  and	  WT	  mice.	  (A,B)	  	  Here	  
presumptive	  radial	  extension	  of	  neocortical	  layers	  is	  inferred	  on	  the	  basis	  of	  the	  neuronal	  packaging	  
profile,	  as	  evaluated	  by	  DAPI	  staining,	  and	  the	  expression	  profiles	  of	  FoxP2,	  Ctip2	  and	  Cux1,	  layer	  VI,	  
V	  and	  II-­‐IV	  markers,	  respectively,	  at	  two	  different	  stages,	  P0	  and	  P7.	  Arrows	  point	  the	  spreading	  of	  
Ctip2+	   cells	   into	   layer	   VI.	   (C)	   Synopsis	   of	   laminar	   profile	   changes	   occurring	   in	   Foxg1-­‐GOF	  mutants.	  
Abbreviations:	   mz,	   marginal	   zone;	   cp/sp,	   cortical	   plate/subplate;	   iz,	   intermediate	   zone;	   e/svz,	  
ependyma/subventricular	   zone;	   i,ii-­‐iv,v,vi	   refers	   to	   cortical	   layers;	   wm/e,	  white	  matter/ependyma;	  
Scale	  bars:	  100µm.	  	  
	  
	   Next,	   we	   inspected	   the	   mutant	   P35	   GOF	   neocortex	   for	   distribution	   and	   spatial	  
frequency	   of	   gabaergic	   interneurons	   expressing	   the	   three	   main	   Ca2+-­‐binding	   proteins,	  
parvalbumin	  (PV),	  somatostatin	  (SST)	  and	  calretinin	  (CR).	  We	  detected	  a	  robust	  and	  specific	  
reduction	  of	  PV+	  cells	  spatial	  frequency	  throughout	  layers	  VI-­‐II	  of	  the	  mutant	  neocortex.	  This	  
phenomenon	  was	  expecially	  pronounced	  within	  the	  rostral-­‐medial	  neocortical	  sector,	  where	  
interneurons	  decreased	  by	  >40%	   (n=3,3,	  p<0.004)	   (Fig.	  R11A,B).	  No	  major	  changes	  of	  SST+	  








Figure	  R11	  Comparative	  quantification	  of	  neocortical	  PV+	   interneurons	   in	  Foxg1-­‐GOF	  and	  WT	  P35	  




and	  medial	  (m),	  neocortical	  sectors	  at	  P35	  (dark	  grey	  in	  silhouettes).	  Presumptive	  radial	  extension	  of	  
layer	   I	   (i),	   layers	   II-­‐VI	   (ii-­‐vi)	   and	  white	  matter/ependyma	   (wm/e)	   was	   inferred	   on	   the	   basis	   of	   the	  
neuronal	   packaging	   profile,	   evaluated	   by	   DAPI	   staining	   (not	   shown).	   Absolute	   PV+	   cell	   densities	   in	  
wild	  type	  animals	  are	  reported	  in	  Fig.	  S1	  (B)	  Examples	  of	  PV	  immunofluorescences	  referred	  to	  in	  (A).	  
Scale	  bars:	  100µm.	  
	  
Finally,	   to	  get	   insights	   into	  aberrant	  molecular	  mechanisms	  possibly	  contributing	   to	  
neural	   tissue	   hyperexcitability,	   we	   profiled	   RNA	   from	   Foxg1-­‐GOF,	   Foxg1-­‐LOF	   and	   WT	   P0	  
neocortices	  for	  a	  small	  gene	  panel	  tuning	  the	  proper	  neuronal	  excitatory/inhibitory	  balance.	  
These	   included:	   Gria1,	   encoding	   for	   the	   major	   GluA1	   subunit	   of	   AMPA	   receptors,	   Grin1,	  
encoding	   for	   the	  major	  GluN1	   subunit	  of	  NMDA	   receptors,	  Slc17a6	   and	  Slc17a7,	   encoding	  
for	  the	  vGluT1	  and	  vGluT2	  vesicular	  glutamate	  transporters,	  Grid1,	  encoding	  for	  the	  GluD1	  
subunit	  of	  ionotropic	  glutamate	  delta	  receptors,	  and	  Gabra1,	  encoding	  for	  the	  major	  GABA	  
receptor	   subunit	  α1.	  We	   found	   that	  Gabra1	  was	  down-­‐regulated	   in	  GOF	  cortices	  by	  more	  
than	  50%	  (p<0.05).	  An	  apparent,	  pronounced	  decrease	  was	  also	  detectable	  for	  Slc17a6	  and	  
Grid1	   in	   both	   GOF	   and	   LOF	   samples,	   however	   it	   dit	   not	   reach	   statistical	   significance	   (Fig.	  
R12A).	   To	   assess	   if	   these	   expression	   changes	   specifically	   occur	   within	   the	   neuronal	  
complement,	   we	   evaluated	   the	   effect	   of	   Foxg1-­‐GOF	   manipulations	   on	   pure	   neuronal	  
cultures	   established	   from	   E14.5	   neocortical	   tissue,	   engineered	   by	   lentiviral	   vectors	   (Fig.	  
R12C).	   Similarly	   and	  even	  more	   than	   in	   acute	   tissue,	  Gabra1	   as	  well	   as	  Grid1	   and	  Slc17a6	  
were	   all	   down-­‐regulated,	   in	   a	   statistically	   significant	   way	   (Fig.	   R12B).	   Because	   of	   the	  
amplitude	   of	   Gabra1-­‐mRNA	   downregulation	   and	   the	   deep	   impact	   that	   it	   might	   have	   on	  
neocortical	   excitability,	  we	  monitored	   the	  distribution	  of	   its	  protein	  product	   in	  Foxg1-­‐GOF	  
neocortices.	   Remarkably,	   Gabra1	   immunoreactivity,	   which	   normally	   gives	   rise	   to	   three	  
stripes	  in	  layers	  I,	  II-­‐IV	  and	  V,	  was	  here	  dramatically	  lowered	  (Fig.	  R13A-­‐C),	  so	  corroborating	  





Figure	   R12	   Preliminary	  molecular	   characterization	   of	   Foxg1-­‐GOF,	   Foxg1-­‐LOF	   and	  WT,	   Foxg1(tTA-­‐or-­‐
+)/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp±/-­‐	   cortico-­‐cerebral	   neural	   cells.	   (A)	  mRNA	   levels	   of	   a	   selection	  of	   genes	  
essential	   for	   proper	   neuronal	   excitatory/inhibitory	   balance,	   as	   measured	   by	   qRTPCR	   on	   P0	  
neocortical	   samples	   from	   Foxg1-­‐GOF	   (Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐),	   Foxg1-­‐LOF	  
(Foxg1tTA/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐)	   and	   wt	   (Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐)	   mice.	   Data	   double	  
normalized	   against	   Gapdh-­‐mRNA	   and	   WT	   controls.	   Statistical	   significance	   (p)	   evaluated	   by	   t-­‐test	  
(one-­‐tailed,	  unpaired).	  n	  is	  the	  number	  of	  biological	  replicates.	  (B)	  mRNA	  levels	  of	  a	  subset	  of	  	  genes	  
shown	   in	   (A),	   as	   measured	   by	   qRTPCR	   in	   neocortical	   precursors	   dissected	   at	   E14.5,	   infected	   with	  
LV_Ptα1-­‐rtTAM2	  and,	  alternatively,	  LV_TREt-­‐Foxg1-­‐IRES-­‐Egfp	  (Foxg1-­‐GOF)	  or	  	  LV_TREt-­‐EGFP	  (controls)	  
and	  cultured	   in	  pro-­‐differentiative	  medium,	  under	  2µg/ml	  doxycyclin	  and	  10mM	  AraC,	   for	  10	  days.	  
Statistical	   significance	   (p)	   evaluated	   by	   t-­‐test	   (one-­‐tailed,	   unpaired).	   n	   is	   the	   number	   of	   biological	  






Figure	  R13	  Comparison	  of	  Gabra1	  expression	  in	  Foxg1-­‐GOF	  mutants	  and	  WT	  P7	  neocortex.	  Rostral	  
(A),	   intermediate	   (B)	   and	   caudal	   (C)	   neocortical	   sections	   immunoprofiled	   for	   Foxg1-­‐driven-­‐
EGFP/Gabra1.	   Presumptive	   radial	   extension	   of	   neocortical	   layers	   was	   inferred	   on	   the	   basis	   of	   the	  
neuronal	  packaging	  profile,	   evaluated	  by	  DAPI	   staining.	  Abbreviations:	   r,	   rostral;	   i,	   intermediate;	   c,	  
caudal;	  mz,	  marginal	  zone;	  ii-­‐iv,	  v,	  vi,	  refers	  to	  cortical	  	  layers;	  wm,	  white	  matter;	  Scale	  bars:	  100µm.	  
	  
	  
4.5	   Putative	   mechanisms	   underlying	   neuronal	   hyperexcitability:	   defective	  
astrogenesis	  
	   We	   showed	   that	   our	   Foxg1-­‐GOF	   transgene	   is	   selectively	   activated	   within	   the	  
neuronogenic	  lineage,	  only	  after	  the	  exit	  of	  neuronal	  cells	  from	  cell	  cycle,	  so	  precluding	  any	  
cell-­‐autonomous	   effect	   by	   this	   transgene	   on	   the	   astrocytic	   complement.	   Nevertheless,	  
neurons	  exert	  a	  deep	  influence	  on	  astrocyte	  generation	  and	  maturation,	  which	  makes	  a	  non-­‐
cell-­‐autonomous	  impact	  of	  our	  mutation	  on	  this	  lineage	  still	  possible.	  To	  address	  this	  issue,	  
we	  scored	  Foxg1-­‐GOF	  cortices	  for	  spatio-­‐temporal	  distribution	  of	  cells	  immunoreactive	  for	  a	  
key	  astrocyte	  marker,	  S100β.	  At	  P0,	  neocortical	  spatial	  frequency	  of	  these	  cells	  was	  reduced	  
by	   about	   20%	   (p<0.064).	   At	   the	   same	   age	   Foxg1-­‐LOF	  mutants	   showed	   an	   opposite	   trend	  





Figure	  R14	  Comparative	  quantification	  of	  S100β+	  astrocytes	  in	  Foxg1-­‐GOF	  and	  WT	  P0	  pups.	  (A)	  Cell	  
counting	  was	  performed	  throughout	  neocortex	  (dark	  grey).	  (B)	  wt-­‐normalized,	  superficial	  density	  of	  
S100β+	   astrocytes	   in	  Foxg1-­‐GOF,	  Foxg1-­‐LOF	   and	   control	  mice.	  Here	  wt	   refers	   to	   data	   from	  pooled	  
Foxg1+/+;Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐	   and	   Foxg1+/+;Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐,	   among	   which	   no	   statistically	  
significant	   differences	   were	   previously	   found.	   [Absolute,	   average	   wt	   frequence	   on	   16mm-­‐thick	  
sections	  was	  2,124	  cells/mm2].	  Statistical	  significance	  (p)	  evaluated	  by	  t-­‐test	  (one-­‐tailed,	  unpaired).	  n	  
is	   the	   number	   of	   biological	   replicates.	   (C)	   Examples	   of	   Foxg1-­‐driven-­‐EGFP	   and	   S100b	  
immunolocalizations	   in	   neocortical	   sectors	   approximately	   corresponding	   to	   the	   boxed	   area	   in	   (A).	  
Scale	  bars:	  100µm.	  
	  
	  At	   P7,	   Foxg1-­‐GOF	   mutants	   showed	   again	   an	   overall	   reduction	   of	   S100β+	   astrocytes	   (-­‐
14.0±2.4%,	   p<0.080,	   n=3,3).	   Frequency	   of	   these	   cells	   was	   diminished	   both	   in	  medial	   and	  
lateral	  neocortex	  (-­‐12.0±2.4%,	  p<0.150,	  and	  -­‐15.9±2.4%,	  p<0.051,	  respectively).	  Moreover	  it	  
was	   specifically	   downregulated	   in	   layer	   I	   and	   II-­‐IV	   (-­‐33.0±2.3%,	   p<0.025,	   and	   -­‐23.2±4.6%,	  
p<0.054,	   respectively),	   as	   well	   as	   slightly	   upregulated	   in	   layer	   VI	   (+14.4±4.0%,	   p<0.029).	  
These	   tangential	   and	   radial	   trends	   combine	   so	   that	   a	   pronounced	   and	   more	   statistically	  










Figure	  R15	  Comparative	  quantification	  of	  S100β+	  astrocytes	  in	  Foxg1-­‐GOF	  and	  WT	  P7	  pups.	  (A)	  wt-­‐
normalized	   densities	   of	   S100β	   +	   cells	   at	   rostral	   (R),	   intermediate	   (I)	   and	   caudal	   (C),	   lateral	   (l)	   and	  
medial	  (m),	  neocortical	  sectors	  at	  P7	  (dark	  grey	  in	  silhouettes).	  Presumptive	  radial	  extension	  of	  layer	  I	  
(i),	  layers	  II-­‐IV	  (ii-­‐iv),	  layer	  V	  (v),	  layer	  VI	  (vi)	  and	  white	  matter	  (wm)	  was	  inferred	  on	  the	  basis	  of	  the	  
neuronal	  packaging	  profile,	  evaluated	  by	  DAPI	  staining	  (not	  shown).	  Absolute	  S100β	  +	  cell	  densities	  in	  
wild	   type	   animals	   are	   reported	   in	   Fig.	   S2.	   (B)	   Examples	   of	   Foxg1-­‐driven-­‐EGFP	   and	   S100β	  
immunofluorescences	  referred	  to	  in	  (A).	  Scale	  bars:	  100µm.	  
	  
	  
4.6	   Putative	   mechanisms	   underlying	   neuronal	   hyperexcitability:	   activity-­‐
linked	  Foxg1-­‐modulation	  
	   Until	   now,	   we	   have	   seen	   that	   exaggerated	   Foxg1	   expression	   leads	   to	   increased	  
neuronal	   activity,	   possibly	  mediated	   by	   complex	   neurodevelopmental	   disorders.	   Next,	   we	  
wondered	  if	  increased	  neuronal	  activity	  might	  -­‐	  in	  turn	  -­‐	  upregulate	  neuronal	  expression	  of	  
Foxg1.	  In	  patient	  cells	  harboring	  FOXG1	  duplications,	  in	  fact,	  this	  phenomenon	  might	  ignite	  a	  
harmful	   vicious	   circle,	   leading	   to	   further	   exacerbated	   neuronal	   hyperactivity	   and	  
contributing	  to	  unique	  EEG	  aberrancies	  of	  these	  patients.	  
	   To	   this	  aim,	  we	  set	  up	  mixed	  cocultures	  of	   cortico-­‐cerebral	  neurons	  and	  astrocytes	  
from	   wild	   type	   E16.5	   mouse	   donors	   (Fig.	   R16A,B)	   and	   challenged	   them	   by	   25mM	  
extracellular	   K+,	   as	   an	   inducer	   of	   neuronal	   hyperactivity.	   Potassium	   stimulation	   was	  
delivered	  for	  different	  times	  and	  time-­‐course	  progression	  of	  Foxg1-­‐mRNA	  was	  profiled.	  We	  
found	   that	   Foxg1	   was	   transiently	   upregulated.	   It	   reached	   its	   peak	   value	   3	   hours	   after	   K+	  
administration	   (2.7±0.2	   folds	   compared	   to	   baseline,	   n	   =	   3,4,	   p<0.001)	   and	   then	   smoothly	  
declined,	  getting	  back	  to	  baseline	  by	  one	  day	  (Fig.	  R17).	  mRNA	  levels	  of	  cFos,	  Egr1	  and	  Egr2	  
iegs	   were	   also	   monitored,	   as	   positive	   controls.	   As	   expected,	   they	   displayed	   a	   transient	  





Figure	  R16	   Immunoprofiling	   of	   primary,	   neuronal,	   astroglial	   and	  mixed	   cultures	   originating	   from	  
murine	   pallial	   precursors.	   (A)	   Graphical	   abstract	   and	   temporal	   articulation	   of	   the	   culturing	  
procedures.	  (B)	  Tubβ3/Gfap	  and	  Tubβ3/S100β	  co-­‐immunoprofiling	  of	  neuronal,	  astroglial	  and	  mixed	  
cultures	  and	  relative	  percentages	  of	  each	  cell	  subpopulation	  at	  the	  time	  of	  analysis.	  	  
	  
Next,	  to	  preliminarly	  dissect	  neuronal	  and	  astroglial	  contributions	  to	  this	  phenomena,	  
we	   set	   up	   isochronous,	   "pure",	   neuronal	   or	   astroglial	   cultures	   from	   the	   same	   source	   (Fig.	  
R16A,B)	   and	   repeated	   the	   assays	   on	   them.	   Foxg1	   displayed	   a	   smooth	   and	   transient	  
upregulation	   in	   astrocytes.	   Here	   it	   peaked	   up	   around	   2	   hours	   (1.7±0.2	   folds	   compared	   to	  
baseline,	  n	  =	  4,4,	  p<0.01)	  and	  got	  back	  to	  baseline	  around	  12	  hours.	   In	  case	  of	  neurons,	   it	  
only	  displayed	  small	  oscillations,	  which	  did	  not	  reach	  statistical	  significance	  (Fig.	  R17).	  As	  a	  
reference,	  cFos,	  Egr1	  and	  Egr2	  generally	  displayed	  a	  transient	  upregulation	  in	  pure	  cultures	  















Figure	   R17	   Time	   course	   of	   Foxg1	   and	   immediate	   early	   genes	   (ieg)	   mRNA	   levels	   in	   primary,	  
neuronal,	  astroglial	  and	  mixed	  cultures	  challenged	  by	  25mM	  of	  K+.	  Analysis	  of	  	  Foxg1-­‐	  (A),	  Fos-­‐	  (B),	  
Egr1-­‐	   (C),	  Egr2-­‐	   (D)	  mRNA	   levels	   in	   primary	   neuronal	   (N),	   astroglial	   (A)	   and	  mixed	   cultures	   (N&A),	  
prepared	  as	  in	  Figure	  R16A,	  following	  culture	  exposure	  to	  25mM	  extracellular	  K+	  for	  different	  times.	  	  
Gene	  expression	  levels	  were	  measured	  by	  qRTPCR	  and	  double-­‐normalized	  against	  Gapdh-­‐mRNA	  and	  
t=0	  controls.	  Statistical	  significance	  (p)	  evaluated	  by	  t-­‐test	  (one-­‐tailed,	  unpaired).	  n	  is	  the	  number	  of	  




We	   wondered	   which	   molecular	   mechanisms	   mediate	   activity-­‐dependent	   Foxg1	  
modulation	  in	  mixed	  neural	  cultures.	  For	  this	  purpose,	  we	  inspected	  the	  human	  FOXG1	  locus	  
for	   binding	   sites	   recognized	   by	   transcription	   factors	   (TFs)	   stimulated	   by	   neuronal	   activity,	  
including	   those	   encoded	   by	   immediate-­‐early	   genes.	   We	   scored	   chromatin	  
immunoprecipitation	  data	  from	  a	  variety	  of	  human	  cell	   lines,	  as	  well	  as	   in	  silico	  TF-­‐binding	  
site	   predictions,	   all	   available	   from	   a	   publicly	   accessible	   repository	  
(https://genome.ucsc.edu).	  We	   focussed	   on	   ieg-­‐TF-­‐binding	   sites	   (BSs)	   falling	   in	   the	   ±5.0kb	  
interval	   around	   the	  FOXG1-­‐transcriptional	   start	   site	   (TSS).	   Among	   them,	  we	   found	  BSs	   for	  
FOS,	   EGR1,	   NFKB,	   CEBP	   and	   CREB	   (Fig.	   R18).	   Foxg1	   locus	   sequence	   is	   highly	   conserved	  
among	   primates	   and	   rodents,	   suggesting	   that	   similar	   BSs	   may	   be	   present	   on	   the	  mouse	  
Foxg1	  locus,	  at	  orthologous	  locations.	  
	  
Figure	   R18	   Selected	   TF-­‐binding	   sites	   at	   the	   human	   FOXG1	   locus,	   UCSC	   Genome	   Borwser.	   Data,	  
harvested	   from	  UCSC	  Genome	  Borwser,	  were	  obtained	  by	  ChIP,	  on	  mixed	  human	  cell	   lines,	  and	   in	  
silico,	  by	  Jaspar	  software.	  
	  
	   To	   assay	   the	   dependence	   of	   Foxg1	   expression	   on	   each	   of	   these	   factors,	   we	  
challenged	   mixed	   neuronal-­‐astrocytic	   cultures	   prepared	   as	   above	   with	   lentiviral	   vectors	  
driving	   TetON-­‐regulated	   expression	   of	   dedicated	   dominant	   negative	   (DN)	   effectors.	   We	  
monitored	   the	   impact	  of	   these	  manipulations	   in	  baseline	  conditions,	  as	  well	  as	   in	   samples	  
exposed	   to	   25	   mM	   K+	   for	   three	   hours	   (Fig.	   R19A,C).	   We	   found	   that	   in	   both	   cases	   DN	  
constructs	  antagonizing	  activity	  stimulated-­‐TFs	  elicited	  a	  pronounced,	  statistically	  significant	  
downregulation	   of	   Foxg1-­‐mRNA	   levels.	   The	   only	   exceptions	   were	   Egr1-­‐DN,	   uneffective	   in	  
baseline	  samples,	  as	  well	  as	  Nfkb-­‐DN,	  uneffective	  in	  K+	  challenged	  samples.	  The	  amplitude	  of	  




conditions	   and	   reduced	   it	   by	   about	   9/10	   under	   K+	   (Fig.	   R19E,F).	   Actually,	   Creb-­‐assays	  
required	   a	   far	   lower	   doxycycline	   concentration,	   as	   TetON	   Creb-­‐DN	   activation	   elicited	   by	  
standard	   concentrations	   was	   often	   lethal	   (R19D).	   	   These	   data	   suggest	   that	   -­‐	   to	   different	  
extents	  -­‐	  cFos,	  Egr1,	  Nfkb,	  Cebp	  and	  Creb	  sustain	  baseline	  neuronal	  Foxg1	  transcription	  and	  
contribute	  to	  its	  elevation	  associated	  to	  electrical	  activity.	  
	   To	   preliminarly	   dissect	   the	   distinct	   contributions	   that	   these	   activity	   stimulated-­‐TFs	  
provide	   to	  Foxg1	   regulation	   in	  mixed	   neural	   cultures,	  we	   repeated	   the	  DN	   assays	   in	   pure	  
neuronal	  and	  astrocytic	  populations	  (Fig.	  R19A-­‐C).	  We	  found	  that	  functional	  knock-­‐down	  of	  	  
these	  TFs	   in	  pure	  neuronal	  cultures	  not	  supplemented	  with	  K+	  depressed	  Foxg1	  expression	  
to	   different	   extents,	   similar	   to	   mixed	   cultures.	   This	   confirms	   the	   pivotal	   role	   that	   these	  
factors	  play	   in	   sustaining	  neuronal	   baseline	  Foxg1	   expression.	  Unexpectedly,	   however,	  we	  
also	   found	   that	   ieg-­‐TF-­‐DNs	  upregulated	  Foxg1	   in	   pure	   astrocyte	   cultures,	   both	   in	   baseline	  
conditions	  and,	  even	  more,	  under	  25mM	  K+.	  This	  effect	  was	  specifically	  pronounced	  in	  case	  
of	  Egr1-­‐DN,	  which	   increased	  Foxg1	  by	  >50%	  under	  high	  potassium	   (p<0.01).	  This	  does	  not	  
apply	   to	   Creb-­‐DN,	   whose	   impact	   on	   astrocytes	   was	   negligible	   (Fig.	   R19E,F).	   These	   data	  
suggest	   that,	   within	   astrocytes,	   activity	   stimulated-­‐TFs	   inhibit	   rather	   than	   promote	   Foxg1	  
expression	   and	   contribute	   to	   dampen	   the	   smooth	   activation	  wave	   that	   this	   gene	   displays	  
upon	   K+	   stimulation.	   Finally,	   we	   found	   that	   a	   substantial	   Foxg1	   upregulation	   was	   also	  
achieved	   by	   Egr1-­‐DN,	   Cebp-­‐DN	   and	   Nfkb-­‐DN	   overexpression	   in	   pure	   neuronal	   cultures	  
stimulated	   by	   K+	   (Fig.	   R19F).	   These	   last	   phenomena	   are	   puzzling.	   It	   is	   really	   difficult	   to	  








Figure	  R19	  Fluctuations	  of	  Foxg1	  mRNA	  levels	  in	  primary,	  neuronal,	  astroglial	  and	  mixed	  cultures,	  
upon	  chronic	  overexpression	  of	   immediate	  early	  gene-­‐	   (ieg)-­‐dominant	  negative	   (DN)	  LV	  effectors	  
and/or	   3	   hours	   exposure	   to	   25mM	  extracellular	   K+.	  Culturing	   procedures	   followed	   for	  mixed	   and	  
neuronal	   (A)	   as	   well	   as	   astroglial	   (B)	   preparations	   subject	   of	   RNA	   profiling.	   (C,D)	   TetON	   lentiviral	  
vector	  sets	  and	  doxycycline	  concentrations	  employed	  for	  DN	  (a,b1)	  and	  control	  (a,b2)	  manipulations.	  









	  5.1	  A	  synopsis	  of	  major	  findings	  
	   Here	   we	   describe	   a	   characterization	   of	   a	   novel	   Foxg1-­‐GOF	   model	   we	   created	   to	  
dissect	   the	   role	   of	   Foxg1	   in	   postmitotic	   neuronal	   differentiation	   and	   reconstruct	  
pathogenetic	  mechanisms	  which	  underlie	  the	  FOXG1	  duplication-­‐linked	  West	  syndrome.	  This	  
is	   a	   devastating	   neurological	   disorder,	   triggered	   by	   a	   complex	   variety	   of	   pathogenic	  
conditions.	   It	   is	   characterized	   by	   infantile	   spasms,	   abnormal	   EEG	  with	   hypsarrhytmia	   and	  
seizures	   and	   dramatic	   cognitive	   impairment,	   for	   which	   only	   symptomatic	   treatments	   are	  
presently	  available.	  
	   As	  expected,	   these	  Foxg1-­‐GOF	  mice	   showed	   increased	  neuronal	  activity	   in	  baseline	  
conditions	  and	  were	  more	  prone	  to	  limbic	  motor	  seizures	  upon	  kainic	  acid	  administration.	  
	   A	   preliminary	   developmental	   profiling	   of	   their	   cerebral	   cortex	   unveiled	   four	  major	  
histogenetic	  anomalies,	  likely	  contributing	  to	  their	  hyperexcitability.	  These	  anomalies	  were:	  
(1)	  an	  altered	  neocortical	   laminar	  blueprint	  with	   impaired	   layer	  VI/layer	  V	  segregation	  and	  
defective	  activation	  of	  layer	  IV-­‐II	  programs;	  (2)	  a	  substantial	  reduction	  of	  PV+	  interneurons;	  
(3)	  a	  patterned,	  area-­‐	  and	  lamina-­‐specific	  astrocyte	  deprivation;	  (4)	  a	  defective	  expression	  of	  
the	  Gabra1	  receptor	  subunit.	  Similar	  phenomena	  might	  concur	  to	  neurological	  anomalies	  of	  	  
West	  syndrome	  patients	  harboring	  FOXG1	  duplications.	  
	   A	  parallel	  in	  vitro	  study,	  run	  on	  dissociated	  cortico-­‐cerebral	  cultures,	  revealed	  that	  a	  
substantial	   Foxg1	   upregulation	   occurred	   upon	   delivery	   of	   depolarizing	   stimuli.	   Neuronal,	  
activity-­‐linked	   Foxg1	   elevation	   required	   the	   presence	   of	   astrocytes.	   Activity-­‐linked	   Foxg1	  
fluctuations	  were	   inter-­‐twinned	  with	   immediate-­‐early	  genes	  fluctuations	  and	  depended	  on	  
them,	   according	   to	   distinct,	   neuron-­‐	   and	   astrocyte-­‐specific	   patterns.	   In	   West	   syndrome	  
patients	  with	   augmented	   FOXG1	   dosage,	   a	   FOXG1-­‐mRNA	   increase	   evoked	   by	   depolarizing	  
stimuli	  might	  ignite	  a	  vicious	  circle,	  exacerbating	  neuronal	  hyperactivity	  and	  contributing	  to	  





5.2	  Generation	  of	  Foxg1	  gain-­‐of-­‐function	  mouse	  models	  
	   Foxg1-­‐GOF	  models	   employed	   for	   this	   study	   were	   generated	   by	   combining	   a	   TREt-­‐
driven	  Foxg1-­‐IRES-­‐Egfp	  transgene	  and	  a	  tTA-­‐TetOFF-­‐transactivator	  encoding	  allele,	  knocked	  
into	  the	  endogenous	  Foxg1	  locus	  by	  homologous	  recombination	  (Fig.	  R1A).	  According	  to	  the	  
experimental	  design,	   they	  were	  expected	  to	   faithfully	   reproduce	  the	  expression	  pattern	  of	  
the	   endogenous	   gene.	   Conversely,	   transgene	   activation	   was	   restricted	   to	   the	   neocortical	  
field.	   No	   transgene	   product	   was	   detected	   in	   archicortex,	   paleocortex,	   subpallium,	   eye,	  
anterior	   hypothalamus	   and	   their	   derivatives,	   all	   expressing	   the	   endogenous	   gene	   (Fig.	   R2	  
and	   R6).	   Moreover,	   within	   neocortex,	   transgene	   products	   were	   absent	   in	   periventricular	  
proliferative	   layers,	   expressing	   the	   endogenous	   gene	   at	   low	   levels.	   They	   were	   only	  
detectable	   in	   embryonic	   cortical	   plate	   and	   deep	   layers	   of	   perinatal/juvenile	   neocortex,	  
characterized	   by	   a	   robust	   activation	   of	   the	   endogenous	   gene	   (Fig.	   R3	   and	   R5).	   Here,	   as	  
expected,	   the	   transgene	  was	   specifically	   expressed	   in	   postmitotic	   pyramidal	   neurons	   (Fig.	  
R4),	  but	  not	  at	  all	  in	  astrocytes	  (Fig.	  R7).	  Transgene	  confinement	  to	  a	  subset	  of	  the	  canonical	  
Foxg1	   expression	   domain	   reasonably	   reflects	   the	   "landing"	   of	   the	   transgene	   into	   a	   poorly	  
permissive	  "chromatin	  environment",	   inhibiting	  tTA	  from	  driving	  transgene	  transcription	   in	  
extra-­‐neocortical	   territories.	   In	   particular,	   delayed	   transgene	   activation	   in	   postmitotic	  
neurons	  (Fig.	  R1C),	  might	  specifically	  originate	  from	  its	  integration	  into	  an	  L1	  LINE	  element,	  
as	  detected	  by	   splinkerette-­‐assisted	  mapping	   (Ochman	  et	  al.,	   1988)	  of	   transgene	   insertion	  
(data	  not	  shown).	   It	  has	  been	  shown	  -­‐	   in	  fact	  -­‐	  that	  L1	  elements	  are	  specifically	  silenced	  in	  
neural	   stem	   cells,	   by	   a	   dedicated	   Sox2/MeCP2/HDAC1-­‐dependent	   mechanism,	   getting	  
permissive	  for	  transcription	  only	  in	  their	  neuronal	  derivatives	  (Coufal	  et	  al.,	  2009).	  	  
	   Total	   mRNA	   originating	   from	   the	   Foxg1	   and	   transgene	   loci	   was	   quantified	   by	  
cumulative	  qRTPCR	  evaluation	  of	  a	  diagnostic	  amplicon	  shared	  by	  the	  Foxg1+,	  Foxg1tTA	  and	  
TREt-­‐Foxg1-­‐IRES-­‐Egfp+	  alleles	  (Fig.	  1A,D).	  Compared	  to	  wt,	  "wt"	  and	  LOF	  animals,	  GOF	  mice	  
showed	  a	  2.1x	  mRNA	  content	  (Fig.	  1D).	  0.5x	  of	  this	  content	  comes	  from	  the	  Foxg1tTA	  allele,	  
1.6x	  really	  encodes	  for	  Foxg1-­‐cds	  (Fig.	  1A),	  so	  suggesting	  that	  a	  net	  +60%	  average	  expression	  
gain	  may	  characterize	  GOF	  mutants	  compared	  to	  controls.	  However,	  at	  P0	  (the	  time	  at	  which	  




expression	  domain	  activates	  the	  transgene.	  Cautiously,	  such	  fraction	  might	  be	  close	  to	  1/3.	  
This	  means	  that	  such	  neurons	  might	  give	  rise	  to	  a	  real	  Foxg1-­‐mRNA	  expression	  gain	  around	  
+3*60%,	  i.e.	  +180%.	  
	   Summing	   up,	   our	   "Foxg1-­‐GOF"	   mutants	   are	   "functionally	   Foxg1-­‐LOF"	   within	   their	  
proliferating	   neural	   precursors	   and	   display	   an	   approximate	   3x	   Foxg1	   expression	   gain	   in	   a	  
large	  subset	  of	  their	  deep	  neocortical	  neurons.	  As	  such,	  they	  are	  not	  a	  "perfect"	  model	  for	  
dissecting	   pathogenetic	   mechanisms	   triggered	   by	   exaggerated	   FOXG1	   dosage.	   However,	  
they	  offer	  the	  unique	  opportunity	  to	  study	  a	  subset	  of	  them	  in	  a	  far	  simplified	  and	  tractable	  
context.	  
	  
5.3	  Hyperexcitability	  of	  Foxg1-­‐GOF	  mice	  
	   To	   unveil	   a	   possible	   hyperexcitability	   of	   Foxg1-­‐GOF	   tissue,	   mutant	   mice	   were	  
challenged	  with	   the	  powerful	  glutamatergic	  agonist	  kainic	  acid.	  As	  expected,	  GOF	  mutants	  
gave	  a	  Racine's	  score	  higher	  than	  pooled	  WT	  (Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp-­‐/-­‐)	  and	  "WT"	  
(Foxg1+/+;Tg:Tre-­‐Foxg1-­‐IRES-­‐Egfp+/-­‐)	   controls,	   which	   resulted	   statistically	   significant	   upon	  
both	   cumulative/non-­‐parametric	   and	   timed/parametric	   evaluation	   of	   results	   (Fig.	   R9A-­‐C).	  
Interestingly,	   LOF	   mutants	   scored	   very	   close	   to	   controls	   and	   no	   statistically	   significant	  
difference	  was	   appreciable	   (Fig.	   R9A-­‐C).	   This	   rules	   out	   that	   the	  GOF	   genotype	   could	   arise	  
form	  a	  dominant	  negative	  effect.	  Moreover,	  comparison	  of	  performances	  of	  WT	  and	  "WT"	  
groups	  (both	  cumulative/non	  parametric	  and	  parametric	  at	  times	  of	  stronger	  GOF/controls	  
discrepancy)	   did	   not	   display	   any	   significant	   change	   (data	   not	   shown).	   This	   further	   implies	  
that	   GOF	   hyperexcitability	   is	   due	   to	   transgene	   activity	   itself	   and	   not	   to	   consequences	   of	  
insertional	  mutagenesis,	  associated	  to	   lentiviral	   integration.	   In	  situ	  analysis	  of	  brains	   taken	  
from	  KA-­‐treated	   animals	   showed	   a	   patterned	   activation	   of	   the	   ieg	   cFos,	   nicely	   correlating	  
with	   the	   animal	   Racine's	   scoring.	   It	   pointed	   to	   the	   hippocampus	   as	   the	   source	   of	  
epileptogenic	  electric	  perturbations	  (Fig.	  R9D).	  
	   Preferential	   involvement	   of	   the	   hippocampus	   in	   epileptogenic	   events	   largely	  
originates	   from	   neurocircuital	   connections	   of	   this	   structure,	   receiving	   neocortical	   and	  
paleocortical	  afferences	  through	  the	  entorhino-­‐hippocampal	  bundle	  and	  reverberating	  them	  




the	  hippocampus	  acts	  as	  a	  "high	  gain	  antenna"	  collecting	  afferences	  from	  all	  over	  the	  cortex	  
and	  providing	  a	  relatively	  simplified	  proxy	  for	  their	  evaluation.	  We	  took	  advantage	  of	  that	  in	  
KA	  assays,	  but	  also	  in	  EEG	  evaluation	  of	  animals,	  in	  "baseline"	  conditions.	  Here	  an	  electrode	  
placed	  between	  CA1	  and	  DG	  (Fig.	  R8A)	  provided	  us	  with	  a	  "comprehensive	  overview"	  of	  the	  
whole	  brain	  electrical	  activity	  (Fig.	  R8C),	  substantially	  corroborating	  conclusions	  of	  KA	  assays.	  
In	   this	   context,	   it	   is	   to	   note	   the	  differences	   of	   cFos	   activation	   evoked	  by	   KA,	   in	  DG,	  more	  
refractory,	   versus	   CA3,	   more	   permissive.	   Self-­‐reverberating	   connections	   of	   CA3	   neurons	  
likely	  undelie	  this	  phenomenon.	  Such	  differences	  allow	  to	  neatly	  discriminate	  among	  Foxg1-­‐
GOF	  and	  other	  mice	  (Fig.	  9D).	  
	  
5.4	  Histogenetic	  disorders	  underlying	  Foxg1-­‐GOF	  mice	  hyperexcitability	  
	   Then	  we	   studied	  a	  number	  of	  histogenetic	   anomalies	  occurring	   to	  Foxg1-­‐GOF	  mice	  
and	  possibly	  underlying	  their	  neural	  hyperexcitability.	  
	   A	  subset	  of	  them	  admit	  a	  cell	  autonomous	  explanation.	  This	  is	  the	  case	  of	  defective	  
segregation	  among	  layer	  VI	  and	  layer	  V	  pyramidal	  neurons,	  both	  expressing	  the	  transgene	  at	  
high	   frequency	   (Fig.	   10A,B).	   This	   applies	   to	   Gabra1	   downregulation,	   which	   takes	   place	   to	  
large	  extent	   in	  cerebral	  neurons	   (Fig.	  R12	  and	  R13).	  This	  can	  also	  be	   the	  case	  of	   shrunken	  
upper	  layer	  neurons.	  
	   Actually,	   the	   interpretation	  of	   this	   last	  phenotype	   requires	   some	  special	   caution.	   In	  
fact,	   a	   similar	   phenomenon	   has	   been	   described	   in	   Foxg1-­‐LOF	   mice,	   possibly	   due	   to	  
precocious	  exhaustion	  of	   the	  periventricular	  proliferating	  pool	   (Eagleson	  et	   al.,	   2007).	  Our	  
"GOF"	  mice	  are	  functionally	  LOF	  within	  this	  pool,	  which	  opens	  the	  possibility	  that	  what	  we	  
observe	  has	  not	  a	  real	  GOF	  origin.	  However,	  it	  has	  been	  firmly	  shown	  that	  the	  occurrence	  of	  
this	  phenomenon	  in	  LOF	  mice	  does	  require	  the	  presence	  of	  a	  specific	  "cre"	  allele	  within	  the	  
null	  Foxg1	   locus	  and	  does	  not	  appear	   in	  the	  presence	  of	  LacZ	  and	  tTA	  alleles.	  Moreover,	   it	  
only	   occurs	   in	   mice	   of	   pure	   C57Bl6	   strain,	   while	   disappearing	   in	   CBA1xC57Bl6	   hybrids	  
(Eagleson	   et	   al.,	   2007).	   Our	   mice	   do	   not	   harbor	   a	   cre	   allele	   and	   moreover	   they	   were	  
generated	  on	  a	  C57Bl6xCD1	  background.	  Therefore	  we	  are	  strongly	  confident	  that	  what	  we	  




	   How	  may	  this	  layer	  IV-­‐II	  shrinkage	  arise	  in	  Foxg1-­‐GOF	  animals?	  	  Mutual	  exclusion	  of	  
Cux1	  and	  EGFP	   in	  mutant	  neocortices	  suggests	  that	  Foxg1	  might	  trans-­‐repress	  Cux1	   in	   late	  
newborn	   neurons,	   channelling	   them	   toward	   deep	   rather	   than	   upper	   layer	   identities.	  
Actually,	   laminar	   specification	   of	   upper	   layer	   neurons	   specifically	   relies	   on	   an	   intricate	  
network	   of	   cross-­‐inhibitory	   interactions	   among	   patterned	   transcription	   factors	   active	   in	  
proliferating	   precursors	   and/or	   their	   post-­‐mitotic	   derivatives.	   In	   particular,	   Tbr1	   indirectly	  
permits	   the	   activation	   of	   layer	   IV-­‐II	   programs,	   via	   inhibition	   of	   their	   inhibitor,	   the	   layer	   V	  
promoter	   Fezf2	   (Han	   et	   al.,	   2011;	   McKenna	   et	   al.,	   2011;	   Srinivasan	   et	   al.,	   2012).	   In	   this	  
context,	   Foxg1	   could	   dampen	   upper	   layer	   specification	   indirectly,	   by	   repressing	   Tbr1	  
transcription	  (Toma	  et	  al.,	  2014).	  
	   Even	  if	  we	  favor	  this	  hypothesis,	  we	  are	  aware	  that	  a	  different,	  not-­‐cell-­‐autonomous	  
mechanism	  may	  contribute	  to	  upper	  layer	  shrinkage.	  Hanashima	  and	  coll.	  (Toma	  et	  al.,	  2014)	  
have	   shown	   that	   deep	   layer	   neurons	   send	   an	   (unknown)	   signal	   to	   periventricular	   layers,	  
pushing	   them	   to	   transit	   to	   upper	   layer	   generation.	   It	   is	   tempting	   to	   speculate	   that	   Foxg1	  
overexpression	   in	   deep	   layer	   neurons	   might	   jeopardize	   the	   transmission	   of	   this	   signal	   or	  
could	  force	  progenitors	  to	  precociously	   leave	  cell	  cycle,	  ultimately	  resulting	   in	  upper	   layers	  
hypoplasia	  
	   Besides	   lamination	   defects,	   our	   Foxg1-­‐GOF	   models	   exhibit	   two	   other	   major	  
histogenetic	  disorders,	  which	  occur	  in	  clonal	  compartments	  not	  originating	  from	  transgene-­‐
expressing	  cells.	  These	  are	  reduced	  PV+	   interneurons	  and	  astrocytes.	  These	  anomalies	  may	  
obviously	  provide	  a	  major	  causative	  contribution	  to	  neuronal	  hyperexcitability.	  As	  both	  PV+	  
cells	   and	   astrocytes	   are	   not	   born	   by	   transgene-­‐expressing	   cells,	   molecular	   mechanisms	  
linking	  transgene	  activation	  to	  their	  scarcity	  reasonably	  include	  not-­‐cell	  autonomous	  ones.	  In	  
particular,	   defective	   signals	   from	   neocortical	   periventricular	   layers	   promoting	   interneuron	  
influx	   from	   subpallium	   (Sessa	   et	   al.,	   2010)	   might	   account	   for	   the	   former	   phenomenon.	  
Unbalanced	   signals	   coming	   from	   pyramidal	   neurons	   and	   tuning	   astrogenic	   rates	   might	  
account	   for	   the	   latter.	   A	   preliminary	   survey	   of	   these	   signals	   (Barnabé-­‐Heider	   et	   al.,	   2005;	  
Seuntjens	   et	   al.,	   2009;	   Sardi	   et	   al.,	   2006)	   did	   not	   revealed	   any	   change.	   Further	   dedicated	  





5.5	  Activity-­‐dependent	  Foxg1	  regulation	  
	   Finally,	   we	   have	   seen	   that	   exaggerated	   Foxg1	   expression	   results	   in	   a	   number	   of	  
neurodevelopmental	   anomalies	   leading	   to	   an	   increase	   of	   neural	   tissue	   excitability.	   We	  
wondered	   if	  electrical	  activity	   in	  turn	  modulates	  Foxg1	  activation.	  We	  addressed	  this	  point	  
by	  evaluating	  the	  impact	  that	  exposure	  to	  high	  extracellular	  potassium,	  an	  established	  tool	  
for	   promoting	   neuronal	   discharge,	   can	   have	   on	   Foxg1-­‐mRNA	   levels,	   in	   mixed	  
neuronal/astroglial	  cultures,	  originating	  from	  cerebral	  cortex	  of	  late	  gestation	  embryos.	  We	  
found	  that	  Foxg1	  was	  upregulated	  starting	  from	  1	  hour,	  peaked	  at	  3	  hours	  and	  got	  back	  to	  
baseline	  by	  24	  hours	  (Fig.	  R17).	  
	   The	  presence	  of	  a	  number	  binding	   sites	   for	  activity-­‐regulated	  TFs	   (cFos,	  Egr1,	  Egr2,	  
Cebp,	  Nfkb,	  Creb)	  within	  the	  Foxg1	  promoter	   (Fig.	  R18)	  suggested	  that	  these	  TFs	  might	  be	  
involved	   in	   controlling	   such	   dynamics.	   To	   verify	   this	   prediction,	   we	   functionally	   knocked	  
down	  these	  TFs	  by	  chronic	  overexpression	  of	  DN	  mutant	  versions	  of	  them.	  In	  all	  cases,	  this	  
treatment	  led	  to	  an	  attenuation	  of	  Foxg1	  expression,	  both	  in	  baseline	  conditions	  and	  under	  
chronic	  K+.	  As	  expected	  (REF:	  Minichiello-­‐Kein),	  three	  of	  these	  factors,	  cFos,	  Egr1	  and	  Egr2,	  
displayed	   a	   peak	   of	   mRNA	   expression	   1	   hour	   after	   K+	   supplementation	   (Fig.	   R17).	   This	  
dynamics	   hardly	   accounts	   for	   a	   role	   of	   these	   genes	   in	   early	   Foxg1-­‐mRNA	   elevation	   and	  
rather	   helps	   explain	   further	   upregulation	   of	   this	   gene	   at	   around	   3	   hours	   and	   later.	  
Conversely,	   a	   pivotal	   role	   in	   early	  Foxg1	   activation	  might	   be	  played	  by	   activity-­‐dependent	  
activation	  of	  Cebp,	  Nfkb	  and	  Creb,	  which	  mainly	  relies	  on	  fast	  post-­‐translational	  regulation.	  
This	  is	  achieved	  by	  neurotrophin-­‐dependent	  recruitment	  to	  chromatine	  (Cebp)	  (Calella	  et	  al.,	  
2007),	   extra-­‐cellular	   signal-­‐modulated	   cytoplasm-­‐to-­‐nucleus	   translocation	   (Nfkb)(Gutierrez	  
and	  Davies,	  2011),	  and	  Ca2+/cAMP-­‐triggered	  phosphorylation	  (Creb)	  (de	  la	  Torre-­‐Ubieta	  and	  
Bonni,	  2011).	  As	  such,	  Cebp,	  Nfkb	  and	  Creb	  may	  promote	  both	  early	  and	  later	  Foxg1-­‐mRNA	  
elevation.	  
	   As	  for	  late	  Foxg1	  decline,	  different	  mechanisms	  may	  account	  for	  it.	  Such	  decline	  may	  
reflect	  the	  parallel	  decrease	  of	  presumptive	  Foxg1	   transactivators	  cFos	  and	  Egr	  (Fig	  R19E,F	  
and	  R17),	   the	  canonical	  autoinhibitory	   loop	   intrinsic	   to	  Nfkb	  signalling	   (Chiao	  et	  al.,	  1994),	  




	   To	   dissect	   neuronal	   and	   astrocytic	   contributions	   to	   the	   Foxg1	   dynamics	   in	   mixed	  
cultures	   under	   K+	   stimulation,	   we	   run	   Foxg1	   time	   course	   analysis	   on	   pure	   neuronal	   or	  
astrocytic	   cultures.	   Astrocytes	   gave	   rise	   to	   an	   activation	   profile	   similar	   to	  mixed	   cultures,	  
however	  missing	  the	  pronounced	  peak	  at	  3	  hours.	  Conversely,	  neurons	  displayed	  only	  small	  
changes,	   not	   statistically	   relevant	   (Fig.	   R17).	   This	   is	   particularly	   intriguing	   as	   our	   mixed	  
cultures	  differred	   from	  neuronal	   cultures	  only	   for	   a	   small	   percentage	  of	   astrocytes	   (about	  
1/12)	  present	  in	  the	  former	  and	  absent	  in	  the	  latter	  (Fig.	  R16).	  This	  suggests	  that	  either	  an	  
event	   of	   the	   chain	   leading	   to	   neuronal	   Foxg1	   transactivation	   takes	   place	   in	   astrocytes,	   or	  
astrocytes	   provide	   neurons	   with	   a	   specific	   input	   needed	   for	   its	   implementation.	   Further	  
hints	  came	  from	  functional	   inhibition	  of	  activity-­‐regulated	  TFs	   in	   (1)	  pure	  astroglial	  and	  (2)	  
neuronal	   populations.	   In	   the	   former	   case	   (Fig.	   R19E,F),	   such	   manipulation	   paradoxycally	  
resulted	   in	   Foxg1	   upregulation,	   both	   in	   baseline	   conditions	   and	   under	   high	   potassium.	   In	  
other	  words,	  within	  astrocytes,	   these	  TFs	   seem	   to	   inhibit	  Foxg1.	  Differential	   expression	  of	  
lineage-­‐specific	   cofactors,	   synergizing	   with	   them	   on	   the	   Foxg1	   promoter	   (Calella	   et	   al.,	  
2007),	  might	  undelie	  this	  discrepancy,	  determining	  the	  distinct	  outcomes	  of	  their	  activity.	  In	  
the	  latter	  case	  (Fig.	  R19E,F),	  transduction	  of	  DN	  constructs	  resulted	  in	  Foxg1	  downregulation	  
and	   its	   upregulation,	   in	   baseline	   conditions	   and	   under	   K+,	   respectively.	   In	   other	   words,	  
neurons,	   deprived	   of	   their	   astrocyte	   companions,	   adopt	   an	   astrocyte-­‐like	   "behaviour",	  
specifically	   if	  exposed	  to	  conditions	  triggering	  electrical	  hyperactivity.	  Molecular	  mechanics	  











6.	  SUPPLEMENTARY	  MATERIAL	  
	  













Thanks	  to	  Dr.	  Manuela	  Allegra	  and	  Dr.	  Matteo	  Calleo	   for	   the	  EEG	  recordings	  performed	  at	  
CNR	  Neuroscience	  Institute	  in	  Pisa.	  	  	  
Thanks	   to	   Prof.Yuri	   Bozzi	   and	  Dr.Giovanni	   Provenzano	   for	   the	   collaboration	   on	   behavioral	  
experiments	  at	  Centre	  for	  Integrative	  Biology	  (CIBIO),	  in	  Trent,	  and	  SISSA,	  in	  Trieste.	  






















Ahn,	  S.,	  Olive,	  M.,	  Aggarwal,	  S.,	  Krylov,	  D.,	  Ginty,	  D.D.,	  and	  Vinson,	  C.	   (1998).	  A	  dominant-­‐
negative	   inhibitor	   of	   CREB	   reveals	   that	   it	   is	   a	   general	   mediator	   of	   stimulus-­‐dependent	  
transcription	  of	  c-­‐fos.	  Mol.	  Cell.	  Biol.	  18,	  967–977.	  
Alcamo,	   E.A.,	   Chirivella,	   L.,	   Dautzenberg,	   M.,	   Dobreva,	   G.,	   Fariñas,	   I.,	   Grosschedl,	   R.,	   and	  
McConnell,	  S.K.	  (2008).	  Satb2	  regulates	  callosal	  projection	  neuron	  identity	  in	  the	  developing	  
cerebral	  cortex.	  Neuron	  57,	  364–377.	  
Altmann,	  C.R.,	  and	  Brivanlou,	  A.H.	   (2001).	  Neural	  patterning	   in	  the	  vertebrate	  embryo.	   Int.	  
Rev.	  Cytol.	  203,	  447–482.	  
Amor,	   D.J.,	   Burgess,	   T.,	   Tan,	   T.Y.,	   and	   Pertile,	  M.D.	   (2012).	   Questionable	   pathogenicity	   of	  
FOXG1	  duplication.	  Eur.	  J.	  Hum.	  Genet.	  EJHG	  20,	  595–596;	  author	  reply	  596–597.	  
Anderson,	  D.J.,	  Groves,	  A.,	  Lo,	  L.,	  Ma,	  Q.,	  Rao,	  M.,	  Shah,	  N.M.,	  and	  Sommer,	  L.	  (1997).	  Cell	  
lineage	  determination	  and	  the	  control	  of	  neuronal	   identity	   in	   the	  neural	  crest.	  Cold	  Spring	  
Harb.	  Symp.	  Quant.	  Biol.	  62,	  493–504.	  
Anderson,	  S.A.,	  Marín,	  O.,	  Horn,	  C.,	  Jennings,	  K.,	  and	  Rubenstein,	  J.L.	  (2001).	  Distinct	  cortical	  
migrations	   from	   the	  medial	   and	   lateral	   ganglionic	   eminences.	  Dev.	   Camb.	   Engl.	  128,	   353–
363.	  
Anderson,	   S.A.,	   Kaznowski,	   C.E.,	   Horn,	   C.,	   Rubenstein,	   J.L.R.,	   and	   McConnell,	   S.K.	   (2002).	  
Distinct	  origins	  of	  neocortical	  projection	  neurons	  and	  interneurons	  in	  vivo.	  Cereb.	  Cortex	  N.	  
Y.	  N	  1991	  12,	  702–709.	  
Ang,	   E.S.B.C.,	   Haydar,	   T.F.,	   Gluncic,	   V.,	   and	   Rakic,	   P.	   (2003).	   Four-­‐dimensional	   migratory	  
coordinates	  of	  GABAergic	   interneurons	   in	   the	  developing	  mouse	  cortex.	   J.	  Neurosci.	  Off.	   J.	  
Soc.	  Neurosci.	  23,	  5805–5815.	  
Angevine,	   J.B.,	   and	   Sidman,	   R.L.	   (1961).	   Autoradiographic	   study	   of	   cell	   migration	   during	  
histogenesis	  of	  cerebral	  cortex	  in	  the	  mouse.	  Nature	  192,	  766–768.	  
Anthony,	   T.E.,	   Klein,	   C.,	   Fishell,	   G.,	   and	   Heintz,	   N.	   (2004).	   Radial	   glia	   serve	   as	   neuronal	  
progenitors	  in	  all	  regions	  of	  the	  central	  nervous	  system.	  Neuron	  41,	  881–890.	  
Araque,	   A.,	   Sanzgiri,	   R.P.,	   Parpura,	   V.,	   and	   Haydon,	   P.G.	   (1999).	   Astrocyte-­‐induced	  
modulation	  of	  synaptic	  transmission.	  Can.	  J.	  Physiol.	  Pharmacol.	  77,	  699–706.	  
Barnabé-­‐Heider,	  F.,	  Wasylnka,	  J.A.,	  Fernandes,	  K.J.L.,	  Porsche,	  C.,	  Sendtner,	  M.,	  Kaplan,	  D.R.,	  
and	   Miller,	   F.D.	   (2005).	   Evidence	   that	   embryonic	   neurons	   regulate	   the	   onset	   of	   cortical	  
gliogenesis	  via	  cardiotrophin-­‐1.	  Neuron	  48,	  253–265.	  
Barnes,	  A.P.,	  Lilley,	  B.N.,	  Pan,	  Y.A.,	  Plummer,	  L.J.,	  Powell,	  A.W.,	  Raines,	  A.N.,	  Sanes,	  J.R.,	  and	  
Polleux,	  F.	   (2007).	  LKB1	  and	  SAD	  kinases	  define	  a	  pathway	  required	   for	   the	  polarization	  of	  
cortical	  neurons.	  Cell	  129,	  549–563.	  
Bertossi,	  C.,	  Cassina,	  M.,	  De	  Palma,	  L.,	  Vecchi,	  M.,	  Rossato,	  S.,	  Toldo,	  I.,	  Donà,	  M.,	  Murgia,	  A.,	  
Boniver,	   C.,	   and	   Sartori,	   S.	   (2014).	   14q12	  duplication	   including	   FOXG1:	   is	   there	   a	   common	  




Bhat,	  K.M.,	  van	  Beers,	  E.H.,	  and	  Bhat,	  P.	  (2000).	  Sloppy	  paired	  acts	  as	  the	  downstream	  target	  
of	  wingless	   in	   the	  Drosophila	   CNS	   and	   interaction	   between	   sloppy	   paired	   and	   gooseberry	  
inhibits	  sloppy	  paired	  during	  neurogenesis.	  Dev.	  Camb.	  Engl.	  127,	  655–665.	  
Bielle,	  F.,	  Griveau,	  A.,	  Narboux-­‐Nême,	  N.,	  Vigneau,	  S.,	  Sigrist,	  M.,	  Arber,	  S.,	  Wassef,	  M.,	  and	  
Pierani,	   A.	   (2005).	  Multiple	   origins	   of	   Cajal-­‐Retzius	   cells	   at	   the	   borders	   of	   the	   developing	  
pallium.	  Nat.	  Neurosci.	  8,	  1002–1012.	  
Brancaccio,	  M.,	  Pivetta,	  C.,	  Granzotto,	  M.,	   Filippis,	  C.,	   and	  Mallamaci,	  A.	   (2010).	  Emx2	  and	  
Foxg1	   inhibit	   gliogenesis	   and	   promote	   neuronogenesis.	   Stem	   Cells	   Dayt.	   Ohio	   28,	   1206–
1218.	  
Britanova,	  O.,	  de	  Juan	  Romero,	  C.,	  Cheung,	  A.,	  Kwan,	  K.Y.,	  Schwark,	  M.,	  Gyorgy,	  A.,	  Vogel,	  T.,	  
Akopov,	  S.,	  Mitkovski,	  M.,	  Agoston,	  D.,	  et	  al.	  (2008).	  Satb2	  is	  a	  postmitotic	  determinant	  for	  
upper-­‐layer	  neuron	  specification	  in	  the	  neocortex.	  Neuron	  57,	  378–392.	  
Brunetti-­‐Pierri,	  N.,	  Paciorkowski,	  A.R.,	  Ciccone,	  R.,	  Della	  Mina,	  E.,	  Bonaglia,	  M.C.,	  Borgatti,	  R.,	  
Schaaf,	  C.P.,	  Sutton,	  V.R.,	  Xia,	  Z.,	   Jelluma,	  N.,	  et	  al.	   (2011).	  Duplications	  of	  FOXG1	  in	  14q12	  
are	   associated	   with	   developmental	   epilepsy,	   mental	   retardation,	   and	   severe	   speech	  
impairment.	  Eur.	  J.	  Hum.	  Genet.	  EJHG	  19,	  102–107.	  
Bystron,	  I.,	  Blakemore,	  C.,	  and	  Rakic,	  P.	  (2008).	  Development	  of	  the	  human	  cerebral	  cortex:	  
Boulder	  Committee	  revisited.	  Nat.	  Rev.	  Neurosci.	  9,	  110–122.	  
Calegari,	   F.,	   and	   Huttner,	   W.B.	   (2003).	   An	   inhibition	   of	   cyclin-­‐dependent	   kinases	   that	  
lengthens,	  but	  does	  not	  arrest,	  neuroepithelial	  cell	  cycle	  induces	  premature	  neurogenesis.	  J.	  
Cell	  Sci.	  116,	  4947–4955.	  
Calella,	   A.M.,	   Nerlov,	   C.,	   Lopez,	   R.G.,	   Sciarretta,	   C.,	   von	   Bohlen	   und	   Halbach,	   O.,	  
Bereshchenko,	  O.,	  and	  Minichiello,	  L.	  (2007).	  Neurotrophin/Trk	  receptor	  signaling	  mediates	  
C/EBPalpha,	  -­‐beta	  and	  NeuroD	  recruitment	  to	  immediate-­‐early	  gene	  promoters	  in	  neuronal	  
cells	  and	  requires	  C/EBPs	  to	   induce	  immediate-­‐early	  gene	  transcription.	  Neural	  Develop.	  2,	  
4.	  
Cavanagh,	   M.E.,	   and	   Parnavelas,	   J.G.	   (1989).	   Development	   of	   vasoactive-­‐intestinal-­‐
polypeptide-­‐immunoreactive	   neurons	   in	   the	   rat	   occipital	   cortex:	   a	   combined	  
immunohistochemical-­‐autoradiographic	  study.	  J.	  Comp.	  Neurol.	  284,	  637–645.	  
Chen,	  B.,	  Wang,	  S.S.,	  Hattox,	  A.M.,	  Rayburn,	  H.,	  Nelson,	  S.B.,	  and	  McConnell,	  S.K.	  (2008).	  The	  
Fezf2-­‐Ctip2	  genetic	  pathway	   regulates	   the	   fate	   choice	  of	   subcortical	  projection	  neurons	   in	  
the	  developing	  cerebral	  cortex.	  Proc.	  Natl.	  Acad.	  Sci.	  U.	  S.	  A.	  105,	  11382–11387.	  
Chenn,	  A.,	  and	  McConnell,	  S.K.	  (1995).	  Cleavage	  orientation	  and	  the	  asymmetric	  inheritance	  
of	  Notch1	  immunoreactivity	  in	  mammalian	  neurogenesis.	  Cell	  82,	  631–641.	  
Cherubini,	   E.,	   and	   Conti,	   F.	   (2001).	   Generating	   diversity	   at	   GABAergic	   synapses.	   Trends	  
Neurosci.	  24,	  155–162.	  
Chiao,	  P.J.,	  Miyamoto,	  S.,	  and	  Verma,	  I.M.	  (1994).	  Autoregulation	  of	  I	  kappa	  B	  alpha	  activity.	  




Coufal,	  N.G.,	  Garcia-­‐Perez,	  J.L.,	  Peng,	  G.E.,	  Yeo,	  G.W.,	  Mu,	  Y.,	  Lovci,	  M.T.,	  Morell,	  M.,	  O’Shea,	  
K.S.,	  Moran,	   J.V.,	   and	  Gage,	   F.H.	   (2009).	   L1	   retrotransposition	   in	  human	  neural	   progenitor	  
cells.	  Nature	  460,	  1127–1131.	  
Danesin,	   C.,	   and	   Houart,	   C.	   (2012).	   A	   Fox	   stops	   the	   Wnt:	   implications	   for	   forebrain	  
development	  and	  diseases.	  Curr.	  Opin.	  Genet.	  Dev.	  22,	  323–330.	  
Danesin,	  C.,	  Peres,	  J.N.,	  Johansson,	  M.,	  Snowden,	  V.,	  Cording,	  A.,	  Papalopulu,	  N.,	  and	  Houart,	  
C.	   (2009).	   Integration	   of	   telencephalic	   Wnt	   and	   hedgehog	   signaling	   center	   activities	   by	  
Foxg1.	  Dev.	  Cell	  16,	  576–587.	  
DeFelipe,	   J.	   (1993).	   Neocortical	   neuronal	   diversity:	   chemical	   heterogeneity	   revealed	   by	  
colocalization	  studies	  of	  classic	  neurotransmitters,	  neuropeptides,	  calcium-­‐binding	  proteins,	  
and	  cell	  surface	  molecules.	  Cereb.	  Cortex	  N.	  Y.	  N	  1991	  3,	  273–289.	  
DeFelipe,	   J.	   (1997).	  Types	  of	  neurons,	   synaptic	  connections	  and	  chemical	  characteristics	  of	  
cells	   immunoreactive	   for	   calbindin-­‐D28K,	   parvalbumin	   and	   calretinin	   in	   the	   neocortex.	   J.	  
Chem.	  Neuroanat.	  14,	  1–19.	  
Dehay,	   C.,	   and	   Kennedy,	   H.	   (2007).	   Cell-­‐cycle	   control	   and	   cortical	   development.	   Nat.	   Rev.	  
Neurosci.	  8,	  438–450.	  
Desai,	   A.R.,	   and	  McConnell,	   S.K.	   (2000).	   Progressive	   restriction	   in	   fate	   potential	   by	   neural	  
progenitors	  during	  cerebral	  cortical	  development.	  Dev.	  Camb.	  Engl.	  127,	  2863–2872.	  
Djukic,	   B.,	   Casper,	   K.B.,	   Philpot,	   B.D.,	   Chin,	   L.-­‐S.,	   and	   McCarthy,	   K.D.	   (2007).	   Conditional	  
knock-­‐out	   of	   Kir4.1	   leads	   to	   glial	   membrane	   depolarization,	   inhibition	   of	   potassium	   and	  
glutamate	  uptake,	   and	  enhanced	   short-­‐term	  synaptic	  potentiation.	   J.	  Neurosci.	  Off.	   J.	   Soc.	  
Neurosci.	  27,	  11354–11365.	  
Doetsch,	   F.,	   Caillé,	   I.,	   Lim,	   D.A.,	   García-­‐Verdugo,	   J.M.,	   and	   Alvarez-­‐Buylla,	   A.	   (1999).	  
Subventricular	  zone	  astrocytes	  are	  neural	  stem	  cells	  in	  the	  adult	  mammalian	  brain.	  Cell	  97,	  
703–716.	  
Dou,	   C.L.,	   Li,	   S.,	   and	   Lai,	   E.	   (1999).	   Dual	   role	   of	   brain	   factor-­‐1	   in	   regulating	   growth	   and	  
patterning	  of	  the	  cerebral	  hemispheres.	  Cereb.	  Cortex	  N.	  Y.	  N	  1991	  9,	  543–550.	  
Eagleson,	   K.L.,	   Schlueter	   McFadyen-­‐Ketchum,	   L.J.,	   Ahrens,	   E.T.,	   Mills,	   P.H.,	   Does,	   M.D.,	  
Nickols,	   J.,	   and	   Levitt,	   P.	   (2007).	   Disruption	   of	   Foxg1	   expression	   by	   knock-­‐in	   of	   cre	  
recombinase:	  effects	  on	   the	  development	  of	   the	  mouse	   telencephalon.	  Neuroscience	  148,	  
385–399.	  
Edlund,	   T.,	   and	   Jessell,	   T.M.	   (1999).	   Progression	   from	  extrinsic	   to	   intrinsic	   signaling	   in	   cell	  
fate	  specification:	  a	  view	  from	  the	  nervous	  system.	  Cell	  96,	  211–224.	  
Falace,	  A.,	   Vanni,	  N.,	  Mallamaci,	   A.,	   Striano,	   P.,	   and	   Zara,	   F.	   (2013).	  Do	   regulatory	   regions	  
matter	  in	  FOXG1	  duplications?	  Eur.	  J.	  Hum.	  Genet.	  EJHG	  21,	  365–366.	  
Fasano,	  C.A.,	  Phoenix,	  T.N.,	  Kokovay,	  E.,	  Lowry,	  N.,	  Elkabetz,	  Y.,	  Dimos,	  J.T.,	  Lemischka,	  I.R.,	  
Studer,	  L.,	  and	  Temple,	  S.	  (2009).	  Bmi-­‐1	  cooperates	  with	  Foxg1	  to	  maintain	  neural	  stem	  cell	  




Fellin,	  T.,	  and	  Carmignoto,	  G.	  (2004).	  Neurone-­‐to-­‐astrocyte	  signalling	  in	  the	  brain	  represents	  
a	  distinct	  multifunctional	  unit.	  J.	  Physiol.	  559,	  3–15.	  
Fietz,	   S.A.,	   and	   Huttner,	   W.B.	   (2011).	   Cortical	   progenitor	   expansion,	   self-­‐renewal	   and	  
neurogenesis-­‐a	  polarized	  perspective.	  Curr.	  Opin.	  Neurobiol.	  21,	  23–35.	  
Flames,	  N.,	  and	  Marín,	  O.	  (2005).	  Developmental	  mechanisms	  underlying	  the	  generation	  of	  
cortical	  interneuron	  diversity.	  Neuron	  46,	  377–381.	  
Follenzi,	  A.,	  and	  Naldini,	   L.	   (2002).	  Generation	  of	  HIV-­‐1	  derived	   lentiviral	  vectors.	  Methods	  
Enzymol.	  346,	  454–465.	  
Fox,	   I.J.,	   and	   Kornblum,	   H.I.	   (2005).	   Developmental	   profile	   of	   ErbB	   receptors	   in	   murine	  
central	   nervous	   system:	   implications	   for	   functional	   interactions.	   J.	  Neurosci.	   Res.	  79,	   584–
597.	  
Franco,	  S.J.,	  Gil-­‐Sanz,	  C.,	  Martinez-­‐Garay,	  I.,	  Espinosa,	  A.,	  Harkins-­‐Perry,	  S.R.,	  Ramos,	  C.,	  and	  
Müller,	   U.	   (2012).	   Fate-­‐restricted	   neural	   progenitors	   in	   the	   mammalian	   cerebral	   cortex.	  
Science	  337,	  746–749.	  
Frantz,	  G.D.,	  and	  McConnell,	  S.K.	   (1996).	  Restriction	  of	   late	  cerebral	  cortical	  progenitors	  to	  
an	  upper-­‐layer	  fate.	  Neuron	  17,	  55–61.	  
Gioran,	  A.,	  Nicotera,	  P.,	  and	  Bano,	  D.	   (2014).	   Impaired	  mitochondrial	   respiration	  promotes	  
dendritic	  branching	  via	  the	  AMPK	  signaling	  pathway.	  Cell	  Death	  Dis.	  5,	  e1175.	  
Gonchar,	   Y.,	  Wang,	  Q.,	   and	  Burkhalter,	   A.	   (2007).	  Multiple	   distinct	   subtypes	   of	  GABAergic	  
neurons	  in	  mouse	  visual	  cortex	  identified	  by	  triple	  immunostaining.	  Front.	  Neuroanat.	  1,	  3.	  
Gorski,	  J.A.,	  Talley,	  T.,	  Qiu,	  M.,	  Puelles,	  L.,	  Rubenstein,	  J.L.R.,	  and	  Jones,	  K.R.	  (2002).	  Cortical	  
excitatory	   neurons	   and	   glia,	   but	   not	   GABAergic	   neurons,	   are	   produced	   in	   the	   Emx1-­‐
expressing	  lineage.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  22,	  6309–6314.	  
Götz,	  M.,	  and	  Huttner,	  W.B.	  (2005).	  The	  cell	  biology	  of	  neurogenesis.	  Nat.	  Rev.	  Mol.	  Cell	  Biol.	  
6,	  777–788.	  
Greig,	   L.C.,	   Woodworth,	   M.B.,	   Galazo,	   M.J.,	   Padmanabhan,	   H.,	   and	   Macklis,	   J.D.	   (2013).	  
Molecular	   logic	   of	   neocortical	   projection	   neuron	   specification,	   development	   and	   diversity.	  
Nat.	  Rev.	  Neurosci.	  14,	  755–769.	  
Grove,	  E.A.,	  Tole,	  S.,	  Limon,	  J.,	  Yip,	  L.,	  and	  Ragsdale,	  C.W.	  (1998).	  The	  hem	  of	  the	  embryonic	  
cerebral	  cortex	   is	  defined	  by	   the	  expression	  of	  multiple	  Wnt	  genes	  and	   is	  compromised	   in	  
Gli3-­‐deficient	  mice.	  Dev.	  Camb.	  Engl.	  125,	  2315–2325.	  
Guruharsha,	   K.G.,	   Kankel,	   M.W.,	   and	   Artavanis-­‐Tsakonas,	   S.	   (2012).	   The	   Notch	   signalling	  
system:	   recent	   insights	   into	   the	   complexity	   of	   a	   conserved	   pathway.	   Nat.	   Rev.	   Genet.	  13,	  
654–666.	  
Gutierrez,	  H.,	  and	  Davies,	  A.M.	  (2011).	  Regulation	  of	  neural	  process	  growth,	  elaboration	  and	  
structural	  plasticity	  by	  NF-­‐κB.	  Trends	  Neurosci.	  34,	  316–325.	  
Gutin,	  G.,	   Fernandes,	  M.,	   Palazzolo,	   L.,	   Paek,	  H.,	   Yu,	   K.,	  Ornitz,	  D.M.,	  McConnell,	   S.K.,	   and	  
Hébert,	   J.M.	   (2006).	   FGF	   signalling	   generates	   ventral	   telencephalic	   cells	   independently	   of	  




Han,	  W.,	   Kwan,	  K.Y.,	   Shim,	   S.,	   Lam,	  M.M.S.,	   Shin,	   Y.,	   Xu,	   X.,	   Zhu,	   Y.,	   Li,	  M.,	   and	  Sestan,	  N.	  
(2011).	  TBR1	  directly	  represses	  Fezf2	  to	  control	  the	  laminar	  origin	  and	  development	  of	  the	  
corticospinal	  tract.	  Proc.	  Natl.	  Acad.	  Sci.	  U.	  S.	  A.	  108,	  3041–3046.	  
Hanashima,	  C.,	  Shen,	  L.,	  Li,	  S.C.,	  and	  Lai,	  E.	   (2002).	  Brain	  factor-­‐1	  controls	   the	  proliferation	  
and	   differentiation	   of	   neocortical	   progenitor	   cells	   through	   independent	   mechanisms.	   J.	  
Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  22,	  6526–6536.	  
Hanashima,	  C.,	  Li,	  S.C.,	  Shen,	  L.,	  Lai,	  E.,	  and	  Fishell,	  G.	  (2004).	  Foxg1	  suppresses	  early	  cortical	  
cell	  fate.	  Science	  303,	  56–59.	  
Hanashima,	   C.,	   Fernandes,	  M.,	   Hebert,	   J.M.,	   and	   Fishell,	   G.	   (2007).	   The	   role	   of	   Foxg1	   and	  
dorsal	  midline	  signaling	   in	  the	  generation	  of	  Cajal-­‐Retzius	  subtypes.	  J.	  Neurosci.	  Off.	   J.	  Soc.	  
Neurosci.	  27,	  11103–11111.	  
Hansen,	  D.V.,	  Lui,	  J.H.,	  Parker,	  P.R.L.,	  and	  Kriegstein,	  A.R.	  (2010).	  Neurogenic	  radial	  glia	  in	  the	  
outer	  subventricular	  zone	  of	  human	  neocortex.	  Nature	  464,	  554–561.	  
Haubensak,	  W.,	  Attardo,	  A.,	  Denk,	  W.,	  and	  Huttner,	  W.B.	  (2004).	  Neurons	  arise	  in	  the	  basal	  
neuroepithelium	  of	  the	  early	  mammalian	  telencephalon:	  a	  major	  site	  of	  neurogenesis.	  Proc.	  
Natl.	  Acad.	  Sci.	  U.	  S.	  A.	  101,	  3196–3201.	  
Heinrich,	   P.C.,	   Behrmann,	   I.,	   Müller-­‐Newen,	   G.,	   Schaper,	   F.,	   and	   Graeve,	   L.	   (1998).	  
Interleukin-­‐6-­‐type	  cytokine	  signalling	  through	  the	  gp130/Jak/STAT	  pathway.	  Biochem.	  J.	  334	  
(	  Pt	  2),	  297–314.	  
Hevner,	  R.F.,	  Shi,	  L.,	  Justice,	  N.,	  Hsueh,	  Y.,	  Sheng,	  M.,	  Smiga,	  S.,	  Bulfone,	  A.,	  Goffinet,	  A.M.,	  
Campagnoni,	  A.T.,	  and	  Rubenstein,	  J.L.	  (2001).	  Tbr1	  regulates	  differentiation	  of	  the	  preplate	  
and	  layer	  6.	  Neuron	  29,	  353–366.	  
Higashi,	  K.,	  Fujita,	  A.,	  Inanobe,	  A.,	  Tanemoto,	  M.,	  Doi,	  K.,	  Kubo,	  T.,	  and	  Kurachi,	  Y.	  (2001).	  An	  
inwardly	   rectifying	   K(+)	   channel,	   Kir4.1,	   expressed	   in	   astrocytes	   surrounds	   synapses	   and	  
blood	  vessels	  in	  brain.	  Am.	  J.	  Physiol.	  Cell	  Physiol.	  281,	  C922–C931.	  
Houart,	   C.,	  Westerfield,	  M.,	   and	  Wilson,	   S.W.	   (1998).	   A	   small	   population	   of	   anterior	   cells	  
patterns	  the	  forebrain	  during	  zebrafish	  gastrulation.	  Nature	  391,	  788–792.	  
Houser,	  C.R.,	  Hendry,	   S.H.,	   Jones,	  E.G.,	   and	  Vaughn,	   J.E.	   (1983).	  Morphological	  diversity	  of	  
immunocytochemically	   identified	   GABA	   neurons	   in	   the	   monkey	   sensory-­‐motor	   cortex.	   J.	  
Neurocytol.	  12,	  617–638.	  
Hrachovy,	  R.A.,	  and	  Frost,	  J.D.	  (1989).	  Infantile	  spasms.	  Pediatr.	  Clin.	  North	  Am.	  36,	  311–329.	  
John	   Rubenstein	   and	   Pasko	   Rakic	   (2013).	   Patterning	   and	   Cell	   type	   specification	   in	   the	  
developing	  Cns	  and	  Pns.	  
Juliandi,	  B.,	  Abematsu,	  M.,	  and	  Nakashima,	  K.	  (2010).	  Chromatin	  remodeling	  in	  neural	  stem	  
cell	  differentiation.	  Curr.	  Opin.	  Neurobiol.	  20,	  408–415.	  
Kaestner,	   K.H.,	   Lee,	   K.H.,	   Schlöndorff,	   J.,	   Hiemisch,	   H.,	   Monaghan,	   A.P.,	   and	   Schütz,	   G.	  
(1993).	   Six	   members	   of	   the	   mouse	   forkhead	   gene	   family	   are	   developmentally	   regulated.	  




Kawaguchi,	   Y.,	   and	   Kondo,	   S.	   (2002).	   Parvalbumin,	   somatostatin	   and	   cholecystokinin	   as	  
chemical	   markers	   for	   specific	   GABAergic	   interneuron	   types	   in	   the	   rat	   frontal	   cortex.	   J.	  
Neurocytol.	  31,	  277–287.	  
Kimelberg,	   H.K.,	   and	   Kettenmann,	   H.	   (1990).	   Swelling-­‐induced	   changes	   in	  
electrophysiological	   properties	   of	   cultured	   astrocytes	   and	   oligodendrocytes.	   I.	   Effects	   on	  
membrane	  potentials,	  input	  impedance	  and	  cell-­‐cell	  coupling.	  Brain	  Res.	  529,	  255–261.	  
Kippin,	  T.E.,	  Martens,	  D.J.,	  and	  van	  der	  Kooy,	  D.	   (2005).	  p21	   loss	  compromises	  the	  relative	  
quiescence	   of	   forebrain	   stem	   cell	   proliferation	   leading	   to	   exhaustion	   of	   their	   proliferation	  
capacity.	  Genes	  Dev.	  19,	  756–767.	  
Kofuji,	   P.,	   and	   Newman,	   E.A.	   (2004).	   Potassium	   buffering	   in	   the	   central	   nervous	   system.	  
Neuroscience	  129,	  1045–1056.	  
Kopan,	  R.,	  and	  Ilagan,	  M.X.G.	  (2009).	  The	  canonical	  Notch	  signaling	  pathway:	  unfolding	  the	  
activation	  mechanism.	  Cell	  137,	  216–233.	  
Kowalczyk,	   T.,	   Pontious,	   A.,	   Englund,	   C.,	   Daza,	   R.A.M.,	   Bedogni,	   F.,	   Hodge,	   R.,	   Attardo,	   A.,	  
Bell,	   C.,	   Huttner,	  W.B.,	   and	   Hevner,	   R.F.	   (2009).	   Intermediate	   neuronal	   progenitors	   (basal	  
progenitors)	  produce	  pyramidal-­‐projection	  neurons	   for	  all	   layers	  of	  cerebral	   cortex.	  Cereb.	  
Cortex	  N.	  Y.	  N	  1991	  19,	  2439–2450.	  
Kriegstein,	  A.,	  and	  Alvarez-­‐Buylla,	  A.	  (2009).	  The	  glial	  nature	  of	  embryonic	  and	  adult	  neural	  
stem	  cells.	  Annu.	  Rev.	  Neurosci.	  32,	  149–184.	  
Krimer,	  L.S.,	  and	  Goldman-­‐Rakic,	  P.S.	  (2001).	  Prefrontal	  microcircuits:	  membrane	  properties	  
and	  excitatory	  input	  of	  local,	  medium,	  and	  wide	  arbor	  interneurons.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  
Neurosci.	  21,	  3788–3796.	  
Krubitzer,	   L.,	   and	   Kaas,	   J.	   (2005).	   The	   evolution	   of	   the	   neocortex	   in	   mammals:	   how	   is	  
phenotypic	  diversity	  generated?	  Curr.	  Opin.	  Neurobiol.	  15,	  444–453.	  
Kucheryavykh,	   Y.V.,	   Kucheryavykh,	   L.Y.,	   Nichols,	   C.G.,	   Maldonado,	   H.M.,	   Baksi,	   K.,	  
Reichenbach,	  A.,	   Skatchkov,	   S.N.,	   and	  Eaton,	  M.J.	   (2007).	  Downregulation	  of	  Kir4.1	   inward	  
rectifying	   potassium	   channel	   subunits	   by	   RNAi	   impairs	   potassium	   transfer	   and	   glutamate	  
uptake	  by	  cultured	  cortical	  astrocytes.	  Glia	  55,	  274–281.	  
Kuschel,	  S.,	  Rüther,	  U.,	  and	  Theil,	  T.	  (2003).	  A	  disrupted	  balance	  between	  Bmp/Wnt	  and	  Fgf	  
signaling	  underlies	  the	  ventralization	  of	  the	  Gli3	  mutant	  telencephalon.	  Dev.	  Biol.	  260,	  484–
495.	  
Lavdas,	  A.A.,	  Grigoriou,	  M.,	  Pachnis,	  V.,	   and	  Parnavelas,	   J.G.	   (1999).	   The	  medial	   ganglionic	  
eminence	   gives	   rise	   to	   a	   population	   of	   early	   neurons	   in	   the	   developing	   cerebral	   cortex.	   J.	  
Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  19,	  7881–7888.	  
Lehre,	   K.P.,	   Levy,	   L.M.,	   Ottersen,	   O.P.,	   Storm-­‐Mathisen,	   J.,	   and	   Danbolt,	   N.C.	   (1995).	  
Differential	  expression	  of	  two	  glial	  glutamate	  transporters	  in	  the	  rat	  brain:	  quantitative	  and	  
immunocytochemical	  observations.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  15,	  1835–1853.	  
Leone,	   D.P.,	   Srinivasan,	   K.,	   Chen,	   B.,	   Alcamo,	   E.,	   and	   McConnell,	   S.K.	   (2008).	   The	  
determination	  of	   projection	  neuron	   identity	   in	   the	  developing	   cerebral	   cortex.	   Curr.	  Opin.	  




Malatesta,	  P.,	  Hartfuss,	  E.,	  and	  Götz,	  M.	  (2000).	  Isolation	  of	  radial	  glial	  cells	  by	  fluorescent-­‐
activated	  cell	  sorting	  reveals	  a	  neuronal	  lineage.	  Dev.	  Camb.	  Engl.	  127,	  5253–5263.	  
Mallamaci,	   A.,	   and	   Stoykova,	   A.	   (2006).	   Gene	   networks	   controlling	   early	   cerebral	   cortex	  
arealization.	  Eur.	  J.	  Neurosci.	  23,	  847–856.	  
Mariani,	   J.,	   Coppola,	   G.,	   Zhang,	   P.,	   Abyzov,	   A.,	   Provini,	   L.,	   Tomasini,	   L.,	   Amenduni,	   M.,	  
Szekely,	   A.,	   Palejev,	   D.,	   Wilson,	   M.,	   et	   al.	   (2015).	   FOXG1-­‐Dependent	   Dysregulation	   of	  
GABA/Glutamate	  Neuron	  Differentiation	  in	  Autism	  Spectrum	  Disorders.	  Cell	  162,	  375–390.	  
Marín,	  O.,	  and	  Rubenstein,	  J.L.R.	  (2003).	  Cell	  migration	  in	  the	  forebrain.	  Annu.	  Rev.	  Neurosci.	  
26,	  441–483.	  
Markram,	  H.,	  Toledo-­‐Rodriguez,	  M.,	  Wang,	  Y.,	  Gupta,	  A.,	  Silberberg,	  G.,	  and	  Wu,	  C.	  (2004).	  
Interneurons	  of	  the	  neocortical	  inhibitory	  system.	  Nat.	  Rev.	  Neurosci.	  5,	  793–807.	  
Martynoga,	   B.,	   Morrison,	   H.,	   Price,	   D.J.,	   and	   Mason,	   J.O.	   (2005).	   Foxg1	   is	   required	   for	  
specification	  of	  ventral	  telencephalon	  and	  region-­‐specific	  regulation	  of	  dorsal	  telencephalic	  
precursor	  proliferation	  and	  apoptosis.	  Dev.	  Biol.	  283,	  113–127.	  
Matsumoto,	  A.,	  Watanabe,	  K.,	  Negoro,	  T.,	  Sugiura,	  M.,	   Iwase,	  K.,	  Hara,	  K.,	  and	  Miyazaki,	  S.	  
(1981).	  Infantile	  spasms:	  etiological	  factors,	  clinical	  aspects,	  and	  long	  term	  prognosis	  in	  200	  
cases.	  Eur.	  J.	  Pediatr.	  135,	  239–244.	  
Mattson,	  M.P.,	  Gleichmann,	  M.,	  and	  Cheng,	  A.	   (2008).	  Mitochondria	   in	  neuroplasticity	  and	  
neurological	  disorders.	  Neuron	  60,	  748–766.	  
Mayer,	   S.I.,	  Dexheimer,	  V.,	  Nishida,	   E.,	   Kitajima,	   S.,	   and	  Thiel,	  G.	   (2008).	   Expression	  of	   the	  
transcriptional	  repressor	  ATF3	  in	  gonadotrophs	  is	  regulated	  by	  Egr-­‐1,	  CREB,	  and	  ATF2	  after	  
gonadotropin-­‐releasing	  hormone	  receptor	  stimulation.	  Endocrinology	  149,	  6311–6325.	  
McKenna,	  W.L.,	  Betancourt,	  J.,	  Larkin,	  K.A.,	  Abrams,	  B.,	  Guo,	  C.,	  Rubenstein,	  J.L.R.,	  and	  Chen,	  
B.	   (2011).	   Tbr1	   and	   Fezf2	   regulate	   alternate	   corticofugal	   neuronal	   identities	   during	  
neocortical	  development.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  31,	  549–564.	  
Miyata,	   T.,	   Kawaguchi,	   A.,	   Saito,	   K.,	   Kawano,	   M.,	   Muto,	   T.,	   and	   Ogawa,	   M.	   (2004).	  
Asymmetric	  production	  of	  surface-­‐dividing	  and	  non-­‐surface-­‐dividing	  cortical	  progenitor	  cells.	  
Dev.	  Camb.	  Engl.	  131,	  3133–3145.	  
Miyoshi,	   G.,	   and	   Fishell,	   G.	   (2011).	   GABAergic	   interneuron	   lineages	   selectively	   sort	   into	  
specific	   cortical	   layers	  during	  early	  postnatal	  development.	  Cereb.	  Cortex	  N.	  Y.	  N	  1991	  21,	  
845–852.	  
Miyoshi,	  G.,	  and	  Fishell,	  G.	  (2012).	  Dynamic	  FoxG1	  expression	  coordinates	  the	  integration	  of	  
multipolar	  pyramidal	  neuron	  precursors	  into	  the	  cortical	  plate.	  Neuron	  74,	  1045–1058.	  
Miyoshi,	   G.,	   Butt,	   S.J.B.,	   Takebayashi,	   H.,	   and	   Fishell,	   G.	   (2007).	   Physiologically	   distinct	  
temporal	   cohorts	   of	   cortical	   interneurons	   arise	   from	   telencephalic	   Olig2-­‐expressing	  
precursors.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  27,	  7786–7798.	  
Molyneaux,	   B.J.,	   Arlotta,	   P.,	   Menezes,	   J.R.L.,	   and	   Macklis,	   J.D.	   (2007).	   Neuronal	   subtype	  




Mondal,	   S.,	   Ivanchuk,	   S.M.,	   Rutka,	   J.T.,	   and	   Boulianne,	   G.L.	   (2007).	   Sloppy	   paired	   1/2	  
regulate	  glial	  cell	  fates	  by	  inhibiting	  Gcm	  function.	  Glia	  55,	  282–293.	  
Muzio,	   L.,	   and	   Mallamaci,	   A.	   (2005).	   Foxg1	   confines	   Cajal-­‐Retzius	   neuronogenesis	   and	  
hippocampal	  morphogenesis	   to	   the	  dorsomedial	  pallium.	   J.	  Neurosci.	  Off.	   J.	   Soc.	  Neurosci.	  
25,	  4435–4441.	  
Naka,	  H.,	  Nakamura,	  S.,	  Shimazaki,	  T.,	  and	  Okano,	  H.	  (2008).	  Requirement	  for	  COUP-­‐TFI	  and	  
II	   in	  the	  temporal	  specification	  of	  neural	  stem	  cells	  in	  CNS	  development.	  Nat.	  Neurosci.	  11,	  
1014–1023.	  
Namihira,	  M.,	  Kohyama,	   J.,	   Semi,	  K.,	   Sanosaka,	  T.,	  Deneen,	  B.,	  Taga,	  T.,	  and	  Nakashima,	  K.	  
(2009).	   Committed	   neuronal	   precursors	   confer	   astrocytic	   potential	   on	   residual	   neural	  
precursor	  cells.	  Dev.	  Cell	  16,	  245–255.	  
Nery,	  S.,	  Fishell,	  G.,	  and	  Corbin,	   J.G.	   (2002).	  The	  caudal	  ganglionic	  eminence	   is	  a	   source	  of	  
distinct	  cortical	  and	  subcortical	  cell	  populations.	  Nat.	  Neurosci.	  5,	  1279–1287.	  
Neves,	   G.,	   Cooke,	   S.F.,	   and	   Bliss,	   T.V.P.	   (2008).	   Synaptic	   plasticity,	   memory	   and	   the	  
hippocampus:	  a	  neural	  network	  approach	  to	  causality.	  Nat.	  Rev.	  Neurosci.	  9,	  65–75.	  
Nielsen,	  S.,	  Nagelhus,	  E.A.,	  Amiry-­‐Moghaddam,	  M.,	  Bourque,	  C.,	  Agre,	  P.,	  and	  Ottersen,	  O.P.	  
(1997).	   Specialized	   membrane	   domains	   for	   water	   transport	   in	   glial	   cells:	   high-­‐resolution	  
immunogold	  cytochemistry	  of	  aquaporin-­‐4	  in	  rat	  brain.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  17,	  
171–180.	  
Nieto,	  M.,	  Schuurmans,	  C.,	  Britz,	  O.,	  and	  Guillemot,	  F.	  (2001).	  Neural	  bHLH	  genes	  control	  the	  
neuronal	  versus	  glial	  fate	  decision	  in	  cortical	  progenitors.	  Neuron	  29,	  401–413.	  
Noctor,	   S.C.,	   Flint,	   A.C.,	   Weissman,	   T.A.,	   Dammerman,	   R.S.,	   and	   Kriegstein,	   A.R.	   (2001).	  
Neurons	  derived	  from	  radial	  glial	  cells	  establish	  radial	  units	  in	  neocortex.	  Nature	  409,	  714–
720.	  
Noctor,	  S.C.,	  Martínez-­‐Cerdeño,	  V.,	  Ivic,	  L.,	  and	  Kriegstein,	  A.R.	  (2004).	  Cortical	  neurons	  arise	  
in	   symmetric	   and	   asymmetric	   division	   zones	   and	   migrate	   through	   specific	   phases.	   Nat.	  
Neurosci.	  7,	  136–144.	  
Ochman,	   H.,	   Gerber,	   A.S.,	   and	   Hartl,	   D.L.	   (1988).	   Genetic	   applications	   of	   an	   inverse	  
polymerase	  chain	  reaction.	  Genetics	  120,	  621–623.	  
Ohkubo,	  Y.,	  Chiang,	  C.,	  and	  Rubenstein,	  J.L.R.	   (2002).	  Coordinate	  regulation	  and	  synergistic	  
actions	  of	  BMP4,	  SHH	  and	  FGF8	  in	  the	  rostral	  prosencephalon	  regulate	  morphogenesis	  of	  the	  
telencephalic	  and	  optic	  vesicles.	  Neuroscience	  111,	  1–17.	  
Ohtsuka,	  T.,	  Sakamoto,	  M.,	  Guillemot,	  F.,	  and	  Kageyama,	  R.	  (2001).	  Roles	  of	  the	  basic	  helix-­‐
loop-­‐helix	  genes	  Hes1	  and	  Hes5	  in	  expansion	  of	  neural	  stem	  cells	  of	  the	  developing	  brain.	  J.	  
Biol.	  Chem.	  276,	  30467–30474.	  
O’Leary,	  D.D.M.,	  and	  Nakagawa,	  Y.	  (2002).	  Patterning	  centers,	  regulatory	  genes	  and	  extrinsic	  
mechanisms	  controlling	  arealization	  of	  the	  neocortex.	  Curr.	  Opin.	  Neurobiol.	  12,	  14–25.	  
O’Leary,	  D.D.M.,	  Chou,	  S.-­‐J.,	  and	  Sahara,	  S.	  (2007).	  Area	  patterning	  of	  the	  mammalian	  cortex.	  




Olive,	   M.,	   Krylov,	   D.,	   Echlin,	   D.R.,	   Gardner,	   K.,	   Taparowsky,	   E.,	   and	   Vinson,	   C.	   (1997).	   A	  
dominant	   negative	   to	   activation	   protein-­‐1	   (AP1)	   that	   abolishes	   DNA	   binding	   and	   inhibits	  
oncogenesis.	  J.	  Biol.	  Chem.	  272,	  18586–18594.	  
Ono,	  K.,	  Takebayashi,	  H.,	  Ikeda,	  K.,	  Furusho,	  M.,	  Nishizawa,	  T.,	  Watanabe,	  K.,	  and	  Ikenaka,	  K.	  
(2008).	   Regional-­‐	   and	   temporal-­‐dependent	   changes	   in	   the	   differentiation	   of	   Olig2	  
progenitors	  in	  the	  forebrain,	  and	  the	  impact	  on	  astrocyte	  development	  in	  the	  dorsal	  pallium.	  
Dev.	  Biol.	  320,	  456–468.	  
Otis,	   T.S.,	   and	   Jahr,	   C.E.	   (1998).	   Anion	   currents	   and	   predicted	   glutamate	   flux	   through	   a	  
neuronal	  glutamate	  transporter.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  18,	  7099–7110.	  
Paek,	   H.,	   Gutin,	   G.,	   and	   Hébert,	   J.M.	   (2009).	   FGF	   signaling	   is	   strictly	   required	   to	  maintain	  
early	  telencephalic	  precursor	  cell	  survival.	  Dev.	  Camb.	  Engl.	  136,	  2457–2465.	  
Pancrazi,	  L.,	  Di	  Benedetto,	  G.,	  Colombaioni,	  L.,	  Della	  Sala,	  G.,	  Testa,	  G.,	  Olimpico,	  F.,	  Reyes,	  
A.,	   Zeviani,	   M.,	   Pozzan,	   T.,	   and	   Costa,	   M.	   (2015).	   Foxg1	   localizes	   to	   mitochondria	   and	  
coordinates	  cell	  differentiation	  and	  bioenergetics.	  Proc.	  Natl.	  Acad.	  Sci.	  U.	  S.	  A.	  112,	  13910–
13915.	  
Park,	   E.A.,	   Song,	   S.,	   Vinson,	   C.,	   and	   Roesler,	  W.J.	   (1999).	   Role	   of	   CCAAT	   enhancer-­‐binding	  
protein	   beta	   in	   the	   thyroid	   hormone	   and	   cAMP	   induction	   of	   phosphoenolpyruvate	  
carboxykinase	  gene	  transcription.	  J.	  Biol.	  Chem.	  274,	  211–217.	  
Parri,	  H.R.,	  Gould,	  T.M.,	  and	  Crunelli,	  V.	   (2001).	  Spontaneous	  astrocytic	  Ca2+	  oscillations	   in	  
situ	  drive	  NMDAR-­‐mediated	  neuronal	  excitation.	  Nat.	  Neurosci.	  4,	  803–812.	  
Pilaz,	  L.-­‐J.,	  Patti,	  D.,	  Marcy,	  G.,	  Ollier,	  E.,	  Pfister,	  S.,	  Douglas,	  R.J.,	  Betizeau,	  M.,	  Gautier,	  E.,	  
Cortay,	  V.,	  Doerflinger,	  N.,	  et	  al.	  (2009).	  Forced	  G1-­‐phase	  reduction	  alters	  mode	  of	  division,	  
neuron	  number,	  and	  laminar	  phenotype	  in	  the	  cerebral	  cortex.	  Proc.	  Natl.	  Acad.	  Sci.	  U.	  S.	  A.	  
106,	  21924–21929.	  
Polleux,	   F.,	   Whitford,	   K.L.,	   Dijkhuizen,	   P.A.,	   Vitalis,	   T.,	   and	   Ghosh,	   A.	   (2002).	   Control	   of	  
cortical	   interneuron	  migration	  by	  neurotrophins	  and	  PI3-­‐kinase	  signaling.	  Dev.	  Camb.	  Engl.	  
129,	  3147–3160.	  
Pontrelli,	   G.,	   Cappelletti,	   S.,	   Claps,	   D.,	   Sirleto,	   P.,	   Ciocca,	   L.,	   Petrocchi,	   S.,	   Terracciano,	   A.,	  
Serino,	   D.,	   Fusco,	   L.,	   Vigevano,	   F.,	   et	   al.	   (2014).	   Epilepsy	   in	   patients	   with	   duplications	   of	  
chromosome	  14	  harboring	  FOXG1.	  Pediatr.	  Neurol.	  50,	  530–535.	  
Pow,	  D.V.,	   and	  Robinson,	   S.R.	   (1994).	  Glutamate	   in	   some	   retinal	   neurons	   is	   derived	   solely	  
from	  glia.	  Neuroscience	  60,	  355–366.	  
Privat,	  A.	  (1995).	  [Treatment	  of	  the	  future	  for	  spinal	  cord	  injuries].	  Rev.	  Prat.	  45,	  2051–2056.	  
Rakic,	  P.	  (1972).	  Mode	  of	  cell	  migration	  to	  the	  superficial	  layers	  of	  fetal	  monkey	  neocortex.	  J.	  
Comp.	  Neurol.	  145,	  61–83.	  
Rakic,	  P.	  (1974).	  Neurons	  in	  rhesus	  monkey	  visual	  cortex:	  systematic	  relation	  between	  time	  
of	  origin	  and	  eventual	  disposition.	  Science	  183,	  425–427.	  
Rakic,	  P.	   (2003).	  Developmental	  and	  evolutionary	  adaptations	  of	  cortical	   radial	  glia.	  Cereb.	  




Rallu,	   M.,	   Machold,	   R.,	   Gaiano,	   N.,	   Corbin,	   J.G.,	   McMahon,	   A.P.,	   and	   Fishell,	   G.	   (2002).	  
Dorsoventral	  patterning	  is	  established	  in	  the	  telencephalon	  of	  mutants	  lacking	  both	  Gli3	  and	  
Hedgehog	  signaling.	  Dev.	  Camb.	  Engl.	  129,	  4963–4974.	  
Rash,	   B.G.,	   and	   Grove,	   E.A.	   (2006).	   Area	   and	   layer	   patterning	   in	   the	   developing	   cerebral	  
cortex.	  Curr.	  Opin.	  Neurobiol.	  16,	  25–34.	  
Regad,	   T.,	   Roth,	   M.,	   Bredenkamp,	   N.,	   Illing,	   N.,	   and	   Papalopulu,	   N.	   (2007).	   The	   neural	  
progenitor-­‐specifying	  activity	  of	  FoxG1	  is	  antagonistically	  regulated	  by	  CKI	  and	  FGF.	  Nat.	  Cell	  
Biol.	  9,	  531–540.	  
Rothstein,	  J.D.,	  Martin,	  L.,	  Levey,	  A.I.,	  Dykes-­‐Hoberg,	  M.,	  Jin,	  L.,	  Wu,	  D.,	  Nash,	  N.,	  and	  Kuncl,	  
R.W.	  (1994).	  Localization	  of	  neuronal	  and	  glial	  glutamate	  transporters.	  Neuron	  13,	  713–725.	  
Sardi,	   S.P.,	  Murtie,	   J.,	   Koirala,	   S.,	   Patten,	  B.A.,	   and	  Corfas,	  G.	   (2006).	   Presenilin-­‐dependent	  
ErbB4	  nuclear	  signaling	  regulates	  the	  timing	  of	  astrogenesis	  in	  the	  developing	  brain.	  Cell	  127,	  
185–197.	  
Sasai,	  Y.,	  and	  De	  Robertis,	  E.M.	   (1997).	  Ectodermal	  patterning	   in	  vertebrate	  embryos.	  Dev.	  
Biol.	  182,	  5–20.	  
Schwarz,	   E.M.,	   Van	   Antwerp,	   D.,	   and	   Verma,	   I.M.	   (1996).	   Constitutive	   phosphorylation	   of	  
IkappaBalpha	   by	   casein	   kinase	   II	   occurs	   preferentially	   at	   serine	   293:	   requirement	   for	  
degradation	  of	  free	  IkappaBalpha.	  Mol.	  Cell.	  Biol.	  16,	  3554–3559.	  
Seoane,	  J.,	  Le,	  H.-­‐V.,	  Shen,	  L.,	  Anderson,	  S.A.,	  and	  Massagué,	  J.	  (2004).	  Integration	  of	  Smad	  
and	  forkhead	  pathways	  in	  the	  control	  of	  neuroepithelial	  and	  glioblastoma	  cell	  proliferation.	  
Cell	  117,	  211–223.	  
Sessa,	   A.,	   Mao,	   C.-­‐A.,	   Colasante,	   G.,	   Nini,	   A.,	   Klein,	   W.H.,	   and	   Broccoli,	   V.	   (2010).	   Tbr2-­‐
positive	   intermediate	   (basal)	   neuronal	   progenitors	   safeguard	   cerebral	   cortex	   expansion	  by	  
controlling	   amplification	   of	   pallial	   glutamatergic	   neurons	   and	   attraction	   of	   subpallial	  
GABAergic	  interneurons.	  Genes	  Dev.	  24,	  1816–1826.	  
Seuntjens,	   E.,	  Nityanandam,	  A.,	  Miquelajauregui,	  A.,	  Debruyn,	   J.,	   Stryjewska,	  A.,	  Goebbels,	  
S.,	   Nave,	   K.-­‐A.,	   Huylebroeck,	   D.,	   and	   Tarabykin,	   V.	   (2009).	   Sip1	   regulates	   sequential	   fate	  
decisions	  by	  feedback	  signaling	  from	  postmitotic	  neurons	  to	  progenitors.	  Nat.	  Neurosci.	  12,	  
1373–1380.	  
Shaikh,	  T.H.,	  Gai,	  X.,	  Perin,	  J.C.,	  Glessner,	  J.T.,	  Xie,	  H.,	  Murphy,	  K.,	  O’Hara,	  R.,	  Casalunovo,	  T.,	  
Conlin,	  L.K.,	  D’Arcy,	  M.,	  et	  al.	  (2009).	  High-­‐resolution	  mapping	  and	  analysis	  of	  copy	  number	  
variations	   in	   the	   human	   genome:	   a	   data	   resource	   for	   clinical	   and	   research	   applications.	  
Genome	  Res.	  19,	  1682–1690.	  
Shigeri,	   Y.,	   Seal,	   R.P.,	   and	   Shimamoto,	   K.	   (2004).	   Molecular	   pharmacology	   of	   glutamate	  
transporters,	  EAATs	  and	  VGLUTs.	  Brain	  Res.	  Brain	  Res.	  Rev.	  45,	  250–265.	  
Shimamura,	  K.,	  and	  Rubenstein,	  J.L.	  (1997).	  Inductive	  interactions	  direct	  early	  regionalization	  
of	  the	  mouse	  forebrain.	  Dev.	  Camb.	  Engl.	  124,	  2709–2718.	  
Shuai,	  K.,	  and	  Liu,	  B.	   (2003).	  Regulation	  of	   JAK-­‐STAT	  signalling	   in	   the	   immune	  system.	  Nat.	  




Siegenthaler,	   J.A.,	   Tremper-­‐Wells,	   B.A.,	   and	  Miller,	   M.W.	   (2008).	   Foxg1	   haploinsufficiency	  
reduces	   the	   population	   of	   cortical	   intermediate	   progenitor	   cells:	   effect	   of	   increased	   p21	  
expression.	  Cereb.	  Cortex	  N.	  Y.	  N	  1991	  18,	  1865–1875.	  
Smart,	   I.H.	   (1973).	   Proliferative	   characteristics	   of	   the	   ependymal	   layer	   during	   the	   early	  
development	  of	  the	  mouse	  neocortex:	  a	  pilot	  study	  based	  on	  recording	  the	  number,	  location	  
and	  plane	  of	  cleavage	  of	  mitotic	  figures.	  J.	  Anat.	  116,	  67–91.	  
Smart,	   I.H.	   (1976).	   A	   pilot	   study	   of	   cell	   production	   by	   the	   ganglionic	   eminences	   of	   the	  
developing	  mouse	  brain.	  J.	  Anat.	  121,	  71–84.	  
Smart,	   I.H.	   (1982).	   Radial	   unit	   analysis	   of	   hippocampal	   histogenesis	   in	   the	  mouse.	   J.	   Anat.	  
135,	  763–793.	  
Smart,	   I.H.M.,	   Dehay,	   C.,	   Giroud,	   P.,	   Berland,	   M.,	   and	   Kennedy,	   H.	   (2002).	   Unique	  
morphological	   features	   of	   the	   proliferative	   zones	   and	   postmitotic	   compartments	   of	   the	  
neural	  epithelium	  giving	  rise	  to	  striate	  and	  extrastriate	  cortex	  in	  the	  monkey.	  Cereb.	  Cortex	  
N.	  Y.	  N	  1991	  12,	  37–53.	  
Sofroniew,	   M.V.,	   and	   Vinters,	   H.V.	   (2010).	   Astrocytes:	   biology	   and	   pathology.	   Acta	  
Neuropathol.	  (Berl.)	  119,	  7–35.	  
Sousa,	   V.H.,	   Miyoshi,	   G.,	   Hjerling-­‐Leffler,	   J.,	   Karayannis,	   T.,	   and	   Fishell,	   G.	   (2009).	  
Characterization	  of	  Nkx6-­‐2-­‐derived	  neocortical	   interneuron	   lineages.	  Cereb.	  Cortex	  N.	  Y.	  N	  
1991	  19	  Suppl	  1,	  i1–i10.	  
Spigoni,	   G.,	   Gedressi,	   C.,	   and	   Mallamaci,	   A.	   (2010).	   Regulation	   of	   Emx2	   expression	   by	  
antisense	  transcripts	  in	  murine	  cortico-­‐cerebral	  precursors.	  PloS	  One	  5,	  e8658.	  
Srinivasan,	   K.,	   Leone,	   D.P.,	   Bateson,	   R.K.,	   Dobreva,	   G.,	   Kohwi,	   Y.,	   Kohwi-­‐Shigematsu,	   T.,	  
Grosschedl,	   R.,	   and	   McConnell,	   S.K.	   (2012).	   A	   network	   of	   genetic	   repression	   and	  
derepression	  specifies	  projection	  fates	  in	  the	  developing	  neocortex.	  Proc.	  Natl.	  Acad.	  Sci.	  U.	  
S.	  A.	  109,	  19071–19078.	  
Storm,	  E.E.,	  Garel,	   S.,	   Borello,	  U.,	  Hebert,	   J.M.,	  Martinez,	   S.,	  McConnell,	   S.K.,	  Martin,	  G.R.,	  
and	  Rubenstein,	  J.L.R.	  (2006).	  Dose-­‐dependent	  functions	  of	  Fgf8	  in	  regulating	  telencephalic	  
patterning	  centers.	  Dev.	  Camb.	  Engl.	  133,	  1831–1844.	  
Stumm,	   R.K.,	   Zhou,	   C.,	   Ara,	   T.,	   Lazarini,	   F.,	   Dubois-­‐Dalcq,	  M.,	   Nagasawa,	   T.,	   Höllt,	   V.,	   and	  
Schulz,	   S.	   (2003).	   CXCR4	   regulates	   interneuron	   migration	   in	   the	   developing	   neocortex.	   J.	  
Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  23,	  5123–5130.	  
Sun,	  Y.,	  Nadal-­‐Vicens,	  M.,	  Misono,	  S.,	  Lin,	  M.Z.,	  Zubiaga,	  A.,	  Hua,	  X.,	  Fan,	  G.,	  and	  Greenberg,	  
M.E.	   (2001).	   Neurogenin	   promotes	   neurogenesis	   and	   inhibits	   glial	   differentiation	   by	  
independent	  mechanisms.	  Cell	  104,	  365–376.	  
Sur,	   M.,	   and	   Rubenstein,	   J.L.R.	   (2005).	   Patterning	   and	   plasticity	   of	   the	   cerebral	   cortex.	  
Science	  310,	  805–810.	  
Sussel,	  L.,	  Marin,	  O.,	  Kimura,	  S.,	  and	  Rubenstein,	  J.L.	  (1999).	  Loss	  of	  Nkx2.1	  homeobox	  gene	  
function	   results	   in	   a	   ventral	   to	   dorsal	   molecular	   respecification	   within	   the	   basal	  
telencephalon:	  evidence	  for	  a	  transformation	  of	  the	  pallidum	  into	  the	  striatum.	  Dev.	  Camb.	  




Tabata,	  H.,	  and	  Nakajima,	  K.	  (2003).	  Multipolar	  migration:	  the	  third	  mode	  of	  radial	  neuronal	  
migration	   in	   the	   developing	   cerebral	   cortex.	   J.	   Neurosci.	   Off.	   J.	   Soc.	   Neurosci.	   23,	   9996–
10001.	  
Taghdiri,	  M.M.,	  and	  Nemati,	  H.	  (2014).	  Infantile	  spasm:	  a	  review	  article.	  Iran.	  J.	  Child	  Neurol.	  
8,	  1–5.	  
Takahashi,	   T.,	   Nowakowski,	   R.S.,	   and	   Caviness,	   V.S.	   (1995).	   The	   cell	   cycle	   of	   the	  
pseudostratified	  ventricular	  epithelium	  of	   the	  embryonic	  murine	  cerebral	  wall.	   J.	  Neurosci.	  
Off.	  J.	  Soc.	  Neurosci.	  15,	  6046–6057.	  
Tanaka,	   K.,	  Watase,	   K.,	  Manabe,	   T.,	   Yamada,	   K.,	  Watanabe,	  M.,	   Takahashi,	   K.,	   Iwama,	   H.,	  
Nishikawa,	  T.,	  Ichihara,	  N.,	  Kikuchi,	  T.,	  et	  al.	  (1997).	  Epilepsy	  and	  exacerbation	  of	  brain	  injury	  
in	  mice	  lacking	  the	  glutamate	  transporter	  GLT-­‐1.	  Science	  276,	  1699–1702.	  
Tao,	  W.,	  and	  Lai,	  E.	   (1992).	  Telencephalon-­‐restricted	  expression	  of	  BF-­‐1,	  a	  new	  member	  of	  
the	  HNF-­‐3/fork	  head	  gene	  family,	  in	  the	  developing	  rat	  brain.	  Neuron	  8,	  957–966.	  
Theil,	  T.,	  Alvarez-­‐Bolado,	  G.,	  Walter,	  A.,	  and	  Rüther,	  U.	  (1999).	  Gli3	  is	  required	  for	  Emx	  gene	  
expression	  during	  dorsal	  telencephalon	  development.	  Dev.	  Camb.	  Engl.	  126,	  3561–3571.	  
Thomas,	  P.,	  and	  Beddington,	  R.	  (1996).	  Anterior	  primitive	  endoderm	  may	  be	  responsible	  for	  
patterning	  the	  anterior	  neural	  plate	  in	  the	  mouse	  embryo.	  Curr.	  Biol.	  CB	  6,	  1487–1496.	  
Tissir,	   F.,	   and	  Goffinet,	   A.M.	   (2003).	   Reelin	   and	   brain	   development.	  Nat.	   Rev.	  Neurosci.	  4,	  
496–505.	  
Tiveron,	  M.-­‐C.,	  Rossel,	  M.,	  Moepps,	  B.,	  Zhang,	  Y.L.,	  Seidenfaden,	  R.,	  Favor,	  J.,	  König,	  N.,	  and	  
Cremer,	   H.	   (2006).	   Molecular	   interaction	   between	   projection	   neuron	   precursors	   and	  
invading	   interneurons	  via	  stromal-­‐derived	  factor	  1	   (CXCL12)/CXCR4	  signaling	   in	  the	  cortical	  
subventricular	  zone/intermediate	  zone.	  J.	  Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  26,	  13273–13278.	  
Tohyama,	   J.,	  Yamamoto,	  T.,	  Hosoki,	  K.,	  Nagasaki,	  K.,	  Akasaka,	  N.,	  Ohashi,	  T.,	  Kobayashi,	  Y.,	  
and	   Saitoh,	   S.	   (2011).	   West	   syndrome	   associated	   with	   mosaic	   duplication	   of	   FOXG1	   in	   a	  
patient	  with	  maternal	  uniparental	  disomy	  of	  chromosome	  14.	  Am.	  J.	  Med.	  Genet.	  A.	  155A,	  
2584–2588.	  
Toma,	  K.,	  Kumamoto,	  T.,	  and	  Hanashima,	  C.	  (2014).	  The	  timing	  of	  upper-­‐layer	  neurogenesis	  
is	  conferred	  by	  sequential	  derepression	  and	  negative	  feedback	  from	  deep-­‐layer	  neurons.	  J.	  
Neurosci.	  Off.	  J.	  Soc.	  Neurosci.	  34,	  13259–13276.	  
de	   la	  Torre-­‐Ubieta,	  L.,	  and	  Bonni,	  A.	   (2011).	  Transcriptional	   regulation	  of	  neuronal	  polarity	  
and	  morphogenesis	  in	  the	  mammalian	  brain.	  Neuron	  72,	  22–40.	  
Tyler,	  W.A.,	  and	  Haydar,	  T.F.	  (2010).	  A	  new	  contribution	  to	  brain	  convolution:	  progenitor	  cell	  
logistics	  during	  cortex	  development.	  Nat.	  Neurosci.	  13,	  656–657.	  
Vallejo,	  M.	   (2009).	  PACAP	  signaling	   to	  DREAM:	  a	   cAMP-­‐dependent	  pathway	   that	   regulates	  
cortical	  astrogliogenesis.	  Mol.	  Neurobiol.	  39,	  90–100.	  
Van	  Antwerp,	  D.J.,	  Martin,	  S.J.,	  Kafri,	  T.,	  Green,	  D.R.,	  and	  Verma,	  I.M.	  (1996).	  Suppression	  of	  




Vigevano,	  F.,	   Fusco,	   L.,	  Cusmai,	  R.,	  Claps,	  D.,	  Ricci,	   S.,	   and	  Milani,	   L.	   (1993).	  The	   idiopathic	  
form	  of	  West	  syndrome.	  Epilepsia	  34,	  743–746.	  
Vucurovic,	  K.,	  Gallopin,	  T.,	  Ferezou,	   I.,	  Rancillac,	  A.,	  Chameau,	  P.,	  van	  Hooft,	   J.A.,	  Geoffroy,	  
H.,	  Monyer,	  H.,	  Rossier,	  J.,	  and	  Vitalis,	  T.	  (2010).	  Serotonin	  3A	  receptor	  subtype	  as	  an	  early	  
and	  protracted	  marker	  of	   cortical	   interneuron	   subpopulations.	  Cereb.	  Cortex	  N.	   Y.	  N	  1991	  
20,	  2333–2347.	  
Walz,	   W.,	   and	   Hertz,	   L.	   (1982).	   Ouabain-­‐sensitive	   and	   ouabain-­‐resistant	   net	   uptake	   of	  
potassium	  into	  astrocytes	  and	  neurons	  in	  primary	  cultures.	  J.	  Neurochem.	  39,	  70–77.	  
Wilson,	   D.A.,	   and	   Rennaker,	   R.L.	   (2010).	   Cortical	   Activity	   Evoked	   by	   Odors.	   In	   The	  
Neurobiology	  of	  Olfaction,	  A.	  Menini,	  ed.	  (Boca	  Raton	  (FL):	  CRC	  Press/Taylor	  &	  Francis),.	  
Wonders,	   C.P.,	   and	   Anderson,	   S.A.	   (2006).	   The	   origin	   and	   specification	   of	   cortical	  
interneurons.	  Nat.	  Rev.	  Neurosci.	  7,	  687–696.	  
Xuan,	   S.,	   Baptista,	   C.A.,	   Balas,	   G.,	   Tao,	   W.,	   Soares,	   V.C.,	   and	   Lai,	   E.	   (1995).	   Winged	   helix	  
transcription	   factor	   BF-­‐1	   is	   essential	   for	   the	   development	   of	   the	   cerebral	   hemispheres.	  
Neuron	  14,	  1141–1152.	  
Yeung,	   A.,	   Bruno,	   D.,	   Scheffer,	   I.E.,	   Carranza,	   D.,	   Burgess,	   T.,	   Slater,	   H.R.,	   and	   Amor,	   D.J.	  
(2009).	  4.45	  Mb	  microduplication	  in	  chromosome	  band	  14q12	  including	  FOXG1	  in	  a	  girl	  with	  
refractory	  epilepsy	  and	  intellectual	  impairment.	  Eur.	  J.	  Med.	  Genet.	  52,	  440–442.	  
Yoshida,	  M.,	  Assimacopoulos,	  S.,	   Jones,	  K.R.,	  and	  Grove,	  E.A.	   (2006).	  Massive	   loss	  of	  Cajal-­‐
Retzius	  cells	  does	  not	  disrupt	  neocortical	  layer	  order.	  Dev.	  Camb.	  Engl.	  133,	  537–545.	  
Zupanc,	  M.L.	  (2003).	  Infantile	  spasms.	  Expert	  Opin.	  Pharmacother.	  4,	  2039–2048.	  
	  
	  
	  
	  
